Uniprot-Accession,S3-Protein,0,3,5,7,9,11,13,15,E-value,Protein,Gene,Length,GO-BP,GO-IDs,Pathway,UniPathway,CDD,Pfam,GO-names
P79099,CHOYP_AQP4.3.3|m.44128,0,0,0,0,0,0,0,0,2.00E-70,Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),AQP2,271,cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; ion transmembrane transport [GO:0034220]; metanephric collecting duct development [GO:0072205]; renal water transport [GO:0003097],GO:0003097; GO:0005794; GO:0005887; GO:0015168; GO:0015250; GO:0016323; GO:0016324; GO:0030659; GO:0034220; GO:0042631; GO:0055037; GO:0070062; GO:0071280; GO:0071288; GO:0072205,,,cd00333;,PF00230;,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome [GO:0055037]; glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; ion transmembrane transport [GO:0034220]; metanephric collecting duct development [GO:0072205]; renal water transport [GO:0003097]
Q96BY7,CHOYP_ATG2A.1.1|m.57169,0,0,0,0,0,0,0,0,0,Autophagy-related protein 2 homolog B,ATG2B C14orf103,2078,autophagosome assembly [GO:0000045]; mitophagy [GO:0000422]; nucleophagy [GO:0044804],GO:0000045; GO:0000407; GO:0000422; GO:0005811; GO:0019898; GO:0034045; GO:0044804,,,,PF13329;PF09333;PF12624;,extrinsic component of membrane [GO:0019898]; lipid particle [GO:0005811]; pre-autophagosomal structure [GO:0000407]; pre-autophagosomal structure membrane [GO:0034045]; autophagosome assembly [GO:0000045]; mitophagy [GO:0000422]; nucleophagy [GO:0044804]
Q920Q2,CHOYP_BRAFLDRAFT_213587.1.1|m.51383,0,0,0,0,0,0,0,0,4.00E-157,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Rev1 Rev1l,1249,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],GO:0003684; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,,,cd00027;,PF16589;PF14377;PF00817;PF11799;PF16727;,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; metal ion binding [GO:0046872]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]
Q9H3N1,CHOYP_BRAFLDRAFT_275793.1.1|m.9519,0,0,0,0,0,0,0,0,1.00E-61,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268,280,cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],GO:0003756; GO:0005789; GO:0006457; GO:0015036; GO:0016021; GO:0034976; GO:0045454,,,,PF00085;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]
O70352,CHOYP_CD82.2.3|m.17728,0,0,0,0,0,0,0,0,3.00E-36,CD82 antigen (Metastasis suppressor Kangai-1 homolog) (CD antigen CD82),Cd82 Kai1,266,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
P48058,CHOYP_GLRK.1.3|m.29909,0,0,0,0,0,0,0,0,1.00E-69,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",GRIA4 GLUR4,902,glutamate receptor signaling pathway [GO:0007215]; transport [GO:0006810],GO:0004970; GO:0004971; GO:0005231; GO:0005234; GO:0005886; GO:0006810; GO:0007215; GO:0030054; GO:0030425; GO:0030666; GO:0032281; GO:0045211; GO:1903561,,,,PF01094;PF00060;PF10613;,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular-glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; glutamate receptor signaling pathway [GO:0007215]; transport [GO:0006810]
Q96LI9,CHOYP_LOC100377974.1.1|m.6543,0.5,0,0,0,0,0,0,0,7.00E-75,Putative uncharacterized protein CXorf58,CXorf58,332,,,,,,,
B4KD90,CHOYP_LOC100533321.1.1|m.38814,0,0,0,0,0,0,0,0,0,Glutamate [NMDA] receptor subunit 1,Nmdar1 GI24494,980,behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; imaginal disc-derived wing morphogenesis [GO:0007476]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975],GO:0004970; GO:0004972; GO:0005234; GO:0007268; GO:0007476; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0030054; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375,,,,PF01094;PF10562;PF00060;PF10613;,cell junction [GO:0030054]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; extracellular-glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; imaginal disc-derived wing morphogenesis [GO:0007476]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]
Q54GB3,CHOYP_LOC100635245.3.4|m.44747,0,0,0,0,0,0,0,0,3.00E-11,Synaptobrevin-B,sybB DDB_G0290363,101,exocytosis [GO:0006887]; vesicle fusion [GO:0006906],GO:0000149; GO:0005484; GO:0006887; GO:0006906; GO:0016021; GO:0030658; GO:0031201,,,,PF00957;,integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; vesicle fusion [GO:0006906]
Q14642,CHOYP_LOC100743250.1.1|m.12309,0.5,0,0,0,0,0,0,0,2.00E-133,"Type I inositol 1,4,5-trisphosphate 5-phosphatase (5PTase) (EC 3.1.3.56)",INPP5A,412,inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0004445; GO:0005622; GO:0005886; GO:0016020; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:0070062,,,,,"extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856]"
Q9EQ28,CHOYP_LOC101156197.1.1|m.31571,0,0,0,0,0,0,0,0,3.00E-59,DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66),Pold3,462,"DNA replication [GO:0006260]; nucleotide-excision repair, DNA gap filling [GO:0006297]",GO:0005634; GO:0005737; GO:0006260; GO:0006297,,,,PF09507;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA replication [GO:0006260]; nucleotide-excision repair, DNA gap filling [GO:0006297]"
Q6NS15,CHOYP_MED15.1.3|m.19384,0,0,0,0,0,0,0,0,8.00E-83,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (xARC105) (Mediator complex subunit 15),med15 arc105,777,"transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0005737; GO:0006351; GO:0016592,,,,PF09606;,"cytoplasm [GO:0005737]; mediator complex [GO:0016592]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription, DNA-templated [GO:0006351]"
P20163,CHOYP_NEMVEDRAFT_V1G212312.5.5|m.58424,0,0,0,0,0,0,0,0,0.000000005,Heat shock 70 kDa protein D,hsp-4 hsp70d F43E2.8,657,embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum unfolded protein response [GO:0030968],GO:0001085; GO:0005524; GO:0005788; GO:0005791; GO:0009792; GO:0030968; GO:0034663,,,,PF00012;,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; RNA polymerase II transcription factor binding [GO:0001085]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum unfolded protein response [GO:0030968]
A2ASS6,CHOYP_PHUM_PHUM226120.1.7|m.673,0,0,0,0,0,0,0,0,2.00E-42,Titin (EC 2.7.11.1) (Connectin),Ttn,35213,actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
P29590,CHOYP_TRI45.13.23|m.35793,0,0,0,0,0,0,0,0,1.00E-14,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),PML MYL PP8675 RNF71 TRIM19,882,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]",GO:0000784; GO:0001666; GO:0001932; GO:0002230; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0006461; GO:0006605; GO:0006915; GO:0006919; GO:0006977; GO:0007050; GO:0007179; GO:0007182; GO:0007184; GO:0008270; GO:0008285; GO:0008630; GO:0008631; GO:0009411; GO:0010332; GO:0010522; GO:0010761; GO:0016032; GO:0016363; GO:0016525; GO:0016605; GO:0030099; GO:0030155; GO:0030308; GO:0030578; GO:0031065; GO:0031625; GO:0031901; GO:0031965; GO:0032183; GO:0032206; GO:0032211; GO:0032469; GO:0032922; GO:0032938; GO:0034097; GO:0042406; GO:0042752; GO:0042771; GO:0042803; GO:0043153; GO:0043161; GO:0045087; GO:0045165; GO:0045345; GO:0045892; GO:0045930; GO:0045944; GO:0046982; GO:0048146; GO:0048384; GO:0050713; GO:0050821; GO:0050897; GO:0051457; GO:0051607; GO:0051974; GO:0060058; GO:0060333; GO:0060444; GO:0070059; GO:0071353; GO:0090398; GO:0097191; GO:1901796; GO:1902187; GO:1904816; GO:2000059; GO:2000779; GO:2001238,,,,PF12126;PF00643;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]"
H2A0M3,CHOYP_AMO.1.5|m.28337,0,0,0,0,0,0,0,0,0,Putative amine oxidase [copper-containing] (EC 1.4.3.-),,781,amine metabolic process [GO:0009308],GO:0005507; GO:0005576; GO:0008131; GO:0009308; GO:0048038,,,,PF01179;,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]
Q6NZJ6,CHOYP_BRAFLDRAFT_277494.1.3|m.54113,0,0,0,0,0,0,0,0,6.00E-105,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1),Eif4g1,1600,behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0001662; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005844; GO:0005913; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0016020; GO:0016281; GO:0030307; GO:0030324; GO:0032270; GO:0033138; GO:0034645; GO:0045471; GO:0045666; GO:0098641; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696; GO:2000507,,,,PF02847;PF02854;PF02020;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]"
Q8VHS2,CHOYP_BRAFLDRAFT_64071.1.35|m.3422,0,0,0,0,0,0,0,0,0.000000003,Protein crumbs homolog 1,Crb1,1405,eye photoreceptor cell development [GO:0042462]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009],GO:0005509; GO:0005886; GO:0005902; GO:0007009; GO:0016021; GO:0042462; GO:0061024,,,,PF00008;PF12661;PF02210;,integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; eye photoreceptor cell development [GO:0042462]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]
O08893,CHOYP_CALCR.1.6|m.856,0.5,0,0,0,0,0,0,0,2.00E-74,Calcitonin receptor (CT-R),CALCR,478,cell surface receptor signaling pathway [GO:0007166],GO:0004948; GO:0005886; GO:0007166; GO:0016021,,,,PF00002;PF02793;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]
Q5HZB6,CHOYP_CLASR.1.2|m.27688,0.5,0,0,0,0,0,0,0,4.00E-102,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Clasrp Sfrs16,668,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0005634; GO:0006397; GO:0008380,,,,PF09750;,nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
Q61493,CHOYP_DPOLZ.1.1|m.49299,0,0,0,0,0,0,0,0,0,DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4),Rev3l Polz Sez4,3122,DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276],GO:0000166; GO:0003677; GO:0003887; GO:0005730; GO:0006260; GO:0006281; GO:0008408; GO:0016035; GO:0042276; GO:0046872; GO:0051539,,,,PF00136;PF03104;PF15735;PF14260;,"nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 3'-5' exonuclease activity [GO:0008408]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]"
Q24157,CHOYP_DPSE_GA18536.2.2|m.47561,0,0,0,0,0,0,0,0,7.00E-43,"Beta-1,3-galactosyltransferase brn (EC 2.4.1.62) (Brainiac protein) (Neurogenic secreted-signaling protein brn)",brn CG4934,325,border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell-cell adhesion [GO:0007299]; ovarian follicle cell development [GO:0030707]; protein glycosylation [GO:0006486],GO:0000139; GO:0001744; GO:0005576; GO:0005795; GO:0006486; GO:0006688; GO:0007219; GO:0007275; GO:0007293; GO:0007298; GO:0007299; GO:0008375; GO:0016021; GO:0016333; GO:0030707; GO:0042248; GO:0046981; GO:0047915; GO:0048477,,,,PF01762;,"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; oogenesis [GO:0048477]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; protein glycosylation [GO:0006486]"
Q6NZJ6,CHOYP_EIF4G1.1.2|m.33170,0,0,0,0,0,0,0,0,5.00E-164,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1),Eif4g1,1600,behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0001662; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005844; GO:0005913; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0016020; GO:0016281; GO:0030307; GO:0030324; GO:0032270; GO:0033138; GO:0034645; GO:0045471; GO:0045666; GO:0098641; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696; GO:2000507,,,,PF02847;PF02854;PF02020;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]"
Q05AM5,CHOYP_ELP2.1.1|m.18394,0,0,0,0,0,0,0,0,0,Elongator complex protein 2 (ELP2),elp2 si:dkey-190l1.1 zgc:153559,821,"proteasome assembly [GO:0043248]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]",GO:0000123; GO:0000502; GO:0005737; GO:0006355; GO:0006368; GO:0008023; GO:0033588; GO:0043248; GO:0061133,,,,PF00400;,"cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; histone acetyltransferase complex [GO:0000123]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]"
Q8SRR1,CHOYP_IRO.2.4|m.10201,0,0,0,0,0,0,0,0,1.00E-11,Homeobox protein HD-12 (EcHD-12),HD-12 ECU06_0740,193,"regulation of transcription, DNA-templated [GO:0006355]",GO:0003677; GO:0005634; GO:0006355,,,,PF05920;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"
Q9R0M3,CHOYP_LOC100367084.10.22|m.44502,0,0,0,0,0,0,0,0,7.00E-22,Sushi-repeat-containing protein SRPX (DRS protein),Srpx,464,autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976],GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0034976; GO:0060244; GO:2001241,,,cd00033;,PF13778;PF02494;PF00084;,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
Q9R0M3,CHOYP_LOC100367084.2.22|m.27296,0,0,0,0,0,0,0,0,7.00E-26,Sushi-repeat-containing protein SRPX (DRS protein),Srpx,464,autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976],GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0034976; GO:0060244; GO:2001241,,,cd00033;,PF13778;PF02494;PF00084;,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
C3YWU0,CHOYP_LOC100367436.1.1|m.20579,1,0,0,0,0,0,0,0,0,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),BRAFLDRAFT_56888,449,fucose metabolic process [GO:0006004],GO:0004560; GO:0005576; GO:0006004,,,,PF01120;PF16757;,extracellular region [GO:0005576]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]
A0JNG4,CHOYP_LOC100374974.12.16|m.47308,0,0,0,0,0,0,0,0,0.000000007,RING finger protein 207,RNF207,556,,GO:0005737; GO:0008270,,,,PF00643;PF00097;,cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
Q86V88,CHOYP_LOC100877618.1.1|m.39871,0.5,0,0,0,0,0,0,0,4.00E-48,Magnesium-dependent phosphatase 1 (MDP-1) (EC 3.1.3.-) (EC 3.1.3.48),MDP1,176,,GO:0004725; GO:0046872; GO:0070062,,,,PF12689;,extracellular exosome [GO:0070062]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]
Q8R151,CHOYP_LOC100891217.1.1|m.63544,0,0,0,0,0,0,0,0,7.00E-43,NFX1-type zinc finger-containing protein 1,Znfx1,1909,,GO:0003700; GO:0003723; GO:0005634; GO:0008270,,,,,"nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]"
Q62656,CHOYP_LOC578045.4.5|m.61073,0,0,0,0,0,0,0,0,2.00E-70,Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (3F8 chondroitin sulfate proteoglycan) (3H1 keratan sulfate proteoglycan) (Phosphacan),Ptprz1 Ptprz Ptpz,2316,axonal fasciculation [GO:0007413]; brain development [GO:0007420]; hippocampus development [GO:0021766]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; neuron development [GO:0048666]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; visual learning [GO:0008542],GO:0004725; GO:0005615; GO:0005737; GO:0006470; GO:0007413; GO:0007420; GO:0007611; GO:0008285; GO:0008542; GO:0010812; GO:0010976; GO:0016020; GO:0016021; GO:0016791; GO:0017134; GO:0021766; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031226; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0045211; GO:0048146; GO:0048666; GO:0048709; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224,,,cd00063;,PF00194;PF00041;PF00102;,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; fibroblast growth factor binding [GO:0017134]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; hippocampus development [GO:0021766]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; neuron development [GO:0048666]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; visual learning [GO:0008542]
Q7T006,CHOYP_LOC588739.1.1|m.19304,0,0,0,0,0,0,0,0,0,Telomere length regulation protein TEL2 homolog,telo2 si:ch211-153c20.2 zgc:153824,822,,GO:0005634; GO:0005737; GO:0016020,,,,PF10193;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]
C3YWU0,CHOYP_LOC660225.1.1|m.35196,0,0,0,0,0,0,0,0,2.00E-159,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),BRAFLDRAFT_56888,449,fucose metabolic process [GO:0006004],GO:0004560; GO:0005576; GO:0006004,,,,PF01120;PF16757;,extracellular region [GO:0005576]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]
Q3J754,CHOYP_PISD.2.2|m.30086,0,0,0,0,0,0,0,0,2.00E-31,Phosphatidylserine decarboxylase proenzyme (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase alpha chain; Phosphatidylserine decarboxylase beta chain],psd Noc_2896,306,phosphatidylethanolamine biosynthetic process [GO:0006646],GO:0004609; GO:0005886; GO:0006646,PATHWAY: Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from CDP-diacylglycerol: step 2/2. {ECO:0000255|HAMAP-Rule:MF_00662}.,,,PF02666;,plasma membrane [GO:0005886]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]
Q9V6K3,CHOYP_PLMN.11.11|m.51036,0,0,0,0,0,0,0,0,1.00E-16,Tyrosine-protein kinase transmembrane receptor Ror2 (dRor2) (EC 2.7.10.1) (Neurospecific receptor tyrosine kinase),Nrk ROR2 CG4007,724,muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007165; GO:0007169; GO:0016021; GO:0042052; GO:0046716; GO:0072499,,,,PF01392;PF00051;PF07714;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; muscle cell cellular homeostasis [GO:0046716]; photoreceptor cell axon guidance [GO:0072499]; protein phosphorylation [GO:0006468]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
P35992,CHOYP_PTPRB.4.4|m.66782,0,0,0,0,0,0,0,0,2.00E-88,Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D),Ptp10D CG1817,1990,axon guidance [GO:0007411]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0045177,,,cd00063;,PF00041;PF00102;,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
Q32LP4,CHOYP_S4A10.2.4|m.24326,0,0,0,0,0,0,0,0,0,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),SLC4A10,1117,anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814],GO:0005452; GO:0005887; GO:0006814; GO:0007399; GO:0008509; GO:0015293; GO:0015297; GO:0015701; GO:0051453; GO:0098656,,,,PF07565;PF00955;,integral component of plasma membrane [GO:0005887]; anion transmembrane transporter activity [GO:0008509]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]
P42687,CHOYP_SRC1.1.1|m.63625,0,0,0,0,0,0,0,0,3.00E-114,Tyrosine-protein kinase SPK-1 (EC 2.7.10.2),,497,,GO:0004715; GO:0005524,,,,PF07714;PF00017;PF00018;,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
P78524,CHOYP_ST5.1.1|m.54184,0,0,0,0,0,0,0,0,2.00E-88,Suppression of tumorigenicity 5 protein (DENN domain-containing protein 2B) (HeLa tumor suppression 1),ST5 DENND2B HTS1,1137,positive regulation of ERK1 and ERK2 cascade [GO:0070374],GO:0017112; GO:0070374,,,,PF03455;PF02141;PF03456;,Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
P82596,CHOYP_AJL2.1.1|m.26431,0,0,0,0,0,0,0,0,3.00E-21,Perlucin,,155,,GO:0030246,,,,PF00059;,carbohydrate binding [GO:0030246]
Q7ZTY7,CHOYP_BRAFLDRAFT_125999.1.1|m.24819,0,0,0,0,0,0,0,0,4.00E-49,Vesicle transport protein USE1 (USE1-like protein),use1 use1l zgc:56402,258,protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],GO:0005789; GO:0015031; GO:0016021; GO:0016192,,,,PF09753;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
Q503Y4,CHOYP_BRAFLDRAFT_126058.1.1|m.1201,0.5,0,0,0,0,0,0,0,2.00E-72,Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog),ovca2 zgc:110011,227,,GO:0016787,,,,PF03959;,hydrolase activity [GO:0016787]
Q61549,CHOYP_BRAFLDRAFT_98740.5.7|m.58200,0,0,0,0,0,0,0,0,7.00E-43,Adhesion G protein-coupled receptor E1 (Cell surface glycoprotein F4/80) (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),Adgre1 Emr1 Gpf480,931,adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166],GO:0002250; GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0071944,,,,PF00002;PF12662;PF07645;PF01825;,cell periphery [GO:0071944]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]
Q710D6,CHOYP_COX5B.1.3|m.20245,0,0,0,0,0,0,0,0,4.00E-13,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb) (Sperm protein 8) (fSP8)",COX5B SP8,128,,GO:0004129; GO:0005743; GO:0046872,,,cd00924;,PF01215;,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]
Q96MK2,CHOYP_FA65A.1.1|m.24019,0,0,0,0,0,0,0,0,9.00E-73,Protein FAM65C,FAM65C C20orf175,946,,,,,,PF15903;,
Q99MK9,CHOYP_ISCW_ISCW007158.2.2|m.53689,0.5,0,0,0,0,0,0,0,5.00E-54,Ras association domain-containing protein 1 (Protein 123F2),Rassf1,340,cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],GO:0000922; GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0006974; GO:0007050; GO:0007265; GO:0015630; GO:0031398; GO:0042802; GO:0046872; GO:0047485; GO:0050821; GO:0070507; GO:0071157,,,cd00029;,PF00130;PF16517;PF00788;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507]
Q9UBX3,CHOYP_K11G12.5.1.1|m.55605,0,0,0,0,0,0,0,0,4.00E-128,Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10),SLC25A10 DIC,287,"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0070221; GO:0071422; GO:0071423; GO:1901677,,,,PF00153;,"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate transmembrane transporter activity [GO:1901677]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]"
Q9U489,CHOYP_LOC100374741.83.83|m.66460,0,0,0,0,0,0,0,0,0.000000003,Protein lin-41 (Abnormal cell lineage protein 41),lin-41 C12C8.3,1147,"epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; multicellular organismal protein metabolic process [GO:0044268]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of gene expression [GO:0010628]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]",GO:0004842; GO:0005737; GO:0007276; GO:0008270; GO:0009957; GO:0010628; GO:0040034; GO:0042787; GO:0044268; GO:0045138; GO:0045604; GO:1990124,,,,PF00630;PF01436;,"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; epidermal cell fate specification [GO:0009957]; gamete generation [GO:0007276]; multicellular organismal protein metabolic process [GO:0044268]; nematode male tail tip morphogenesis [GO:0045138]; positive regulation of gene expression [GO:0010628]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of development, heterochronic [GO:0040034]; regulation of epidermal cell differentiation [GO:0045604]"
Q6NXH2,CHOYP_LOC100718937.1.1|m.13522,0,0,0,0,0,0,0,0,5.00E-153,"Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (mEndo) (EC 3.2.1.130)",Manea,462,,GO:0000139; GO:0004569; GO:0005794; GO:0016021,,,cd11574;,PF16317;,"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]"
Q96MB7,CHOYP_LOC101171725.3.3|m.62457,0,0,0,0,0,0,0,0,2.00E-61,Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease),HARBI1 C11orf77,349,,GO:0004518; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0046872,,,,PF13359;,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
Q9NYQ7,CHOYP_MEGF6.53.59|m.55485,0,0,0,0,0,0,0,0,0.0000002,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),CELSR3 CDHF11 EGFL1 FMI1 KIAA0812 MEGF2,3312,"axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:1904938,,,,PF00002;PF00028;PF00008;PF16489;PF01825;PF00053;PF02210;,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
P16620,CHOYP_PTPRK.10.20|m.31769,0,0,0,0,0,0,0,0,3.00E-56,Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP),Ptp69D DPTP CG10975,1462,axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470],GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0046331; GO:0048813; GO:0097155,,,cd00063;,PF00041;PF00102;,axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]
Q8BYK8,CHOYP_ZC3H4.1.1|m.57516,0.5,0,0,0,0,0,0,0,3.00E-32,Zinc finger CCCH domain-containing protein 6,Zc3h6 Zc3hdc6,1177,,GO:0046872,,,,PF00642;,metal ion binding [GO:0046872]
Q9C0A0,CHOYP_AXO.1.1|m.44228,0,0,0,0,0,0,0,0,4.00E-63,Contactin-associated protein-like 4 (Cell recognition molecule Caspr4),CNTNAP4 CASPR4 KIAA1763,1308,"cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]",GO:0007155; GO:0016021; GO:0030054; GO:0030425; GO:0032225; GO:0032228; GO:0042734; GO:2000821,,,,PF00754;PF02210;,"cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]"
Q9NQG7,CHOYP_BRAFLDRAFT_84245.2.2|m.53621,0,0,0,0,0,0,0,0,5.00E-21,Hermansky-Pudlak syndrome 4 protein (Light-ear protein homolog),HPS4 KIAA1667,708,blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; membrane organization [GO:0061024]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],GO:0005085; GO:0005737; GO:0005764; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0017137; GO:0030318; GO:0031085; GO:0042470; GO:0042803; GO:0042827; GO:0046983; GO:0048075; GO:0050821; GO:0061024; GO:1903232; GO:1903955,,,,,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; membrane organization [GO:0061024]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]
P27393,CHOYP_CO9A1.1.1|m.62338,0,0,0,0,0,0,0,0,6.00E-64,Collagen alpha-2(IV) chain,,1763,,GO:0005201; GO:0005581; GO:0005604,,,,PF01413;PF01391;,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]
P07291,CHOYP_HNRPR.1.2|m.44126,0,0,0,0,0,0,0,0,8.00E-62,"Myosin essential light chain, striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC)",,157,,GO:0005509; GO:0016459,,,cd00051;,PF13499;,myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
P86221,CHOYP_LOC100366486.1.1|m.15010,1.5,0,0,0,0,0,0,0,4.00E-104,Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments),TUBB4B TUBB2C,290,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q92113,CHOYP_LOC100367956.2.2|m.62044,0,0,0,0,0,0,0,0,1.00E-62,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)",CYP17A1 CYP17,509,sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0016020; GO:0020037; GO:0047442,PATHWAY: Lipid metabolism; steroid biosynthesis.,,,PF00067;,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
Q5XJ13,CHOYP_LOC100371435.1.1|m.6503,1,0,0,0,0,0,0,0,3.00E-11,Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),anks6 samd6 zgc:85964,739,pronephros development [GO:0048793],GO:0005929; GO:0048793,,,,PF12796;PF00536;,cilium [GO:0005929]; pronephros development [GO:0048793]
Q09654,CHOYP_LOC100374741.13.83|m.17527,0,0,0,0,0,0,0,0,0.0000003,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
Q80Y83,CHOYP_LOC100377347.1.1|m.11235,0.5,0,0,0,0,0,0,0,1.00E-112,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Dixdc1 Ccd1 Kiaa1735,711,canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; cell proliferation in forebrain [GO:0021846]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],GO:0005829; GO:0005925; GO:0007049; GO:0019904; GO:0021795; GO:0021799; GO:0021846; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0090263,,,cd00014;,PF00307;PF00778;,cytosol [GO:0005829]; focal adhesion [GO:0005925]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; cell proliferation in forebrain [GO:0021846]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]
P30170,CHOYP_LOC100533357.1.2|m.56849,0,0,0,0,0,0,0,0,2.00E-78,Actin-85C (Fragment),AC85C,195,,GO:0005524; GO:0005737; GO:0005856,,,,PF00022;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
E9QBI7,CHOYP_LOC594646.2.2|m.38865,0,0,0,0,0,0,0,0,1.00E-80,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)",oma1 si:ch73-215a11.1,478,diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; response to stress [GO:0006950],GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0006950; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0046872; GO:0097009,,,,PF01435;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; response to stress [GO:0006950]
Q8IYS1,CHOYP_P20D2.2.2|m.47191,0.5,0,0,0,0,0,0,0,1.00E-137,Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2),PM20D2 ACY1L2,436,proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],GO:0005654; GO:0006508; GO:0016805; GO:0032268; GO:0070062,,,,PF07687;PF01546;,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
Q8IY92,CHOYP_SLX4.1.1|m.278,0,0,0,0,0,0,0,0,1.00E-33,Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12),SLX4 BTBD12 KIAA1784 KIAA1987,1834,DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0004520; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0010792; GO:0017108; GO:0030054; GO:0033557; GO:0036297; GO:0061820; GO:0072429; GO:0090656; GO:1904357; GO:1904431,,,,PF00651;PF09494;,"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; endodeoxyribonuclease activity [GO:0004520]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]"
Q09654,CHOYP_TIF1A.5.8|m.32570,1,0,0,0,0,0,0,0,0.000002,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
Q6IP57,CHOYP_UBD2A.1.1|m.63050,0.5,0,0,0,0,0,0,0,2.00E-28,UBA-like domain-containing protein 2-A,ubald2-a fam100b-a,166,,,,,,,
Q9VR59,CHOYP_VIP2.1.1|m.54883,1.5,0,0,0,0,0,0,0,0,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase),l(1)G0196 CG14616,1696,inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724,,,cd07061;,PF00328;,"cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"
Q92636,CHOYP_BRAFLDRAFT_100614.1.1|m.31700,0,0,0,0,0,0,0,0,0,Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation),NSMAF FAN,917,ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165],GO:0005057; GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065; GO:2000304,,,cd06071;,PF02138;PF02893;PF00400;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; signal transducer activity, downstream of receptor [GO:0005057]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165]"
Q39565,CHOYP_BRAFLDRAFT_108792.3.5|m.34514,16.5,0,0,0,0,0,0,0,7.00E-155,"Dynein beta chain, flagellar outer arm",ODA4 ODA-4 SUP1,4568,cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0016887; GO:0030030; GO:0030286; GO:0031514,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]
Q9BRS2,CHOYP_BRAFLDRAFT_124526.1.1|m.25228,0.5,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1),RIOK1,568,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006364; GO:0016787; GO:0030490; GO:0030688; GO:0042274; GO:0046872; GO:2000234,,,,,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"
Q7TQE6,CHOYP_BRAFLDRAFT_89952.1.1|m.59629,0,0,0,0,0,0,0,0,0,Macoilin (Brain-specific adapter protein C61) (Transmembrane protein 57),Tmem57,664,brain development [GO:0007420],GO:0005634; GO:0007420; GO:0016021; GO:0030424; GO:0031965; GO:0043005; GO:0044306; GO:0045202,,,,PF09726;,axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; synapse [GO:0045202]; brain development [GO:0007420]
G5ED84,CHOYP_DGRI_GH14766.1.1|m.27098,0,0,0,0,0,0,0,0,4.00E-11,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
G5ED84,CHOYP_LOC100123307.1.1|m.13647,0,0,0,0,0,0,0,0,0.000002,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
Q9UPT6,CHOYP_LOC100374908.1.1|m.51418,0,0,0,0,0,0,0,0,3.00E-70,C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3),MAPK8IP3 JIP3 KIAA1066,1336,activation of JUN kinase activity [GO:0007257]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; positive regulation of neuron differentiation [GO:0045666]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange [GO:0007585]; vesicle-mediated transport [GO:0016192],GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0007257; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030425; GO:0030673; GO:0030900; GO:0045666; GO:0046328; GO:0048286; GO:0060425,,,,PF16471;PF09744;,axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; smooth endoplasmic reticulum [GO:0005790]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; positive regulation of neuron differentiation [GO:0045666]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange [GO:0007585]; vesicle-mediated transport [GO:0016192]
O02228,CHOYP_LOC100375425.1.1|m.7316,0,0,0,0,0,0,0,0,1.00E-61,High-affinity choline transporter 1,cho-1 C48D1.3,576,acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871],GO:0005307; GO:0005887; GO:0008021; GO:0008292; GO:0015220; GO:0015871; GO:0030424; GO:0033265; GO:0043005; GO:0043025; GO:0045202,,,,PF00474;,axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]
Q8WXW3,CHOYP_LOC100377791.1.1|m.4144,0,0,0,0,0,0,0,0,0,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),PIBF1 C13orf24 PIBF,757,activation of JAK1 kinase activity [GO:0010531]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of Stat4 protein [GO:0042521]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of Stat6 protein [GO:0042526]; protein localization to centrosome [GO:0071539],GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0007080; GO:0010531; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042521; GO:0042526; GO:0071539; GO:0090307; GO:1905515,,,,,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of JAK1 kinase activity [GO:0010531]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of Stat4 protein [GO:0042521]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of Stat6 protein [GO:0042526]; protein localization to centrosome [GO:0071539]
Q8IX29,CHOYP_LOC100486001.1.1|m.6209,1,0,0,0,0,0,0,0,2.00E-68,F-box only protein 16,FBXO16 FBX16,292,,,,,,PF12937;,
A0A0R4IBK5,CHOYP_LOC100537840.1.1|m.55651,0,0,0,0,0,0,0,0,6.00E-11,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
G5ED84,CHOYP_LOC100698240.2.4|m.14964,0,0,0,0,0,0,0,0,4.00E-11,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
Q99M80,CHOYP_LOC101384981.1.1|m.53468,0,0,0,0,0,0,0,0,8.00E-65,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q99572,CHOYP_LOC585718.2.2|m.40232,0,0,0,0,0,0,0,0,7.00E-17,P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor),P2RX7,595,activation of MAPK activity [GO:0000187]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane budding [GO:0006900]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; multicellular organismal protein catabolic process [GO:0044254]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid scrambling [GO:0017121]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytolysis [GO:0045919]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of other organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098],GO:0000187; GO:0000902; GO:0001530; GO:0001614; GO:0001845; GO:0001916; GO:0002028; GO:0004931; GO:0005102; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0006509; GO:0006649; GO:0006900; GO:0006954; GO:0007005; GO:0007166; GO:0007596; GO:0009612; GO:0009897; GO:0010043; GO:0010524; GO:0010628; GO:0014049; GO:0014054; GO:0016020; GO:0016079; GO:0016485; GO:0017121; GO:0019233; GO:0019835; GO:0030501; GO:0031594; GO:0031668; GO:0032059; GO:0032060; GO:0032308; GO:0032496; GO:0032755; GO:0032963; GO:0033198; GO:0034405; GO:0034767; GO:0035590; GO:0042098; GO:0042493; GO:0042803; GO:0043025; GO:0043029; GO:0043132; GO:0043409; GO:0044254; GO:0045332; GO:0045779; GO:0045794; GO:0045821; GO:0045919; GO:0046513; GO:0046931; GO:0048705; GO:0048873; GO:0050717; GO:0050718; GO:0050830; GO:0051209; GO:0051259; GO:0051495; GO:0051592; GO:0051602; GO:0051709; GO:0051899; GO:0051901; GO:0070230; GO:0071359; GO:0072593; GO:0097190; GO:0097191; GO:0098793; GO:0098794; GO:1904172,,,,PF00864;,bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; extracellular ATP-gated cation channel activity [GO:0004931]; lipopolysaccharide binding [GO:0001530]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; receptor binding [GO:0005102]; activation of MAPK activity [GO:0000187]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane budding [GO:0006900]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; multicellular organismal protein catabolic process [GO:0044254]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid scrambling [GO:0017121]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytolysis [GO:0045919]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of other organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]
Q8BZH4,CHOYP_PAR15.5.6|m.60634,0,0,0,0,0,0,0,0,6.00E-32,Pogo transposable element with ZNF domain,Pogz Kiaa0461,1409,cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064],GO:0000790; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0046872; GO:0051301; GO:0051382,,,,PF03184;PF03221;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]
A0A0R4IBK5,CHOYP_RNF213.1.4|m.3458,0.5,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
Q5RE11,CHOYP_TSN3.1.1|m.57074,0,0,0,0,0,0,0,0,7.00E-46,Tetraspanin-3 (Tspan-3),TSPAN3,253,,GO:0016021; GO:0070062,,,,PF00335;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]
Q8NFA0,CHOYP_UBP32.1.1|m.56373,0,0,0,0,0,0,0,0,0,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),USP32 USP10,1604,protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579,,,cd00051;,PF06337;PF13202;PF14836;PF00443;,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
P06605,CHOYP_AAEL_AAEL013229.1.2|m.30359,4.5,0,0,0,0,0,0,0,1.00E-80,Tubulin alpha-3 chain,alphaTub84D TubA84D CG2512,450,microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281],GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005811; GO:0005874; GO:0007017; GO:0017022; GO:0048471,,,,PF00091;PF03953;,lipid particle [GO:0005811]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281]
Q9DGG6,CHOYP_APLD.1.1|m.9873,0,0,0,0,0,0,0,0,0,Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9),ADCY9,1334,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],GO:0004016; GO:0004383; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0006182; GO:0007165; GO:0007189; GO:0008074; GO:0016021; GO:0035556; GO:0046872; GO:0071880,,,,PF00211;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]"
Q9CQY2,CHOYP_BRAFLDRAFT_221294.2.2|m.52722,2,0,0,0,0,0,0,0,0.000000006,RNMT-activating mini protein (RAM) (Protein FAM103A1),Fam103a1,119,7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031],GO:0003723; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0032259; GO:0036031,,,,PF15320;,mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031]
Q5ZI03,CHOYP_CIR1.1.2|m.16125,0,0,0,0,0,0,0,0,1.00E-87,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor),CIR1 CIR RCJMB04_31l21,460,"mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]",GO:0000118; GO:0006351; GO:0006397; GO:0008380; GO:0016607; GO:0045892,,,,PF10197;,"histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"
Q6ZRF8,CHOYP_EME1.1.1|m.33089,0,0,0,0,0,0,0,0,0.0000002,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P86788,CHOYP_GIGA5.3.4|m.17227,0,0,0,0,0,0,0,0,4.00E-41,Gigasin-5 (Fragment),,113,,,,,,,
P70365,CHOYP_ISCW_ISCW017872.2.2|m.60293,0,0,0,0,0,0,0,0,5.00E-74,Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Nuclear receptor coactivator protein 1) (mNRC-1) (Steroid receptor coactivator 1) (SRC-1),Ncoa1 Src1,1447,"cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription, DNA-templated [GO:0006351]",GO:0000435; GO:0000790; GO:0001012; GO:0002155; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006351; GO:0007595; GO:0008134; GO:0008584; GO:0016922; GO:0019899; GO:0021549; GO:0021766; GO:0021854; GO:0021987; GO:0030331; GO:0030374; GO:0032355; GO:0032526; GO:0032570; GO:0032870; GO:0035257; GO:0043005; GO:0043065; GO:0043967; GO:0044849; GO:0045666; GO:0045893; GO:0045925; GO:0045944; GO:0047485; GO:0060179; GO:0060713; GO:1904017; GO:2001038; GO:2001141,,,cd00130;,PF07469;PF00010;PF08815;PF00989;PF08832;,"cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; ligand-dependent nuclear receptor binding [GO:0016922]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; nuclear hormone receptor binding [GO:0035257]; protein N-terminus binding [GO:0047485]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription, DNA-templated [GO:0006351]"
Q8K4Q8,CHOYP_LECG.3.4|m.29627,0,0,0,0,0,0,0,0,2.00E-16,Collectin-12 (Collectin placenta protein 1) (CL-P1) (Scavenger receptor with C-type lectin),Colec12 Clp1 Srcl,742,"cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]",GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0070062; GO:0071360,,,cd03590;,PF01391;PF00059;,"collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
Q5RAY1,CHOYP_LOC100121969.1.1|m.52130,0,0,0,0,0,0,0,0,0,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),PIK3C2A,1685,endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015],GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0006887; GO:0006897; GO:0030136; GO:0031982; GO:0035005; GO:0035091; GO:0048015,,,,PF00168;PF00454;PF00792;PF00794;PF00613;PF00787;,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015]
Q9NQZ5,CHOYP_LOC100374471.1.1|m.55948,0,0,0,0,0,0,0,0,4.00E-65,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",STARD7 GTT1,370,phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of protein targeting to mitochondrion [GO:1903955],GO:0005741; GO:0006656; GO:0008289; GO:1903955,,,,PF01852;,mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of protein targeting to mitochondrion [GO:1903955]
P42674,CHOYP_LOC100377541.2.4|m.15307,0,0,0,0,0,0,0,0,4.00E-65,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
P42205,CHOYP_LOC100378615.1.2|m.25321,0,0,0,0,0,0,0,0,0.000000005,Probable glucarate transporter (D-glucarate permease),gudP,456,transmembrane transport [GO:0055085],GO:0005215; GO:0005886; GO:0016021; GO:0055085,,,cd06174;,PF07690;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; transmembrane transport [GO:0055085]
Q55CD9,CHOYP_LOC100634472.2.3|m.17596,0,0,0,0,0,0,0,0,9.00E-105,Probable NADH dehydrogenase (EC 1.6.-.-),DDB_G0270104,451,,GO:0016491,,,,PF07992;,oxidoreductase activity [GO:0016491]
A9ULC7,CHOYP_LOC100888334.1.1|m.40374,0,0,0,0,0,0,0,0,7.00E-24,Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha),slc51a osta,339,bile acid and bile salt transport [GO:0015721]; transport [GO:0006810],GO:0005215; GO:0005789; GO:0005886; GO:0006810; GO:0015721; GO:0016021; GO:0042803; GO:0043234; GO:0046982,,,,PF03619;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; transport [GO:0006810]
Q47944,CHOYP_LOC100903758.1.1|m.43697,0,0,0,0,0,0,0,0,3.00E-97,L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32),,531,,GO:0016614; GO:0050660,,,,PF05199;PF00732;,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
P83425,CHOYP_LOC101159074.1.1|m.29872,0,0,0,0,0,0,0,0,0.00000002,Heavy metal-binding protein HIP,,213,,GO:0005576; GO:0046872,,,,PF00386;,extracellular region [GO:0005576]; metal ion binding [GO:0046872]
Q9ESN4,CHOYP_LOC794295.1.1|m.42748,0,0,0,0,0,0,0,0,0.000000007,Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13) (CTRP13) (Gliacolin),C1ql3 C1ql Ctrp13,255,regulation of synapse organization [GO:0050807],GO:0005576; GO:0005581; GO:0050807,,,,PF00386;PF01391;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; regulation of synapse organization [GO:0050807]
Q6ZQ89,CHOYP_MARH6.1.1|m.11430,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase MARCH6 (EC 2.3.2.27) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (RING-type E3 ubiquitin transferase MARCH6),March6 Kiaa0597,909,ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; proteasomal protein catabolic process [GO:0010498]; protein K48-linked ubiquitination [GO:0070936],GO:0004842; GO:0005783; GO:0008270; GO:0010498; GO:0016020; GO:0016021; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0070936; GO:1904264; GO:1990381,PATHWAY: Protein modification; protein ubiquitination.,,,PF12906;,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; proteasomal protein catabolic process [GO:0010498]; protein K48-linked ubiquitination [GO:0070936]
Q8QFV0,CHOYP_PHUM_PHUM562900.1.1|m.43674,0,0,0,0,0,0,0,0,0,Potassium channel subfamily T member 1 (Sequence like a calcium-activated potassium channel subunit),KCNT1 SLACK,1201,,GO:0005249; GO:0008076; GO:0015269,,,,PF03493;PF07885;,voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; voltage-gated potassium channel activity [GO:0005249]
P42674,CHOYP_PLMN.4.11|m.29150,0.5,0,0,0,0,0,0,0,2.00E-41,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
Q58DZ9,CHOYP_PRRT1.2.5|m.28553,0,0,0,0,0,0,0,0,0.00000002,Synapse differentiation-inducing gene protein 1 (SynDIG1) (Dispanin subfamily C member 2) (DSPC2) (Transmembrane protein 90B),Syndig1 Tmem90b,258,intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; response to biotic stimulus [GO:0009607]; synaptic vesicle clustering [GO:0097091],GO:0005887; GO:0006886; GO:0009607; GO:0014069; GO:0030054; GO:0031901; GO:0035254; GO:0042803; GO:0043197; GO:0043198; GO:0043231; GO:0044297; GO:0045211; GO:0051965; GO:0060076; GO:0097091; GO:0098793,,,,PF04505;,cell body [GO:0044297]; cell junction [GO:0030054]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; glutamate receptor binding [GO:0035254]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; response to biotic stimulus [GO:0009607]; synaptic vesicle clustering [GO:0097091]
Q96M20,CHOYP_SMP_147320.1.1|m.27463,0,0,0,0,0,0,0,0,1.00E-11,Cyclic nucleotide-binding domain-containing protein 2,CNBD2 C20orf152,576,spermatogenesis [GO:0007283],GO:0005829; GO:0007283; GO:0030552,,,,PF00027;,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
Q6ZRF8,CHOYP_TR12A.1.2|m.32633,0,0,0,0,0,0,0,0,0.00000007,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
Q6ZRF8,CHOYP_TVAG_127540.1.10|m.21803,0,0,0,0,0,0,0,0,0.00000003,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
Q6R7F6,CHOYP_Y071.1.1|m.29248,0,0,0,0,0,0,0,0,9.00E-134,Uncharacterized protein ORF72,ORF72,188,,GO:0016021; GO:0033644,,,,,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]
P70193,CHOYP_BRAFLDRAFT_95739.1.2|m.53575,0,0,0,0,0,0,0,0,5.00E-19,Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1),Lrig1,1091,hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605],GO:0005886; GO:0007605; GO:0016021; GO:0022405; GO:0032474; GO:0060384,,,,PF07679;PF13855;PF01463;PF01462;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]
Q9P2E3,CHOYP_CED1.8.29|m.29029,0,0,0,0,0,0,0,0,0.0000002,NFX1-type zinc finger-containing protein 1,ZNFX1 KIAA1404,1918,,GO:0003700; GO:0003723; GO:0005634; GO:0008270,,,,,"nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]"
Q6TH47,CHOYP_FA13A.1.2|m.297,0,0,0,0,0,0,0,0,1.00E-73,STAM-binding protein-like A (EC 3.4.19.-),stambpa amsh stambp,418,,GO:0008237; GO:0046872,,,,PF01398;PF08969;,metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
Q9NRD1,CHOYP_FBX6.1.1|m.62308,0,0,0,0,0,0,0,0,9.00E-58,F-box only protein 6 (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2),FBXO6 FBG2 FBS2 FBX6,293,DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0000077; GO:0000209; GO:0001948; GO:0004842; GO:0005737; GO:0005829; GO:0006281; GO:0006508; GO:0006516; GO:0006986; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0044322; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF12937;PF04300;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum quality control compartment [GO:0044322]; SCF ubiquitin ligase complex [GO:0019005]; carbohydrate binding [GO:0030246]; glycoprotein binding [GO:0001948]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
P35220,CHOYP_LOC100368833.1.1|m.52947,0,0,0,0,0,0,0,0,1.00E-40,Catenin alpha,alpha-Cat CG17947,917,adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelium development [GO:0060429]; establishment or maintenance of cell polarity [GO:0007163]; germarium-derived egg chamber formation [GO:0007293]; head morphogenesis [GO:0060323],GO:0003779; GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0005914; GO:0005915; GO:0007016; GO:0007155; GO:0007163; GO:0007293; GO:0008092; GO:0015629; GO:0016342; GO:0034332; GO:0060323; GO:0060429,,,,PF01044;,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; spot adherens junction [GO:0005914]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; structural molecule activity [GO:0005198]; adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelium development [GO:0060429]; establishment or maintenance of cell polarity [GO:0007163]; germarium-derived egg chamber formation [GO:0007293]; head morphogenesis [GO:0060323]
Q6NXP6,CHOYP_LOC100375012.1.1|m.11931,1,0,0,0,0,0,0,0,2.00E-56,NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148),NOXRED1 C14orf148,359,proline biosynthetic process [GO:0006561],GO:0004735; GO:0006561,,,,PF03807;,pyrroline-5-carboxylate reductase activity [GO:0004735]; proline biosynthetic process [GO:0006561]
P48545,CHOYP_LOC100749745.1.1|m.11523,0,0,0,0,0,0,0,0,4.00E-83,"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)",Kcnj5 Girk4,419,membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import [GO:0010107]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091],GO:0005242; GO:0005887; GO:0008076; GO:0009897; GO:0010107; GO:0015467; GO:0030315; GO:0086089; GO:0086091; GO:0098914; GO:1990573,,,,PF01007;,external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import [GO:0010107]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]
Q9NRF2,CHOYP_LOC552012.1.1|m.65224,0.5,0,0,0,0,0,0,0,1.00E-74,"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)",SH2B1 KIAA1299 SH2B,756,blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],GO:0004871; GO:0005634; GO:0005829; GO:0007596; GO:0016020; GO:0030032; GO:0035556; GO:0035591; GO:0045840; GO:2000278,,,,PF00169;PF08916;PF00017;,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; signal transducer activity [GO:0004871]; signaling adaptor activity [GO:0035591]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278]
Q9U3P2,CHOYP_PHUM_PHUM068980.4.5|m.56739,0.5,0,0,0,0,0,0,0,0.0000001,Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2),syg-2 C26G2.1,1270,cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039],GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839,,,cd00063;,PF08205;PF00041;PF07679;,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]
Q803M3,CHOYP_TEX10.2.3|m.28279,0,0,0,0,0,0,0,0,3.00E-67,Testis-expressed protein 10 homolog,tex10 zgc:55523,933,,GO:0005730; GO:0016021; GO:0031965; GO:0071339; GO:0097344,,,,PF12333;,integral component of membrane [GO:0016021]; MLL1 complex [GO:0071339]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344]
Q98943,CHOYP_TRIADDRAFT_62397.1.1|m.65618,0,0,0,0,0,0,0,0,0.0000004,Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12],CASP2 ICH1,424,execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981],GO:0005737; GO:0042981; GO:0097194; GO:0097200,,,cd00032;,PF00619;,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]
Q5UPH4,CHOYP_TVAG_020440.14.21|m.33137,0,0,0,0,0,0,0,0,0.000000009,Putative ankyrin repeat protein R96,MIMI_R96,1015,,,,,,PF12796;,
Q6R7G4,CHOYP_Y061.1.1|m.29896,0,0,0,0,0,0,0,0,0,Uncharacterized protein ORF61,ORF61,578,,,,,,,
Q08420,CHOYP_contig_050645|m.60289,1,0,0,0,0,0,0,0,0.000000002,Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B),Sod3 Sod-3,244,response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303],GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062,,,cd00305;,PF00080;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
Q02357,CHOYP_ANR44.1.5|m.29530,0,0,0,0,0,0,0,0,2.00E-44,Ankyrin-1 (ANK-1) (Erythrocyte ankyrin),Ank1 Ank-1,1862,ER to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; protein targeting to plasma membrane [GO:0072661]; signal transduction [GO:0007165],GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0014731; GO:0015672; GO:0016020; GO:0016529; GO:0019899; GO:0030507; GO:0030863; GO:0048821; GO:0051117; GO:0055072; GO:0072661,,,,PF12796;PF00531;PF00791;,cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; spectrin binding [GO:0030507]; ER to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; iron ion homeostasis [GO:0055072]; monovalent inorganic cation transport [GO:0015672]; porphyrin-containing compound biosynthetic process [GO:0006779]; protein targeting to plasma membrane [GO:0072661]; signal transduction [GO:0007165]
Q00808,CHOYP_BRAFLDRAFT_117940.1.1|m.59223,0.5,0,0,0,0,0,0,0,1.00E-12,Vegetative incompatibility protein HET-E-1,HET-E1,1356,,GO:0005525,,,,PF06985;PF00400;,GTP binding [GO:0005525]
A8DYE2,CHOYP_BRAFLDRAFT_118277.1.1|m.61321,0,0,0,0,0,0,0,0,3.00E-77,"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)",Trpm CG44240,2023,cation transmembrane transport [GO:0098655]; cell growth [GO:0016049]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],GO:0005261; GO:0007005; GO:0010960; GO:0016049; GO:0034703; GO:0046873; GO:0051262; GO:0055069; GO:0070838; GO:0097682; GO:0098655,,,,PF00520;PF16519;,"cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; metal ion transmembrane transporter activity [GO:0046873]; cation transmembrane transport [GO:0098655]; cell growth [GO:0016049]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"
Q5UQ50,CHOYP_BRAFLDRAFT_276908.1.1|m.28794,0,0,0,0,0,0,0,0,6.00E-11,Collagen-like protein 6,MIMI_L668,1387,,GO:0019012,,,,PF01391;,virion [GO:0019012]
Q8NC51,CHOYP_BRAFLDRAFT_60200.1.3|m.22202,0,0,0,0,0,0,0,0,1.00E-11,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),SERBP1 PAIRBP1 CGI-55,408,regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488],GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0042981; GO:0043488; GO:0045296; GO:0048471; GO:0070062,,,,PF04774;PF16174;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
Q92485,CHOYP_BRAFLDRAFT_67999.1.1|m.44535,0,0,0,0,0,0,0,0,3.00E-100,Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-),SMPDL3B ASML3B,455,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0046872; GO:0050728; GO:0070062,,,,PF00149;,"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
O18783,CHOYP_BRAFLDRAFT_90679.1.1|m.33411,0,0,0,0,0,0,0,0,7.00E-83,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]",PLG,806,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771,,,cd00190;,PF00051;PF00024;PF00089;,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
Q5T2R2,CHOYP_DPS1.1.1|m.11868,0,0,0,0,0,0,0,0,1.00E-128,Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),PDSS1 DPS1 TPRT,415,isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744],GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0051290; GO:1990234,PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.,,,PF00348;,mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; ubiquinone biosynthetic process [GO:0006744]
A6LM32,CHOYP_HSPA12A.27.27|m.65384,0,0,0,0,0,0,0,0,0.000000001,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK Tmel_1128,596,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q5M8V0,CHOYP_ISCW_ISCW006277.2.2|m.66212,0,0,0,0,0,0,0,0,2.00E-61,Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4),btf3l4 TNeu120e23.1,158,,,,,,PF01849;,
Q5RBG4,CHOYP_KAT5.1.1|m.9015,0,0,0,0,0,0,0,0,0,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5),KAT5 HTATIP TIP60,461,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; transcription, DNA-templated [GO:0006351]",GO:0000812; GO:0003713; GO:0004402; GO:0005730; GO:0006351; GO:0006978; GO:0032777; GO:0035267; GO:0040008; GO:0045893; GO:0046872; GO:0048471,,,,PF01853;PF11717;,"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; transcription, DNA-templated [GO:0006351]"
Q28178,CHOYP_LOC100332237.1.1|m.18128,0,0,0,0,0,0,0,0,8.00E-18,Thrombospondin-1,THBS1 TSP-1 TSP1,1170,behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0016525; GO:0016529; GO:0034976; GO:0048266; GO:0050840,,,,PF12662;PF00090;PF02412;PF05735;PF00093;,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]
P70227,CHOYP_LOC100375107.1.4|m.8458,0,0,0,0,0,0,0,0,3.00E-66,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",Itpr3,2670,calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917],GO:0005220; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0006816; GO:0007613; GO:0015278; GO:0016020; GO:0035091; GO:0043235; GO:0050913; GO:0050916; GO:0050917; GO:0051592; GO:0060291; GO:0060402; GO:0070679,,,,PF08709;PF00520;PF02815;PF08454;PF01365;,"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]"
Q20191,CHOYP_LOC581452.2.4|m.25348,0,0,0,0,0,0,0,0,5.00E-45,Zinc metalloproteinase nas-13 (EC 3.4.24.21) (Nematode astacin 13),nas-13 F39D8.4,450,,GO:0004222; GO:0005576; GO:0008270,,,cd04280;,PF01400;PF01549;,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
P80109,CHOYP_LOC590298.2.3|m.4191,0.5,0,0,0,0,0,0,0,5.00E-132,Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D),GPLD1 PIGPLD,839,cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633],GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0005578; GO:0005615; GO:0005737; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0032869; GO:0034364; GO:0035690; GO:0035774; GO:0043065; GO:0043231; GO:0045919; GO:0046470; GO:0051044; GO:0051047; GO:0070633; GO:0071277; GO:0071397; GO:0071401; GO:0071467; GO:1900076,,,,PF01839;PF00882;,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; proteinaceous extracellular matrix [GO:0005578]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]
Q80ZE5,CHOYP_PAQR8.1.2|m.7723,0,0,0,0,0,0,0,0,1.00E-56,Membrane progestin receptor beta (mPR beta) (Progestin and adipoQ receptor family member VIII),Paqr8 Mprb,354,multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545],GO:0003707; GO:0005496; GO:0005794; GO:0005886; GO:0007275; GO:0016021; GO:0048477; GO:0048545,,,,PF03006;,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545]
O17287,CHOYP_TOMM22.1.1|m.48750,0,0,0,0,0,0,0,0,1.00E-18,Mitochondrial import receptor subunit TOM22 homolog,tomm-22 W10D9.5,109,protein import into mitochondrial matrix [GO:0030150]; protein import into mitochondrial outer membrane [GO:0045040],GO:0005742; GO:0030150; GO:0031307; GO:0045040,,,,PF04281;,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; protein import into mitochondrial matrix [GO:0030150]; protein import into mitochondrial outer membrane [GO:0045040]
P08043,CHOYP_ZN568.1.1|m.61611,0,0,0,0,0,0,0,0,2.00E-85,Zinc finger protein 2 (Zfp-2) (Protein mKR2),Zfp2 Fnp-2 Mkr2 Zfp-2,459,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P09690,CHOYP_ACH91.1.1|m.48865,0,0,0,0,0,0,0,0,6.00E-59,Acetylcholine receptor subunit beta,Chrnb1 Acrb,501,"behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; neurological system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]",GO:0001941; GO:0003009; GO:0005886; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007271; GO:0007274; GO:0015267; GO:0022848; GO:0030054; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0045202; GO:0045211; GO:0048747; GO:0050877,,,,PF02931;PF02932;,"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; neurological system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]"
Q7ZWB7,CHOYP_BBS5.1.1|m.56560,0.5,0,0,0,0,0,0,0,0,Bardet-Biedl syndrome 5 protein homolog,bbs5 zgc:56578,342,cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0042051; GO:0046907; GO:0048749; GO:0051877; GO:0060170; GO:0060271; GO:0070121; GO:0072116,,,,PF07289;,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]
Q5XKA2,CHOYP_LOC100186763.2.2|m.27544,0,0,0,0,0,0,0,0,8.00E-38,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",timm21 tim21,232,protein import into mitochondrial matrix [GO:0030150],GO:0005744; GO:0016021; GO:0030150,,,,PF08294;,integral component of membrane [GO:0016021]; mitochondrial inner membrane presequence translocase complex [GO:0005744]; protein import into mitochondrial matrix [GO:0030150]
Q9BGT1,CHOYP_LOC100366957.1.1|m.10938,0.5,0,0,0,0,0,0,0,2.00E-30,Tetratricopeptide repeat protein 9C (TPR repeat protein 9C),TTC9C QflA-13179,171,,,,,,PF07719;,
Q3ZBY7,CHOYP_LOC100378209.1.2|m.7336,0,0,0,0,0,0,0,0,5.00E-152,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1),DEGS1 DES1,323,ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633],GO:0005739; GO:0005789; GO:0006633; GO:0016021; GO:0042284; GO:0046513,,,,PF00487;PF08557;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]
P05140,CHOYP_LOC100378295.2.4|m.15030,0,0,0,0,0,0,0,0,2.00E-10,Type-2 ice-structuring protein (Type II antifreeze protein) (AFP),,163,,GO:0005576; GO:0030246,,,,PF00059;,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
P31597,CHOYP_LOC100691601.2.2|m.40748,0,0,0,0,0,0,0,0,1.00E-164,Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1),SLC1A1 EAAC1 EAAT3,524,cysteine transport [GO:0042883]; D-aspartate import [GO:0070779]; L-glutamate transmembrane transport [GO:0089711],GO:0005313; GO:0005886; GO:0015293; GO:0016021; GO:0016324; GO:0033229; GO:0042883; GO:0070779; GO:0089711,,,,PF00375;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cysteine transmembrane transporter activity [GO:0033229]; L-glutamate transmembrane transporter activity [GO:0005313]; symporter activity [GO:0015293]; cysteine transport [GO:0042883]; D-aspartate import [GO:0070779]; L-glutamate transmembrane transport [GO:0089711]
P35448,CHOYP_LOC100888702.1.1|m.56287,0,0,0,0,0,0,0,0,6.00E-13,Thrombospondin-1,thbs1 tsp1,1173,cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0016525; GO:0016529; GO:0050840,,,,PF12947;PF00090;PF02412;PF05735;PF00093;,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]
C8V4D4,CHOYP_LOC100891447.1.1|m.18284,0,0,0,0,0,0,0,0,0.00000002,SCF E3 ubiquitin ligase complex F-box protein grrA (F-box and leucine-rich repeat protein grrA) (F-box/LRR-repeat protein grrA) (SCF substrate adapter protein grrA),grrA grr1 AN10516,585,ascospore formation [GO:0030437],GO:0005737; GO:0019005; GO:0030437,,,,PF12937;,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ascospore formation [GO:0030437]
Q32KN8,CHOYP_LOC585338.2.2|m.40816,0,0,0,0,0,0,0,0,5.00E-170,Tubulin alpha-3 chain (Alpha-tubulin 3) [Cleaved into: Detyrosinated tubulin alpha-3 chain],TUBA3,450,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;PF03953;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q9CXJ4,CHOYP_MDR1A.1.1|m.47026,0,0,0,0,0,0,0,0,1.00E-114,"ATP-binding cassette sub-family B member 8, mitochondrial",Abcb8,717,,GO:0005524; GO:0005634; GO:0005730; GO:0005739; GO:0005743; GO:0016021; GO:0042626,,,,PF00664;PF00005;,"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]"
P49747,CHOYP_PHUM_PHUM370970.1.2|m.40102,0.5,0,0,0,0,0,0,0,0,Cartilage oligomeric matrix protein (COMP) (Thrombospondin-5) (TSP5),COMP,757,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; skeletal system development [GO:0001501],GO:0001501; GO:0002020; GO:0003417; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005578; GO:0005615; GO:0006915; GO:0007155; GO:0008201; GO:0009887; GO:0030198; GO:0043066; GO:0043395; GO:0060173; GO:0070062,,,,PF11598;PF07645;PF02412;PF05735;,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protease binding [GO:0002020]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; skeletal system development [GO:0001501]
Q8INF0,CHOYP_SGCBETA-3.1.1|m.66126,0,0,0,0,0,0,0,0,0,Soluble guanylate cyclase 88E (EC 4.6.1.2),Gyc88E CG4154,947,cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165],GO:0000302; GO:0001666; GO:0004383; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0008074; GO:0019825; GO:0019826; GO:0020037; GO:0035556; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026,,,,PF00211;PF07700;PF07701;,"guanylate cyclase complex, soluble [GO:0008074]; plasma membrane [GO:0005886]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]"
P98194,CHOYP_SPCA.1.1|m.6746,0,0,0,0,0,0,0,0,0,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 3.6.3.8) (ATP-dependent Ca(2+) pump PMR1),ATP2C1 KIAA1347 PMR1L HUSSY-28,919,actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],GO:0000139; GO:0004871; GO:0005388; GO:0005509; GO:0005524; GO:0005794; GO:0005802; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0015410; GO:0016020; GO:0016021; GO:0016339; GO:0030026; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0034220; GO:0043123; GO:0046872,,,,PF00689;PF00690;PF00122;,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-transporting ATPase activity [GO:0005388]; manganese ion binding [GO:0030145]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; signal transducer activity [GO:0004871]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]
Q66L58,CHOYP_VAC14.1.1|m.31290,0,0,0,0,0,0,0,0,0,Protein VAC14 homolog,vac14 zgc:100945,771,regulation of lipid kinase activity [GO:0043550],GO:0010008; GO:0043550; GO:0070772,,,,PF12755;PF11916;,endosome membrane [GO:0010008]; PAS complex [GO:0070772]; regulation of lipid kinase activity [GO:0043550]
Q6INE8,CHOYP_VMP1.1.1|m.34831,0,0,0,0,0,0,0,0,1.00E-171,Vacuole membrane protein 1 (Transmembrane protein 49),vmp1 tmem49,406,,GO:0005774; GO:0005783; GO:0005886; GO:0016021; GO:0033116,,,,PF09335;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]
Q8C2P3,CHOYP_VPP1.2.2|m.13421,0,0,0,0,0,0,0,0,0,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 1-like),Dus1l,475,,GO:0017150; GO:0050660,,,,PF01207;,flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]
Q9JHB4,CHOYP_WDR31.2.2|m.65613,0,0,0,0,0,0,0,0,5.00E-87,WD repeat-containing protein 31 (Spermatid WD repeat-containing protein) (spWD),Wdr31,367,,,,,,PF00400;,
O15014,CHOYP_ZN609.1.1|m.44387,0.5,0,0,0,0,0,0,0,5.00E-55,Zinc finger protein 609,ZNF609 KIAA0295,1411,,GO:0005634; GO:0046872,,,,,nucleus [GO:0005634]; metal ion binding [GO:0046872]
Q08295,CHOYP_BRAFLDRAFT_265208.7.7|m.62510,1.5,0,0,0,0,0,0,0,8.00E-34,"Oligo-1,6-glucosidase IMA2 (EC 3.2.1.10) (Alpha-glucosidase) (Isomaltase 2)",IMA2 YOL157C,589,disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023],GO:0000023; GO:0004574; GO:0004575; GO:0046352,,,,PF00128;,"oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023]"
Q9BPW9,CHOYP_BRAFLDRAFT_290492.1.1|m.21887,0,0,0,0,0,0,0,0,4.00E-74,Dehydrogenase/reductase SDR family member 9 (EC 1.1.-.-) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),DHRS9 RDH15 SDR9C4 UNQ835/PRO1773,319,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],GO:0004022; GO:0004745; GO:0005789; GO:0008209; GO:0016854; GO:0030176; GO:0030855; GO:0031090; GO:0042448; GO:0042572; GO:0042904; GO:0047035,,,,PF00106;,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]
Q9BG93,CHOYP_BRAFLDRAFT_87834.1.1|m.37325,0,0,0,0,0,0,0,0,8.00E-21,Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1),NR0B1 DAX1,470,"adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; steroid biosynthetic process [GO:0006694]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003707; GO:0003723; GO:0004879; GO:0005634; GO:0005737; GO:0006351; GO:0006694; GO:0008104; GO:0008406; GO:0008584; GO:0016020; GO:0019904; GO:0030325; GO:0032448; GO:0033144; GO:0035258; GO:0042788; GO:0042803; GO:0043565; GO:0045892,,,,PF00104;PF14046;,"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; DNA binding [GO:0003677]; DNA hairpin binding [GO:0032448]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; steroid hormone receptor binding [GO:0035258]; adrenal gland development [GO:0030325]; gonad development [GO:0008406]; male gonad development [GO:0008584]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; steroid biosynthetic process [GO:0006694]; transcription, DNA-templated [GO:0006351]"
Q8IWY4,CHOYP_BRAFLDRAFT_98740.3.7|m.46571,0.5,0,0,0,0,0,0,0,2.00E-40,"Signal peptide, CUB and EGF-like domain-containing protein 1",SCUBE1,988,adult heart development [GO:0007512]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]; signal transduction [GO:0007165],GO:0005509; GO:0005615; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0030154; GO:0042802; GO:0045446; GO:0045880; GO:0046982; GO:0051260,,,cd00041;,PF12662;PF00431;PF12947;PF07645;PF07699;,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]; signal transduction [GO:0007165]
Q5XQC7,CHOYP_CPNE8.2.2|m.58379,0,0,0,0,0,0,0,0,2.00E-133,Protein BONZAI 3,BON3 At1g08860 F7G19.25,584,defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332],GO:0005544; GO:0005886; GO:0006952; GO:0060548; GO:0090332,,,cd01459;,PF00168;PF07002;,plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; defense response [GO:0006952]; negative regulation of cell death [GO:0060548]; stomatal closure [GO:0090332]
O75841,CHOYP_DMOJ_GI12939.1.3|m.5732,0,0,0,0,0,0,0,0,0.000001,Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb),UPK1B TSPAN20,260,cell surface receptor signaling pathway [GO:0007166]; epithelial cell differentiation [GO:0030855],GO:0005198; GO:0005887; GO:0007166; GO:0016021; GO:0016324; GO:0030855; GO:0070062,,,,PF00335;,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; structural molecule activity [GO:0005198]; cell surface receptor signaling pathway [GO:0007166]; epithelial cell differentiation [GO:0030855]
Q5VY43,CHOYP_DVIR_GJ12529.1.1|m.21031,0,0,0,0,0,0,0,0,5.00E-39,Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12),PEAR1 MEGF12,1037,negative regulation of Notch signaling pathway [GO:0045746]; recognition of apoptotic cell [GO:0043654],GO:0001891; GO:0016021; GO:0043654; GO:0045746,,,,PF00053;,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; negative regulation of Notch signaling pathway [GO:0045746]; recognition of apoptotic cell [GO:0043654]
Q9VCA9,CHOYP_FASN.3.4|m.60280,0,0,0,0,0,0,0,0,2.00E-79,Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit),Spase22-23 CG5677,179,protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0031090; GO:0045047,,,,PF04573;,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]
P16354,CHOYP_LOC100149324.1.1|m.5536,0,0,0,0,0,0,0,0,5.00E-28,Phospholipase A2 isozymes PA3A/PA3B/PA5 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),,143,arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482,,,,PF05826;,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]
Q7JQD3,CHOYP_LOC100371249.1.1|m.63118,0,0,0,0,0,0,0,0,4.00E-108,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),AM,367,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0007275; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051693,,,,PF00626;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]
E7FAM5,CHOYP_LOC100374741.70.83|m.60164,0,0,0,0,0,0,0,0,0.00000006,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),trim71 lin41,824,embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0072089; GO:2000177,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;,P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
Q9VCA2,CHOYP_LOC100878786.1.1|m.55152,0,0,0,0,0,0,0,0,4.00E-111,Organic cation transporter protein,Orct CG6331,548,apoptotic process [GO:0006915],GO:0005887; GO:0006915; GO:0008514; GO:0016021,,,cd06174;,PF00083;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; apoptotic process [GO:0006915]
Q9VUL9,CHOYP_LOC663102.1.1|m.8869,0,0,0,0,0,0,0,0,4.00E-39,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)",FucTA CG6869,503,nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486],GO:0000139; GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036071; GO:0046920,PATHWAY: Protein modification; protein glycosylation.,,,PF17039;PF00852;,"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
Q8R5M3,CHOYP_LRC15.2.3|m.43746,0,0,0,0,0,0,0,0,4.00E-44,Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid) (rLib),Lrrc15 Lib,578,cell communication [GO:0007154]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469],GO:0004860; GO:0005622; GO:0005737; GO:0006469; GO:0007154; GO:0016021; GO:0019221; GO:0046426,,,,PF00560;PF13855;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; protein kinase inhibitor activity [GO:0004860]; cell communication [GO:0007154]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]
Q8BLI0,CHOYP_MADD-4.1.1|m.33455,0,0,0,0,0,0,0,0,2.00E-39,ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1),Adamtsl1,1745,,GO:0005578; GO:0008237; GO:0008270,,,,PF07679;PF08686;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]
Q8BU85,CHOYP_MSRB3.2.4|m.17278,1,0,0,0,0,0,0,0,3.00E-61,"Methionine-R-sulfoxide reductase B3, mitochondrial (MsrB3) (EC 1.8.4.-)",Msrb3,253,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743,,,,PF01641;,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
Q8TBZ2,CHOYP_MYBPP.1.1|m.45264,0,0,0,0,0,0,0,0,4.00E-38,MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1),MYCBPAP AMAP1,947,cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005737; GO:0007268; GO:0007275; GO:0007283; GO:0016020; GO:0030154,,,,PF14646;,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
O05218,CHOYP_NEMVEDRAFT_V1G169538.1.2|m.18155,0.5,0,0,0,0,0,0,0,8.00E-55,Putative gamma-glutamyltransferase YwrD (EC 2.3.2.2) (Glutathione hydrolase) (EC 3.4.19.13) [Cleaved into: Gamma-glutamyltranspeptidase large chain; Gamma-glutamyltranspeptidase small chain],ywrD BSU36100,525,glutathione catabolic process [GO:0006751],GO:0003840; GO:0006751; GO:0036374,,,,PF01019;,gamma-glutamyltransferase activity [GO:0003840]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751]
A0JPI9,CHOYP_NEMVEDRAFT_V1G245744.1.1|m.36806,0.5,0,0,0,0,0,0,0,1.00E-44,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),Lrrc74a Lrrc74,479,,,,,,PF13516;,
Q9Y4C8,CHOYP_RBM19.1.2|m.28228,0,0,0,0,0,0,0,0,0,Probable RNA-binding protein 19 (RNA-binding motif protein 19),RBM19 KIAA0682,960,multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019],GO:0000166; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016020; GO:0040019,,,,PF00076;,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]
Q9NEN6,CHOYP_RS6.5.12|m.23146,0.5,0,0,0,0,0,0,0,4.00E-99,40S ribosomal protein S6,rps-6 Y71A12B.1,246,determination of adult lifespan [GO:0008340]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412],GO:0003735; GO:0006364; GO:0006412; GO:0008340; GO:0022627; GO:0042274,,,,PF01092;,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; determination of adult lifespan [GO:0008340]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]
Q9TU34,CHOYP_TRIADDRAFT_55241.1.1|m.41679,0,0,0,0,0,0,0,0,2.00E-74,"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)",ITPR1,2709,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209],GO:0005220; GO:0005509; GO:0005789; GO:0005791; GO:0005886; GO:0015278; GO:0016021; GO:0030141; GO:0030658; GO:0035091; GO:0048471; GO:0051209; GO:0070059,,,,PF08709;PF00520;PF02815;PF08454;PF01365;,"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209]"
O01761,CHOYP_UNC89.17.19|m.58312,0,0,0,0,0,0,0,0,5.00E-21,Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89),unc-89 C09D1.1,8081,myosin filament assembly [GO:0031034]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; regulation of Rho protein signal transduction [GO:0035023]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0035023; GO:0050850; GO:0060298; GO:0071688; GO:1905552,,,cd00063;,PF00041;PF07679;PF00069;PF05177;PF00621;,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; myosin filament assembly [GO:0031034]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; regulation of Rho protein signal transduction [GO:0035023]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]
P35570,CHOYP_BRAFLDRAFT_124878.1.1|m.55561,0,0,0,0,0,0,0,0,3.00E-57,Insulin receptor substrate 1 (IRS-1) (pp185),Irs1 Irs-1,1235,aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434],GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0007568; GO:0008286; GO:0014823; GO:0019901; GO:0019904; GO:0031000; GO:0042169; GO:0042327; GO:0043231; GO:0043434; GO:0043548; GO:0043552; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0051291; GO:0060397; GO:0070094; GO:0071478; GO:0090275; GO:1904385; GO:1990416,,,cd01204;,PF02174;PF00169;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434]
P15129,CHOYP_BRAFLDRAFT_61250.8.14|m.44214,0,0,0,0,0,0,0,0,2.00E-115,Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450 L-2) (Cytochrome P450 isozyme 5),Cyp4b1 Cyp4b-1,511,biphenyl metabolic process [GO:0018879]; cellular aromatic compound metabolic process [GO:0006725]; exogenous drug catabolic process [GO:0042738]; fluorene metabolic process [GO:0018917],GO:0004497; GO:0005506; GO:0005789; GO:0006725; GO:0008144; GO:0015643; GO:0018585; GO:0018879; GO:0018917; GO:0020037; GO:0031090; GO:0042738; GO:0043231; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; drug binding [GO:0008144]; fluorene oxygenase activity [GO:0018585]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; toxic substance binding [GO:0015643]; biphenyl metabolic process [GO:0018879]; cellular aromatic compound metabolic process [GO:0006725]; exogenous drug catabolic process [GO:0042738]; fluorene metabolic process [GO:0018917]
A2AIW0,CHOYP_BRAFLDRAFT_65137.1.1|m.64534,0,0,0,0,0,0,0,0,7.00E-18,Serologically defined colon cancer antigen 3 homolog,Sdccag3,432,"cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport, endosome to plasma membrane [GO:1990126]",GO:0005768; GO:0005769; GO:0007049; GO:0015031; GO:0030496; GO:0030904; GO:0032465; GO:0051301; GO:0055037; GO:1990126,,,,,"early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport, endosome to plasma membrane [GO:1990126]"
P20481,CHOYP_BUCC.1.2|m.10972,0,0,0,0,0,0,0,0,4.00E-40,Buccalin [Cleaved into: Buccalin-D; Buccalin-E; Buccalin-F; Buccalin-G; Buccalin-H; Buccalin-A; Buccalin-I; Buccalin-J; Buccalin-K; Buccalin-L; Buccalin-B (BUCb); Buccalin-M; Buccalin gene-predicted acidic peptide A (BGPAP A); Buccalin-N; Buccalin-O; Buccalin-P; Buccalin-Q; Buccalin-R; Buccalin-C; Buccalin-S; Buccalin gene-predicted acidic peptide B (BGPAP B)],,505,neuropeptide signaling pathway [GO:0007218],GO:0005576; GO:0007218,,,,,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
Q2KIS9,CHOYP_DPSE_GA18582.1.1|m.58686,0,0,0,0,0,0,0,0,0.000002,Tetraspanin-8 (Tspan-8),TSPAN8,238,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
Q5H8C1,CHOYP_FREM1.1.1|m.55119,0,0,0,0,0,0,0,0,0,FRAS1-related extracellular matrix protein 1 (Protein QBRICK),FREM1 C9orf143 C9orf145 C9orf154,2179,cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094],GO:0005604; GO:0007154; GO:0007160; GO:0016021; GO:0030246; GO:0046872; GO:0097094,,,,PF03160;PF00059;,basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094]
P45842,CHOYP_ISCW_ISCW001285.2.2|m.15985,0,0,0,0,0,0,0,0,1.00E-24,60S ribosomal protein L34 (L31),RpL34 RpL31,130,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01199;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q2M2Z5,CHOYP_KIZ.1.1|m.57618,0.5,0,0,0,0,0,0,0,2.00E-14,Centrosomal protein kizuna (Polo-like kinase 1 substrate 1),KIZ C20orf19 NCRNA00153 PLK1S1 HT013,673,spindle organization [GO:0007051],GO:0005737; GO:0005813; GO:0007051; GO:0019901; GO:0042995,,,,,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051]
O35963,CHOYP_LOC100367291.1.1|m.51818,0,0,0,0,0,0,0,0,3.00E-100,Ras-related protein Rab-33B,Rab33b,229,"autophagy [GO:0006914]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein targeting to Golgi [GO:0000042]; regulation of autophagosome assembly [GO:2000785]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]; small GTPase mediated signal transduction [GO:0007264]",GO:0000042; GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005796; GO:0006891; GO:0006914; GO:0007264; GO:0048705; GO:0070062; GO:1903358; GO:1903434; GO:2000156; GO:2000785,,,,PF00071;,"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein targeting to Golgi [GO:0000042]; regulation of autophagosome assembly [GO:2000785]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]; small GTPase mediated signal transduction [GO:0007264]"
Q0V9W6,CHOYP_LOC100375232.1.2|m.2686,0,0,0,0,0,0,0,0,1.00E-51,BTB/POZ domain-containing protein 6,btbd6,529,neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162],GO:0000932; GO:0005829; GO:0019005; GO:0022008; GO:0030162; GO:0031625; GO:0042787; GO:0043161,,,,PF07707;PF00651;PF08005;,cytosol [GO:0005829]; P-body [GO:0000932]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162]
Q9VYY9,CHOYP_LOC100378224.1.1|m.4326,0,0,0,0,0,0,0,0,0,Ecotropic viral integration site 5 ortholog,Evi5 CG11727,807,activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]; regulation of vesicle fusion [GO:0031338],GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0007298; GO:0017137; GO:0030334; GO:0031338; GO:0031982; GO:0032880; GO:0043087; GO:0090630,,,,PF00566;,cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; border follicle cell migration [GO:0007298]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]; regulation of vesicle fusion [GO:0031338]
Q6AYR9,CHOYP_LOC101157895.2.2|m.28009,0,0,0,0,0,0,0,0,0.00000004,Tetraspanin-1 (Tspan-1),Tspan1,241,cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],GO:0005654; GO:0005765; GO:0005887; GO:0007166; GO:0008283; GO:0016477; GO:0030054; GO:0045807; GO:0048471; GO:0050821; GO:0070062,,,,PF00335;,cell junction [GO:0030054]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]
Q95JD5,CHOYP_LOC101169780.1.1|m.46531,0,0,0,0,0,0,0,0,2.00E-24,Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (cSULT1B1) (EC 2.8.2.-),SULT1B1 ST1B2,296,epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0051923,,,,PF00685;,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
Q0V8J4,CHOYP_LOC565211.2.2|m.55017,0,0,0,0,0,0,0,0,5.00E-32,von Willebrand factor A domain-containing protein 7 (Protein G7c),VWA7 G7C,891,,GO:0005576,,,,,extracellular region [GO:0005576]
C7G0B5,CHOYP_PIF.5.6|m.44293,0,0,0,0,0,0,0,0,3.00E-51,Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)],,1007,chitin metabolic process [GO:0006030],GO:0005578; GO:0006030; GO:0008061,,,,PF00092;,proteinaceous extracellular matrix [GO:0005578]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
P48459,CHOYP_PP1A.1.1|m.25950,0,0,0,0,0,0,0,0,2.00E-84,Putative serine/threonine-protein phosphatase C23G10.1 (EC 3.1.3.16),C23G10.1,354,,GO:0004721; GO:0046872,,,,PF00149;,metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]
E9PGG2,CHOYP_SIX1.1.2|m.49270,0,0,0,0,0,0,0,0,1.00E-11,Anomalous homeobox protein,ANHX,379,"regulation of transcription, DNA-templated [GO:0006355]",GO:0005634; GO:0006355; GO:0043565,,,,PF00046;PF16878;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]"
Q9CYB0,CHOYP_TIF1A.3.8|m.12841,0,0,0,0,0,0,0,0,0.000001,E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (Putative tumor suppressor RFP2) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13),Trim13 Rfp2,407,ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; innate immune response [GO:0045087]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; response to gamma radiation [GO:0010332],GO:0004842; GO:0004871; GO:0005737; GO:0005789; GO:0008270; GO:0010332; GO:0010942; GO:0016021; GO:0016239; GO:0030433; GO:0032897; GO:0043123; GO:0043161; GO:0045087; GO:0051092; GO:0051865; GO:0097038; GO:1902187,PATHWAY: Protein modification; protein ubiquitination.,,,PF00643;PF13445;,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; signal transducer activity [GO:0004871]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; innate immune response [GO:0045087]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; response to gamma radiation [GO:0010332]
Q8NCA9,CHOYP_ZNF43.1.1|m.6773,0,0,0,0,0,0,0,0,2.00E-22,Zinc finger protein 784,ZNF784,323,"hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0002244; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6DJK9,CHOYP_BRAFLDRAFT_119424.1.1|m.15350,0,0,0,0,0,0,0,0,7.00E-103,Coiled-coil domain-containing protein 130,ccdc130,384,,,,,,PF04502;,
B3DLA6,CHOYP_BRAFLDRAFT_202604.1.1|m.41616,0,0,0,0,0,0,0,0,6.00E-97,Endoribonuclease Dicer (EC 3.1.26.3),dicer1,1893,pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0046872; GO:0070578,,,cd00593;,PF00270;PF03368;PF00271;PF02170;PF00636;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]
P21613,CHOYP_BRAFLDRAFT_208436.27.32|m.61232,0,0,0,0,0,0,0,0,3.00E-31,Kinesin heavy chain,,967,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018,,,,PF00225;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q16960,CHOYP_DC1I2.2.3|m.54049,0,0,0,0,0,0,0,0,9.00E-28,"Dynein intermediate chain 3, ciliary",,597,,GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286,,,,,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]
O75954,CHOYP_DGRI_GH15333.1.2|m.45725,0,0,0,0,0,0,0,0,4.00E-17,Tetraspanin-9 (Tspan-9) (Tetraspan NET-5),TSPAN9 NET5,239,cell surface receptor signaling pathway [GO:0007166],GO:0005886; GO:0005887; GO:0005925; GO:0007166; GO:0097197,,,,PF00335;,focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; cell surface receptor signaling pathway [GO:0007166]
Q9U4L6,CHOYP_DPSE_GA11443.1.1|m.19526,0,0,0,0,0,0,0,0,8.00E-103,Mitochondrial import receptor subunit TOM40 homolog 1 (dtom40) (Male sterile protein 15) (Translocase of outer membrane 40 kDa subunit homolog 1),Tom40 mit ms(1)15 CG12157,344,cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],GO:0005739; GO:0005742; GO:0006626; GO:0006811; GO:0015266; GO:0015288; GO:0015450; GO:0030150; GO:0046930; GO:0071456,,,,PF01459;,mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; porin activity [GO:0015288]; protein channel activity [GO:0015266]; cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]
Q3UVX5,CHOYP_GRM1.1.2|m.48217,0,0,0,0,0,0,0,0,0,Metabotropic glutamate receptor 5 (mGluR5),Grm5 Gprc1e Mglur5,1203,"adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [GO:0007196]; cognition [GO:0050890]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; locomotory behavior [GO:0007626]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, glutamatergic [GO:0051966]",GO:0001639; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007196; GO:0007216; GO:0007612; GO:0007626; GO:0008066; GO:0014069; GO:0042734; GO:0043005; GO:0048169; GO:0050890; GO:0051966; GO:0070062; GO:0099530; GO:0099583,,,,PF00003;PF01094;PF10606;PF07562;,"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; G-protein coupled receptor activity [GO:0004930]; G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G-protein coupled glutamate receptor activity [GO:0001639]; adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [GO:0007196]; cognition [GO:0050890]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; locomotory behavior [GO:0007626]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
P53013,CHOYP_LOC100118048.1.1|m.62638,0,0,0,0,0,0,0,0,1.00E-115,Elongation factor 1-alpha (EF-1-alpha),eft-3 F31E3.5; eft-4 R03G5.1,463,embryo development ending in birth or egg hatching [GO:0009792]; growth [GO:0040007],GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737; GO:0008135; GO:0009792; GO:0040007,,,,PF03144;PF03143;,"cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; embryo development ending in birth or egg hatching [GO:0009792]; growth [GO:0040007]"
A0JM12,CHOYP_LOC100176721.6.6|m.66056,0,0,0,0,0,0,0,0,6.00E-20,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),megf10,1114,cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],GO:0005886; GO:0006909; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0030239,,,,PF12661;PF00053;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
Q9Y7M3,CHOYP_LOC100367312.7.13|m.37567,0,0,0,0,0,0,0,0,0.000000003,FYVE-type zinc finger-containing protein C9B6.03,SPBC9B6.03,293,"phosphatidylinositol phosphorylation [GO:0046854]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000285; GO:0000324; GO:0000329; GO:0005829; GO:0010008; GO:0035091; GO:0042147; GO:0046854; GO:0046872,,,,PF01363;,"cytosol [GO:0005829]; endosome membrane [GO:0010008]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol phosphorylation [GO:0046854]; retrograde transport, endosome to Golgi [GO:0042147]"
Q6ITT3,CHOYP_LOC100372236.1.4|m.16991,0,0,0,0,0,0,0,0,2.00E-90,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",MGAT4C,478,carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486],GO:0000139; GO:0005975; GO:0006486; GO:0008454; GO:0016021; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF04666;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]"
Q5U3T0,CHOYP_LOC100372236.3.4|m.54964,0,0,0,0,0,0,0,0,2.00E-68,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",mgat4c zgc:101663,454,carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486],GO:0000139; GO:0005975; GO:0006486; GO:0008454; GO:0016021; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF04666;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]"
Q6DBY9,CHOYP_LOC100372809.1.1|m.39753,0,0,0,0,0,0,0,0,1.00E-14,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),chst1 zgc:100904,420,carbohydrate metabolic process [GO:0005975]; sulfur compound metabolic process [GO:0006790],GO:0000139; GO:0001517; GO:0005975; GO:0006790; GO:0016021; GO:0045130,,,,PF00685;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; sulfur compound metabolic process [GO:0006790]
Q9C026,CHOYP_LOC100373444.23.79|m.27899,1.5,0,0,0,0,0,0,0,0.000002,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),TRIM9 KIAA0282 RNF91,710,negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of SNARE complex assembly [GO:0035544]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; synaptic vesicle exocytosis [GO:0016079],GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0008021; GO:0008270; GO:0016079; GO:0030054; GO:0030425; GO:0035544; GO:0042803; GO:0043161; GO:0045955,PATHWAY: Protein modification; protein ubiquitination.,,cd00063;,PF00041;PF00622;PF00643;,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of SNARE complex assembly [GO:0035544]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; synaptic vesicle exocytosis [GO:0016079]
Q86VH2,CHOYP_LOC100373898.1.1|m.24900,0,0,0,0,0,0,0,0,0,Kinesin-like protein KIF27,KIF27,1401,cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],GO:0003351; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008574; GO:0021591; GO:0060271; GO:0070062,,,,PF00225;,"cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]"
Q6YHK3,CHOYP_LOC100647494.1.1|m.55801,0,0,0,0,0,0,0,0,1.00E-102,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),CD109 CPAMD7,1445,C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0006501; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675,,,,PF00207;PF07678;PF01835;PF07703;PF07677;PF10569;,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; C-terminal protein lipidation [GO:0006501]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
Q4V348,CHOYP_LOC100730443.1.1|m.57698,1.5,0,0,0,0,0,0,0,1.00E-25,Zinc finger protein 658B,ZNF658B,819,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9CWL2,CHOYP_LOC100749506.1.1|m.8950,0,0,0,0,0,0,0,0,3.00E-91,Zinc finger protein castor homolog 1 (Castor-related protein),Casz1 Cst D4Ertd432e Kiaa3026,1761,"negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005654; GO:0005829; GO:0006351; GO:0043231; GO:0045665; GO:0045893; GO:0046872; GO:0060040; GO:0060223; GO:0060226; GO:1902870,,,,,"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223]; transcription, DNA-templated [GO:0006351]"
A1XBS5,CHOYP_LOC100879052.1.1|m.53743,0,0,0,0,0,0,0,0,9.00E-49,Protein FAM92A1,FAM92A1,289,cilium assembly [GO:0060271],GO:0005634; GO:0005737; GO:0005814; GO:0036064; GO:0060271,,,,PF06730;,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271]
Q6VMQ6,CHOYP_LOC100881659.1.1|m.14698,0,0,0,0,0,0,0,0,2.00E-29,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),ATF7IP MCAF MCAF1,1270,"DNA methylation [GO:0006306]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]",GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0006351; GO:0016032; GO:0016604; GO:0016887; GO:0045892; GO:0045893; GO:0045898,,,,PF16788;PF16794;,"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ATPase activity [GO:0016887]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]"
Q4V348,CHOYP_LOC100918713.1.1|m.17833,0.5,0,0,0,0,0,0,0,4.00E-19,Zinc finger protein 658B,ZNF658B,819,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9JII1,CHOYP_LOC101070553.1.1|m.9549,0.5,0,0,0,0,0,0,0,2.00E-119,"72 kDa inositol polyphosphate 5-phosphatase (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV)",Inpp5e,647,inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],GO:0000139; GO:0001726; GO:0004439; GO:0005886; GO:0005930; GO:0032580; GO:0046488; GO:0046855; GO:0046856,,,,PF03372;,"axoneme [GO:0005930]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]"
Q9VXT2,CHOYP_LOC755300.1.1|m.8324,0,0,0,0,0,0,0,0,3.00E-94,DnaJ homolog subfamily C member 25 homolog,CG7872,333,,GO:0012505; GO:0016021,,,cd06257;,PF00226;,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]
P0C6B8,CHOYP_LRP1B.2.2|m.54317,0,0,0,0,0,0,0,0,4.00E-20,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1",Svep1,3564,cell adhesion [GO:0007155],GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020,,,cd00033;cd00152;,PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
P97532,CHOYP_MPST.1.1|m.11853,0,0,0,0,0,0,0,0,1.00E-95,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),Mpst,297,hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],GO:0001822; GO:0001889; GO:0004792; GO:0005737; GO:0005739; GO:0005829; GO:0016784; GO:0019346; GO:0021510; GO:0030054; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814,,,,PF00581;,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346]
Q5I147,CHOYP_PTPRM.14.15|m.57240,0,0,0,0,0,0,0,0,4.00E-21,Tyrosine phosphatase-like protein H1 (PTP-H1),H1,336,,GO:0004725,,,,PF00102;,protein tyrosine phosphatase activity [GO:0004725]
P15145,CHOYP_AMPN.1.1|m.28244,0,0,0,0,0,0,0,0,3.00E-28,Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13),ANPEP,963,angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165],GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006,,,cd09601;,PF11838;PF01433;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]
Q6CEJ6,CHOYP_BRAFLDRAFT_109077.1.1|m.7494,0.5,0,0,0,0,0,0,0,2.00E-36,Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase),CCR4 YALI0B15147g,705,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0046872,,,,PF03372;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6DF57,CHOYP_BRAFLDRAFT_264304.1.1|m.35625,0,0,0,0,0,0,0,0,5.00E-66,G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75),gpatch11 ccdc75,261,,GO:0000776; GO:0000777; GO:0003676,,,,PF13821;PF01585;,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]
Q68EK2,CHOYP_CALCR.6.6|m.62289,0,0,0,0,0,0,0,0,1.00E-72,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor),calcrla calcrl si:dkey-249o24.2 zgc:100872,470,angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; somitogenesis [GO:0001756],GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844,,,,PF00002;PF02793;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; somitogenesis [GO:0001756]
Q29496,CHOYP_CYP3A89.1.1|m.53245,0,0,0,0,0,0,0,0,1.00E-100,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),CYP3A24,503,,GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0031090; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
P35555,CHOYP_ISCW_ISCW021545.1.1|m.25379,0,0,0,0,0,0,0,0,1.00E-70,Fibrillin-1 [Cleaved into: Asprosin],FBN1 FBN,2871,activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; regulation of cellular response to growth factor stimulus [GO:0090287]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005578; GO:0005604; GO:0005615; GO:0005622; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0022617; GO:0030023; GO:0030198; GO:0031012; GO:0032403; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0043010; GO:0045671; GO:0048048; GO:0048050; GO:0070062; GO:0071560; GO:0090287; GO:1990314; GO:2001205,,,,PF12662;PF07645;PF00683;,basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; regulation of cellular response to growth factor stimulus [GO:0090287]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
Q6IQ55,CHOYP_KC1A.1.2|m.14719,0.5,0,0,0,0,0,0,0,4.00E-45,Tau-tubulin kinase 2 (EC 2.7.11.1),TTBK2 KIAA0847,1244,ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005814; GO:0005829; GO:0007224; GO:0008360; GO:0018105; GO:0035869; GO:0036064; GO:0060271; GO:0097711,,,,PF00069;,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]
Q9NG98,CHOYP_LOC100121991.1.1|m.13778,0,0,0,0,0,0,0,0,1.00E-17,DNA topoisomerase 3-alpha (EC 5.99.1.2) (DNA topoisomerase III alpha),Top3alpha CG10123,1250,developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],GO:0000002; GO:0000724; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0005739; GO:0006265; GO:0008270; GO:0042246; GO:0048589,,,cd00186;cd03362;,PF01131;PF01751;PF01396;PF06839;,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]
Q6V0I7,CHOYP_LOC100366518.4.6|m.40074,0,0,0,0,0,0,0,0,1.00E-34,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),FAT4 CDHF14 FATJ Nbla00548,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307,,,,PF00028;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q9BYK8,CHOYP_LOC100368178.1.3|m.36490,0,0,0,0,0,0,0,0,3.00E-159,"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)",HELZ2 KIAA1769 PRIC285,2649,"cellular lipid metabolic process [GO:0044255]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005654; GO:0006351; GO:0016020; GO:0030374; GO:0044255; GO:0045944; GO:0046872,,,,,"membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular lipid metabolic process [GO:0044255]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]"
Q9VEN1,CHOYP_LOC100369791.1.2|m.8271,0,0,0,0,0,0,0,0,6.00E-46,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1),cher cheerio sko CG3937,2210,"behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]",GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495,,,cd00014;,PF00307;PF00630;,"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
A7RX26,CHOYP_LOC100371597.1.1|m.3330,0,0,0,0,0,0,0,0,8.00E-142,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),amdhd1 v1g163675,429,histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],GO:0005737; GO:0019556; GO:0019557; GO:0046872; GO:0050480,PATHWAY: Amino-acid degradation; L-histidine degradation into L-glutamate; N-formimidoyl-L-glutamate from L-histidine: step 3/3.,,cd01296;,PF01979;,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]
B3EWZ6,CHOYP_LOC100372487.1.1|m.39712,0,0,0,0,0,0,0,0,4.00E-21,MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment),,7311,,GO:0005576; GO:0016020,,,cd06263;cd00111;,PF00057;PF00629;PF00088;,extracellular region [GO:0005576]; membrane [GO:0016020]
Q60738,CHOYP_LOC100677972.1.1|m.12181,0.5,0,0,0,0,0,0,0,4.00E-97,Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1),Slc30a1 Znt1,503,cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc II ion transport [GO:0006829],GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010043; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0061088; GO:0070509; GO:0070574; GO:0071584; GO:0071585; GO:0090281,,,,PF01545;,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc II ion transport [GO:0006829]
Q5BJI9,CHOYP_LOC101063838.1.1|m.50540,0,0,0,0,0,0,0,0,1.00E-80,Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),spcs2 zgc:110364,201,protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0031090; GO:0045047,,,,PF06703;,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]
Q8IYE1,CHOYP_LOC594533.1.1|m.58830,0,0,0,0,0,0,0,0,1.00E-106,Coiled-coil domain-containing protein 13,CCDC13,715,cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],GO:0005634; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515,,,,,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515]
Q9BUE0,CHOYP_MED18.1.1|m.28719,0,0,0,0,0,0,0,0,8.00E-68,Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18) (p28b),MED18,208,termination of RNA polymerase II transcription [GO:0006369],GO:0000151; GO:0001104; GO:0006369; GO:0016592; GO:0061630; GO:0070847,,,,PF09637;,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II transcription cofactor activity [GO:0001104]; ubiquitin protein ligase activity [GO:0061630]; termination of RNA polymerase II transcription [GO:0006369]
B3EWZ6,CHOYP_NEMVEDRAFT_V1G198667.1.15|m.3453,0,0,0,0,0,0,0,0,0,MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment),,7311,,GO:0005576; GO:0016020,,,cd06263;cd00111;,PF00057;PF00629;PF00088;,extracellular region [GO:0005576]; membrane [GO:0016020]
Q6UPR8,CHOYP_NEMVEDRAFT_V1G238593.1.1|m.8407,0,0,0,0,0,0,0,0,2.00E-105,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Ermp1 Fxna,898,ovarian follicle development [GO:0001541],GO:0001541; GO:0005783; GO:0005789; GO:0008237; GO:0016021; GO:0046872,,,,PF04389;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541]
P20273,CHOYP_PHUM_PHUM427190.1.1|m.57126,0,0,0,0,0,0,0,0,2.00E-21,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),CD22 SIGLEC2,847,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0070062,,,,PF08205;PF13895;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
Q5XIN7,CHOYP_POMGNT1.1.1|m.33377,0,0,0,0,0,0,0,0,0,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Pomgnt1,660,protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0047223,PATHWAY: Protein modification; protein glycosylation. {ECO:0000250|UniProtKB:Q8WZA1}.,,,PF03071;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; protein O-linked glycosylation [GO:0006493]"
Q8BUM3,CHOYP_PTPRT.40.45|m.61584,0,0,0,0,0,0,0,0,2.00E-52,Tyrosine-protein phosphatase non-receptor type 7 (EC 3.1.3.48) (Hematopoietic protein-tyrosine phosphatase) (HEPTP),Ptpn7,359,protein dephosphorylation [GO:0006470],GO:0004725; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0009898,,,,PF00102;,cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470]
Q8R508,CHOYP_SREC2.7.9|m.44662,0,0,0,0,0,0,0,0,0.000003,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Fat3,4555,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275],GO:0005509; GO:0005886; GO:0007156; GO:0007275; GO:0016021,,,,PF00028;PF00008;PF02210;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]
Q9P3U8,CHOYP_TVAG_199400.1.1|m.52426,0.5,0,0,0,0,0,0,0,0.0000002,Uncharacterized RING finger protein C548.05c,SPCC548.05c,468,CENP-A containing nucleosome assembly [GO:0034080]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],GO:0005634; GO:0006368; GO:0008270; GO:0016567; GO:0034080; GO:0035861; GO:0043161; GO:0044732; GO:0061630,,,,,mitotic spindle pole body [GO:0044732]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; CENP-A containing nucleosome assembly [GO:0034080]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]
P56695,CHOYP_WFS1.1.1|m.25462,0,0,0,0,0,0,0,0,5.00E-94,Wolframin,Wfs1,890,calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],GO:0000122; GO:0000502; GO:0001822; GO:0003091; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030425; GO:0030433; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042048; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045762; GO:0045927; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:1902236; GO:1903892; GO:2000675,,,,,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; ubiquitin protein ligase binding [GO:0031625]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurological system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
Q91857,CHOYP_AAEL_AAEL006988.1.1|m.49733,0,0,0,0,0,0,0,0,0,Transcription initiation factor TFIID subunit 6 (xTAF6) (Transcription initiation factor TFIID 60 kDa subunit) (TAF(II)60) (TAFII-60) (TAFII60) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70),taf6,618,"DNA-templated transcription, initiation [GO:0006352]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090]",GO:0006352; GO:0051090; GO:0071339,,,,PF02969;PF07571;,"MLL1 complex [GO:0071339]; DNA-templated transcription, initiation [GO:0006352]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090]"
B5X2S3,CHOYP_ACT6.1.2|m.20329,0,0,0,0,0,0,0,0,2.00E-11,Actin-related protein 8,actr8,632,"cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitotic nuclear division [GO:0007067]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005524; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0006355; GO:0007067; GO:0031011; GO:0051301,,,,PF00022;,"Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitotic nuclear division [GO:0007067]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q62283,CHOYP_BRAFLDRAFT_265104.1.1|m.4645,0,0,0,0,0,0,0,0,6.00E-63,Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231),Tspan7 Mxs1 Tm4sf2,249,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
O00462,CHOYP_BRAFLDRAFT_65994.1.1|m.40535,0,0,0,0,0,0,0,0,7.00E-90,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),MANBA MANB1,879,cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0009313; GO:0035577; GO:0043202; GO:0043231; GO:0043312,PATHWAY: Glycan metabolism; N-glycan degradation.,,,PF02836;,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]
Q62283,CHOYP_BRAFLDRAFT_96598.1.1|m.54770,0,0,0,0,0,0,0,0,5.00E-17,Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231),Tspan7 Mxs1 Tm4sf2,249,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
Q9U1H0,CHOYP_CIC.1.2|m.57436,0,0,0,0,0,0,0,0,3.00E-36,Putative transcription factor capicua (Protein fettucine),cic fet CG43122,1832,"dorsal appendage formation [GO:0046843]; eye morphogenesis [GO:0048592]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; terminal region determination [GO:0007362]; transcription, DNA-templated [GO:0006351]; wing disc dorsal/ventral pattern formation [GO:0048190]",GO:0000122; GO:0005634; GO:0006351; GO:0006355; GO:0007362; GO:0007474; GO:0030308; GO:0043565; GO:0045892; GO:0046843; GO:0048190; GO:0048592; GO:0070491,,,,PF00505;,"nucleus [GO:0005634]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; dorsal appendage formation [GO:0046843]; eye morphogenesis [GO:0048592]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; terminal region determination [GO:0007362]; transcription, DNA-templated [GO:0006351]; wing disc dorsal/ventral pattern formation [GO:0048190]"
Q0MQD8,CHOYP_DGRI_GH15309.1.1|m.15570,0,0,0,0,0,0,0,0,2.00E-15,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",NDUFB5,189,oxidation-reduction process [GO:0055114],GO:0005654; GO:0005747; GO:0016021; GO:0055114,,,,PF09781;,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; oxidation-reduction process [GO:0055114]
Q505D1,CHOYP_ISCW_ISCW019933.1.1|m.884,0,0,0,0,0,0,0,0,0.00000002,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK),Ankrd28,1053,,GO:0005654,,,,PF00023;PF12796;,nucleoplasm [GO:0005654]
Q15070,CHOYP_LOC100117732.1.1|m.18587,0,0,0,0,0,0,0,0,4.00E-52,Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),OXA1L,435,aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex I biogenesis [GO:0097031]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]; protein complex assembly [GO:0006461]; protein insertion into membrane [GO:0051205]; protein tetramerization [GO:0051262],GO:0005739; GO:0005746; GO:0006461; GO:0009060; GO:0031966; GO:0032592; GO:0032780; GO:0032981; GO:0033615; GO:0042803; GO:0043234; GO:0051205; GO:0051262; GO:0051354; GO:0055114; GO:0097031; GO:0097177,,,,PF02096;,integral component of mitochondrial membrane [GO:0032592]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain [GO:0005746]; mitochondrion [GO:0005739]; protein complex [GO:0043234]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex I biogenesis [GO:0097031]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]; protein complex assembly [GO:0006461]; protein insertion into membrane [GO:0051205]; protein tetramerization [GO:0051262]
Q62940,CHOYP_LOC100367954.2.2|m.66596,0,0,0,0,0,0,0,0,0.000000002,E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4),Nedd4 Nedd4a,887,immune response [GO:0006955]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; response to denervation involved in regulation of muscle adaptation [GO:0014894],GO:0004842; GO:0005737; GO:0005886; GO:0005902; GO:0006955; GO:0008022; GO:0014894; GO:0016567; GO:0030948; GO:0045121; GO:0048814; GO:0070534,PATHWAY: Protein modification; protein ubiquitination.,,cd00078;,PF00168;PF00632;PF00397;,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; response to denervation involved in regulation of muscle adaptation [GO:0014894]
P09848,CHOYP_LOC100371429.1.1|m.13499,0,0,0,0,0,0,0,0,0,Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)],LCT LPH,1927,carbohydrate metabolic process [GO:0005975]; glycosyl compound metabolic process [GO:1901657]; polysaccharide digestion [GO:0044245],GO:0000016; GO:0005886; GO:0005887; GO:0005975; GO:0008422; GO:0016020; GO:0016324; GO:0017042; GO:0044245; GO:1901657,,,,PF00232;,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; glycosyl compound metabolic process [GO:1901657]; polysaccharide digestion [GO:0044245]
Q08DB5,CHOYP_LOC100372966.1.1|m.18755,0,0,0,0,0,0,0,0,4.00E-120,Syntaxin-5,STX5,355,early endosome to Golgi transport [GO:0034498]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0016021; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0048278; GO:0090166; GO:1903358,,,,PF05739;PF11416;,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]
Q9D882,CHOYP_LOC100374742.1.2|m.209,0.5,0,0,0,0,0,0,0,3.00E-10,Uncharacterized protein C10orf35 homolog,,120,,GO:0016021,,,,PF15378;,integral component of membrane [GO:0016021]
P27401,CHOYP_LOC100679608.3.3|m.55829,0,0,0,0,0,0,0,0,9.00E-14,Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)],pol,1143,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732],GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0019012; GO:0030430; GO:0042025; GO:0046718; GO:0046872; GO:0075713; GO:0075732,,,,PF00075;PF00665;PF00078;PF03539;,host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion [GO:0019012]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]
Q8R087,CHOYP_LOC100693702.1.1|m.8794,0,0,0,0,0,0,0,0,9.00E-103,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) [Includes: Xylosylprotein 4-beta-galactosyltransferase (EC 2.4.1.133) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein beta-1,4-galactosyltransferase)]",B4galt7 Xgalt1,327,carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435],GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435,PATHWAY: Protein modification; protein glycosylation.,,,PF02709;PF13733;,"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"
Q9WTN5,CHOYP_LOC100714922.1.1|m.39817,0,0,0,0,0,0,0,0,8.00E-60,Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1),Tpcn1 Tpc1,817,membrane depolarization during action potential [GO:0086010],GO:0005245; GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0072345; GO:0086010,,,,PF00520;,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; membrane depolarization during action potential [GO:0086010]
O35598,CHOYP_LOC100745330.1.1|m.65802,0,0,0,0,0,0,0,0,7.00E-172,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),Adam10 Kuz Madm,749,constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612],GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005925; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007173; GO:0007219; GO:0007220; GO:0008237; GO:0008284; GO:0009986; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0019901; GO:0030307; GO:0030335; GO:0034612; GO:0042117; GO:0042169; GO:0042803; GO:0046872; GO:0051088; GO:0051089; GO:0070062; GO:0097038; GO:0097197,,,cd04270;,PF00200;PF01562;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612]
A2ALS5,CHOYP_LOC100889245.1.2|m.999,0,0,0,0,0,0,0,0,1.00E-127,Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90),Rap1gap Kiaa0474 Rap1ga1,663,negative regulation of microvillus assembly [GO:1903697]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],GO:0000139; GO:0005096; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0042803; GO:0043087; GO:0043547; GO:0050766; GO:0051056; GO:1903697,,,,PF02188;PF02145;,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; negative regulation of microvillus assembly [GO:1903697]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]
O75095,CHOYP_LOC101242430.1.2|m.23519,0,0,0,0,0,0,0,0,0.000002,Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3),MEGF6 EGFL3 KIAA0815,1541,,GO:0005509; GO:0005576,,,,PF07645;PF12661;PF00053;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
Q5ZT34,CHOYP_LOC574855.4.9|m.22339,0,0,0,0,0,0,0,0,0.000001,Malonyl-[acyl-carrier protein] O-methyltransferase (Malonyl-ACP O-methyltransferase) (EC 2.1.1.197) (Biotin synthesis protein BioC),bioC lpg2331,284,biotin biosynthetic process [GO:0009102],GO:0009102; GO:0010340,PATHWAY: Cofactor biosynthesis; biotin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_00835}.,,,PF08241;,carboxyl-O-methyltransferase activity [GO:0010340]; biotin biosynthetic process [GO:0009102]
Q02858,CHOYP_LOC753176.3.3|m.54259,0,0,0,0,0,0,0,0,5.00E-10,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b),Tek Hyk Tie-2 Tie2,1122,angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to retinoic acid [GO:0032526]; single organismal cell-cell adhesion [GO:0016337]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570],GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001935; GO:0001936; GO:0002040; GO:0002741; GO:0004713; GO:0004714; GO:0004872; GO:0005524; GO:0005576; GO:0005815; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016021; GO:0016323; GO:0016324; GO:0016337; GO:0016525; GO:0018108; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0033138; GO:0034446; GO:0042307; GO:0043066; GO:0043552; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0046777; GO:0048014; GO:0048471; GO:0050900; GO:0051259; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1901222; GO:1902533; GO:2000251; GO:2000352,,,cd00063;,PF00041;PF10430;PF07714;,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; receptor activity [GO:0004872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to retinoic acid [GO:0032526]; single organismal cell-cell adhesion [GO:0016337]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]
Q5JR59,CHOYP_LOC763960.1.2|m.17062,0,0,0,0,0,0,0,0,2.00E-36,Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa),MTUS2 CAZIP KIAA0774 TIP150,1369,,GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0042803,,,,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]
O00462,CHOYP_MANBA.2.2|m.47433,0,0,0,0,0,0,0,0,0,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),MANBA MANB1,879,cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0009313; GO:0035577; GO:0043202; GO:0043231; GO:0043312,PATHWAY: Glycan metabolism; N-glycan degradation.,,,PF02836;,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]
O35276,CHOYP_MUC5AC.1.2|m.17430,0,0,0,0,0,0,0,0,2.00E-26,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Nrp2,925,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],GO:0001525; GO:0005021; GO:0007411; GO:0007507; GO:0008201; GO:0016021; GO:0017154; GO:0021612; GO:0021649; GO:0021828; GO:0030424; GO:0036486; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:1901166; GO:1902285; GO:1903375; GO:1904835,,,cd00041;cd06263;,PF00431;PF11980;PF00754;PF00629;,axon [GO:0030424]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]
Q2VJ60,CHOYP_MYS.2.7|m.2064,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.-) (Double ring-finger protein) (Dorfin) (RING finger protein 19A),RNF19A RNF19,838,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0000151; GO:0000209; GO:0005737; GO:0005813; GO:0008270; GO:0016021; GO:0031624; GO:0032436; GO:0042787; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF01485;,centrosome [GO:0005813]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
B4KCD5,CHOYP_NCBP2.1.1|m.60410,0.5,0,0,0,0,0,0,0,3.00E-84,Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20),Cbp20 GI23717,154,"mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]",GO:0000166; GO:0000339; GO:0005846; GO:0005875; GO:0030422; GO:0031053; GO:0045071; GO:0045292; GO:0071011; GO:0071013,,,cd12240;,PF00076;,"catalytic step 2 spliceosome [GO:0071013]; microtubule associated complex [GO:0005875]; nuclear cap binding complex [GO:0005846]; precatalytic spliceosome [GO:0071011]; nucleotide binding [GO:0000166]; RNA cap binding [GO:0000339]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]"
B0V2N1,CHOYP_PTPRE.7.19|m.34309,0,0,0,0,0,0,0,0,2.00E-73,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (PTPNU-3) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma),Ptprs,1907,cell adhesion [GO:0007155]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; spinal cord development [GO:0021510],GO:0004725; GO:0005886; GO:0007155; GO:0008201; GO:0010977; GO:0016021; GO:0021510; GO:0021549; GO:0021766; GO:0021987; GO:0022038; GO:0030517; GO:0035335; GO:0035374; GO:0048681; GO:0070062; GO:0090557,,,cd00063;,PF00041;PF07679;PF00102;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; spinal cord development [GO:0021510]
Q8TCJ2,CHOYP_STT3B.1.1|m.58945,0,0,0,0,0,0,0,0,0,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),STT3B SIMP,826,co-translational protein modification [GO:0043686]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],GO:0004579; GO:0005783; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0043686; GO:0043687,PATHWAY: Protein modification; protein glycosylation.,,,PF02516;,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; co-translational protein modification [GO:0043686]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]
Q96JM2,CHOYP_XFIN.1.4|m.606,0,0,0,0,0,0,0,0,0.00000009,Zinc finger protein 462,ZNF462 KIAA1803,2506,"chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006325; GO:0006351; GO:0043392; GO:0045944; GO:0046872,,,,,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]"
P22105,CHOYP_BRAFLDRAFT_235412.2.2|m.58139,0,0,0,0,0,0,0,0,2.00E-23,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q6P632,CHOYP_BRAFLDRAFT_284784.1.1|m.12397,0,0,0,0,0,0,0,0,2.00E-94,N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit),naa20 nat5,178,N-terminal peptidyl-methionine acetylation [GO:0017196],GO:0004596; GO:0005634; GO:0005737; GO:0017196; GO:0031416,,,,PF00583;,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]
Q5ZM73,CHOYP_BRAFLDRAFT_93126.2.3|m.15451,0,0,0,0,0,0,0,0,0,Mitochondrial Rho GTPase 1 (MIRO-1) (EC 3.6.5.-) (Ras homolog gene family member T1),RHOT1 RCJMB04_2p2,619,cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]; small GTPase mediated signal transduction [GO:0007264],GO:0003924; GO:0005509; GO:0005525; GO:0007264; GO:0019725; GO:0031307; GO:0047497; GO:0097345,,,,PF08355;PF08356;PF00071;,integral component of mitochondrial outer membrane [GO:0031307]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion transport along microtubule [GO:0047497]; small GTPase mediated signal transduction [GO:0007264]
Q6AZ60,CHOYP_BRAFLDRAFT_99630.6.9|m.39673,0,0,0,0,0,0,0,0,0.000008,Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7),Egfl7 Cbl20 Megf7,279,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570],GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0031012; GO:0045746,,,,PF07974;PF07645;PF07546;,extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]
Q6AZ60,CHOYP_BRAFLDRAFT_99630.9.9|m.62562,0,0,0,0,0,0,0,0,0.000008,Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7),Egfl7 Cbl20 Megf7,279,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570],GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0031012; GO:0045746,,,,PF07974;PF07645;PF07546;,extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]
Q70E20,CHOYP_DLLC.2.2|m.27073,0,0,0,0,0,0,0,0,4.00E-28,"Sushi, nidogen and EGF-like domain-containing protein 1 (Secreted protein SST-3) (Stromal nidogen extracellular matrix protein)",Sned1 Snep,1403,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0070062,,,cd00033;cd00063;,PF00008;PF00041;PF12661;PF06119;,extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q9Z1T6,CHOYP_FYV1.1.1|m.41923,0,0,0,0,0,0,0,0,0,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (p235),Pikfyve Kiaa0981 Pip5k3,2097,"intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000139; GO:0000285; GO:0005524; GO:0005829; GO:0005911; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0030659; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0034504; GO:0035556; GO:0042147; GO:0045121; GO:0048471; GO:0052810; GO:2000785,,,,PF00118;PF00610;PF01363;PF01504;,"cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]"
P97521,CHOYP_ISCW_ISCW022609.1.1|m.26988,0,0,0,0,0,0,0,0,2.00E-148,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20),Slc25a20 Cact,301,carnitine transport [GO:0015879]; mitochondrial transport [GO:0006839]; transport [GO:0006810],GO:0005476; GO:0005743; GO:0006810; GO:0006839; GO:0015226; GO:0015879; GO:0016021,,,,PF00153;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; carnitine transmembrane transporter activity [GO:0015226]; carnitine:acyl carnitine antiporter activity [GO:0005476]; carnitine transport [GO:0015879]; mitochondrial transport [GO:0006839]; transport [GO:0006810]
P22105,CHOYP_LOC100160385.1.2|m.40193,0,0,0,0,0,0,0,0,0.000008,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
P22105,CHOYP_LOC100199605.1.1|m.2421,0,0,0,0,0,0,0,0,1.00E-35,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q9D2K4,CHOYP_LOC100368865.1.1|m.48100,0.5,0,0,0,0,0,0,0,0,IQ domain-containing protein H,Iqch,1071,,,,,,,
P22105,CHOYP_LOC100369350.2.6|m.42373,0,0,0,0,0,0,0,0,4.00E-47,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q80VI1,CHOYP_LOC100370907.3.3|m.36832,0,0,0,0,0,0,0,0,3.00E-13,E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56),Trim56,734,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],GO:0003723; GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187,,,,PF00643;PF13445;,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
Q2Q1W2,CHOYP_LOC100376608.2.4|m.47059,0,0,0,0,0,0,0,0,0.000000005,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),TRIM71 LIN41,868,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;,P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
Q8WZ42,CHOYP_LOC100536583.1.1|m.58016,0,0,0,0,0,0,0,0,1.00E-38,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),TTN,34350,cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]
Q01815,CHOYP_LOC100647135.1.2|m.21531,1,0,0,0,0,0,0,0,0,"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2)",Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1,2139,adult walking behavior [GO:0007628]; calcium ion regulated exocytosis [GO:0017156]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542],GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006874; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0014069; GO:0016020; GO:0016021; GO:0017156; GO:0019229; GO:0019899; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0035115; GO:0042593; GO:0043010; GO:0043025; GO:0043198; GO:0045211; GO:0046620; GO:0046872; GO:0051393; GO:0060083; GO:0061337; GO:0061577; GO:0070588; GO:0086002; GO:0086007; GO:0086010; GO:0086012; GO:0086045; GO:0086056; GO:0086091; GO:0098911; GO:0098912; GO:1905030; GO:1990454,,,,PF08763;PF16885;PF16905;PF00520;,caveolar macromolecular signaling complex [GO:0002095]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; adult walking behavior [GO:0007628]; calcium ion regulated exocytosis [GO:0017156]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542]
Q7ZWI4,CHOYP_LOC100888910.1.1|m.64827,0,0,0,0,0,0,0,0,2.00E-29,GSK3-beta interaction protein (GSKIP),gskip zgc:55683,133,,GO:0005737,,,,PF05303;,cytoplasm [GO:0005737]
Q9QXW9,CHOYP_LOC100904518.1.1|m.53104,0,0,0,0,0,0,0,0,4.00E-172,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8),Slc7a8 Lat2,531,amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804],GO:0005275; GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0015807; GO:0016323; GO:0019534; GO:0070062,,,,PF13520;,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; toxin transporter activity [GO:0019534]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; neutral amino acid transport [GO:0015804]
O14522,CHOYP_LOC578968.2.2|m.54316,0,0,0,0,0,0,0,0,2.00E-61,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),PTPRT KIAA0283,1441,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0045294; GO:0045295; GO:0045296; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
P53369,CHOYP_LOC587752.1.1|m.66173,0,0,0,0,0,0,0,0,2.00E-62,"7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",Nudt1 Mth1,156,aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0035539; GO:0036219; GO:0042262; GO:0046061; GO:0046686; GO:0046872; GO:0047693; GO:0070062,,,,PF00293;,"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]"
A4IHD9,CHOYP_MED25.2.2|m.42845,0.5,0,0,0,0,0,0,0,1.00E-64,Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25),med25,805,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355,,,,PF11232;PF11244;PF11235;PF11265;,"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
A6NJ78,CHOYP_METTL15.1.1|m.14094,0,0,0,0,0,0,0,0,1.00E-103,Probable methyltransferase-like protein 15 (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1),METTL15 METT5D1,407,,GO:0008168,,,,PF01795;,methyltransferase activity [GO:0008168]
Q8CI17,CHOYP_NEMVEDRAFT_V1G206032.1.1|m.58857,0,0,0,0,0,0,0,0,0.000000009,Protein mab-21-like 3,Mab21L3,429,,,,,,PF03281;,
Q8CIW5,CHOYP_PEO1.1.1|m.14775,0,0,0,0,0,0,0,0,3.00E-10,"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase)",Peo1,685,cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; transcription from mitochondrial promoter [GO:0006390],GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0006264; GO:0006268; GO:0006390; GO:0034214; GO:0042645; GO:0043139; GO:0051260; GO:0071333,,,cd01029;,,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; transcription from mitochondrial promoter [GO:0006390]
Q6XBJ3,CHOYP_PHUM_PHUM228480.1.1|m.498,0,0,0,0,0,0,0,0,0.00000005,One cut domain family member 2 (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),Onecut2 Oc2,505,anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pancreas development [GO:0031016]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],GO:0000978; GO:0001077; GO:0001889; GO:0001952; GO:0002064; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0009653; GO:0015629; GO:0030335; GO:0030512; GO:0031016; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271,,,,PF02376;PF00046;,"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pancreas development [GO:0031016]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]"
P22105,CHOYP_PTPRM.11.15|m.52054,0,0,0,0,0,0,0,0,2.00E-22,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q96M86,CHOYP_TRIADDRAFT_56463.2.2|m.36123,0,0,0,0,0,0,0,0,0.00000002,Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35),DNHD1 C11orf47 CCDC35 DHCD1 DNHD1L UNQ5781/PRO12970,4753,microtubule-based movement [GO:0007018],GO:0003777; GO:0007018; GO:0030286; GO:0070062,,,,PF08393;PF03028;PF12777;,dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
P82251,CHOYP_BAT1.1.4|m.3906,0,0,0,0,0,0,0,0,7.00E-175,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",SLC7A9 BAT1,487,amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein complex assembly [GO:0006461],GO:0005886; GO:0005887; GO:0006461; GO:0006865; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900,,,,PF13520;,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein complex assembly [GO:0006461]
Q6PGL7,CHOYP_BRAFLDRAFT_118099.1.6|m.1356,0,0,0,0,0,0,0,0,1.00E-90,WASH complex subunit 2,Washc2 D6Wsu116e Fam21 Kiaa0592,1334,"protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0031901; GO:0032266; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1905394,,,,PF15255;,"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
A9CPT4,CHOYP_BRAFLDRAFT_125037.2.3|m.13981,0,0,0,0,0,0,0,0,2.00E-48,Tudor domain-containing protein 1,tdrd1,1133,DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546,,,,PF00567;PF01753;,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
Q6X862,CHOYP_CAD1.2.2|m.61448,0.5,0,0,0,0,0,0,0,3.00E-116,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome),PCDH11X PCDH11 PCDHX,1347,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],GO:0005509; GO:0005886; GO:0007156; GO:0010923; GO:0016021,,,,PF00028;PF08266;PF08374;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
P15253,CHOYP_LOC100083524.1.1|m.50023,0,0,0,0,0,0,0,0,0,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),CALR,418,protein folding [GO:0006457]; protein stabilization [GO:0050821],GO:0005509; GO:0006457; GO:0030246; GO:0033018; GO:0050821,,,,PF00262;,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; protein folding [GO:0006457]; protein stabilization [GO:0050821]
P79402,CHOYP_LOC100371043.3.5|m.24649,0,0,0,0,0,0,0,0,1.00E-49,Cytochrome P450 2C42 (EC 1.14.14.1) (CYPIIC42) (Fragment),CYP2C42,327,epoxygenase P450 pathway [GO:0019373],GO:0005506; GO:0005789; GO:0008392; GO:0019373; GO:0020037; GO:0031090; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; epoxygenase P450 pathway [GO:0019373]
Q66IH2,CHOYP_LOC100708602.1.1|m.65805,0.5,0,0,0,0,0,0,0,1.00E-67,Transforming growth factor beta regulator 1,tbrg1 TEgg020g14.1,409,cell cycle [GO:0007049],GO:0005634; GO:0007049,,,,PF05965;PF05964;,nucleus [GO:0005634]; cell cycle [GO:0007049]
Q9VMY1,CHOYP_LOC100879807.1.1|m.14598,0,0,0,0,0,0,0,0,3.00E-34,"Probable 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24)",mRpL24 CG8849,247,mitochondrial translation [GO:0032543]; sensory perception of pain [GO:0019233]; translation [GO:0006412],GO:0003735; GO:0005762; GO:0006412; GO:0019233; GO:0032543,,,,PF00467;PF17136;,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; sensory perception of pain [GO:0019233]; translation [GO:0006412]
O54926,CHOYP_LOC100892743.1.1|m.55850,0.5,0,0,0,0,0,0,0,3.00E-21,Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP),Siva1 Siva,175,activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0097191; GO:1901030,,,,PF05458;,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]
B0JZV4,CHOYP_LOC100893981.1.1|m.56774,0,0,0,0,0,0,0,0,6.00E-152,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5),agbl5 ccp5,944,defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0051607; GO:0072686,,,cd06236;,PF00246;,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]
Q8BK48,CHOYP_LOC100922782.1.1|m.5582,0.5,0,0,0,0,0,0,0,9.00E-84,Pyrethroid hydrolase Ces2e (EC 3.1.1.88) (carboxylesterase 2E),Ces2e Ces5,559,,GO:0005783; GO:0052689; GO:0102209,,,,PF00135;,endoplasmic reticulum [GO:0005783]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209]
F4JS25,CHOYP_LOC587791.2.3|m.33887,0.5,0,0,0,0,0,0,0,3.00E-10,"Suppressor of RPS4-RLD 1 (Protein SUPPRESSOR OF npr1-1, CONSTITUTIVE 5) (AtSNC5)",SRFR1 SNC5 At4g37460 F6G17.110,1052,"defense response to bacterium [GO:0042742]; defense response to bacterium, incompatible interaction [GO:0009816]; negative regulation of defense response [GO:0031348]; negative regulation of transcription, DNA-templated [GO:0045892]",GO:0005634; GO:0005737; GO:0005783; GO:0009816; GO:0016021; GO:0031348; GO:0032947; GO:0042742; GO:0043231; GO:0045892; GO:0048471,,,,PF13181;,"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex scaffold [GO:0032947]; defense response to bacterium [GO:0042742]; defense response to bacterium, incompatible interaction [GO:0009816]; negative regulation of defense response [GO:0031348]; negative regulation of transcription, DNA-templated [GO:0045892]"
Q14919,CHOYP_NC2A.1.1|m.22786,0.5,0,0,0,0,0,0,0,4.00E-47,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),DRAP1,205,"negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006351; GO:0042802,,,,PF00808;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]"
Q8QZY6,CHOYP_PMTR.1.1|m.46450,0,0,0,0,0,0,0,0,0.00000003,Tetraspanin-14 (Tspan-14) (Transmembrane 4 superfamily member 14),Tspan14 D14Ertd226e Tm4sf14,270,cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604],GO:0005886; GO:0005887; GO:0007166; GO:0009986; GO:0019899; GO:0045747; GO:0051604; GO:0090002; GO:0097197,,,,PF00335;,cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604]
A4YCY6,CHOYP_RS2.4.10|m.21705,0,0,0,0,0,0,0,0,8.00E-54,30S ribosomal protein S5,rps5 Msed_0111,214,translation [GO:0006412],GO:0003735; GO:0006412; GO:0015935; GO:0019843,,,,PF00333;PF03719;,small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q8TKI9,CHOYP_RS3A.7.15|m.20182,0,0,0,0,0,0,0,0,3.00E-19,30S ribosomal protein S3Ae (Ribosomal protein S1e),rps3ae MA_3416,203,translation [GO:0006412],GO:0003735; GO:0005829; GO:0005840; GO:0006412,,,,PF01015;,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
O43451,CHOYP_SUIS.2.2|m.16063,0,0,0,0,0,0,0,0,2.00E-135,"Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]",MGAM MGA MGAML,1857,neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983],GO:0003824; GO:0004339; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016160; GO:0016324; GO:0030246; GO:0032450; GO:0043312; GO:0044245; GO:0070062; GO:0070821; GO:0101003,,,cd00111;,PF01055;PF16863;PF00088;,"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983]"
O13046,CHOYP_WDHD1.1.1|m.23505,0,0,0,0,0,0,0,0,0,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),wdhd1,1127,,GO:0003677; GO:0005654; GO:0005737,,,,PF08662;PF00505;PF12341;PF00400;,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]
Q6R7F2,CHOYP_Y077.1.1|m.27629,0,0,0,0,0,0,0,0,0,Uncharacterized protein ORF77,ORF77,1264,,GO:0016021; GO:0033644,,,,,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]
Q08D64,CHOYP_ABCB6.3.3|m.53101,0,0,0,0,0,0,0,0,0,"ATP-binding cassette sub-family B member 6, mitochondrial",abcb6,849,,GO:0005524; GO:0005741; GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0042626,,,,PF00664;PF00005;PF16185;,"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]"
Q9I931,CHOYP_BRAFLDRAFT_189049.2.2|m.59154,0,0,0,0,0,0,0,0,3.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
Q9VIU7,CHOYP_BRAFLDRAFT_276832.1.2|m.7666,0,0,0,0,0,0,0,0,0.00000003,Probable dolichol-phosphate mannosyltransferase (DPM synthase) (Dolichol-phosphate mannose synthase) (EC 2.4.1.83) (Dolichyl-phosphate beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase),CG10166,241,protein glycosylation [GO:0006486],GO:0004582; GO:0005783; GO:0006486,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;,endoplasmic reticulum [GO:0005783]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; protein glycosylation [GO:0006486]
Q05932,CHOYP_BRAFLDRAFT_284412.1.1|m.37396,1,0,0,0,0,0,0,0,3.00E-158,"Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolylpolyglutamate synthase) (Tetrahydrofolate synthase)",FPGS,587,animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid-containing compound metabolic process [GO:0006760]; folic acid metabolic process [GO:0046655]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],GO:0001889; GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006139; GO:0006536; GO:0006730; GO:0006760; GO:0007420; GO:0008283; GO:0031100; GO:0046655; GO:0046872; GO:0046901,PATHWAY: Cofactor biosynthesis; tetrahydrofolylpolyglutamate biosynthesis.,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]
Q69Z89,CHOYP_BRAFLDRAFT_85170.1.1|m.8699,0,0,0,0,0,0,0,0,5.00E-86,Ras-associating and dilute domain-containing protein,Radil Kiaa1849,1099,multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],GO:0005874; GO:0007165; GO:0007275; GO:0034446,,,,PF01843;PF00595;PF00788;,microtubule [GO:0005874]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]
P51892,CHOYP_DNLI1.1.2|m.19123,0.5,0,0,0,0,0,0,0,0,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),lig1,1070,cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897,,,,PF04679;PF01068;PF04675;,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]
Q9JK41,CHOYP_DPSE_GA20368.1.1|m.6272,0,0,0,0,0,0,0,0,4.00E-13,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1),Slc31a1 Copt1 Ctr1,187,cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import into cell [GO:1902861]; drug transmembrane transport [GO:0006855],GO:0005375; GO:0005737; GO:0005770; GO:0005886; GO:0006855; GO:0006878; GO:0015088; GO:0015677; GO:0016021; GO:0043025; GO:0055037; GO:0072719; GO:1902861,,,,PF04145;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; copper uptake transmembrane transporter activity [GO:0015088]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import into cell [GO:1902861]; drug transmembrane transport [GO:0006855]
Q1RMT1,CHOYP_ERCC3.1.1|m.34841,0,0,0,0,0,0,0,0,0,TFIIH basal transcription factor complex helicase XPB subunit (EC 3.6.4.12) (DNA excision repair protein ERCC-3),ERCC3,782,"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]",GO:0000717; GO:0003677; GO:0004003; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:1901990,,,,PF16203;PF13625;PF04851;,"holo TFIIH complex [GO:0005675]; transcription factor TFIID complex [GO:0005669]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II carboxy-terminal domain kinase activity [GO:0008353]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription from RNA polymerase II promoter [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
Q9I931,CHOYP_FUCL1.1.1|m.28893,11.5,0,0,0,0,0,0,0,1.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
Q6AXX4,CHOYP_ISCW_ISCW011328.1.1|m.8861,0,0,0,0,0,0,0,0,1.00E-80,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog),Utp3 Crlz1 Sas10,470,"brain development [GO:0007420]; covalent chromatin modification [GO:0016569]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]",GO:0000462; GO:0003723; GO:0005634; GO:0005730; GO:0007420; GO:0016569; GO:0032040,,,,PF09368;PF04000;,"nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; brain development [GO:0007420]; covalent chromatin modification [GO:0016569]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
Q640B4,CHOYP_LOC100180920.1.1|m.17133,0,0,0,0,0,0,0,0,1.00E-89,Crossover junction endonuclease MUS81 (EC 3.1.22.-),mus81,612,double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; mitotic G2 DNA damage checkpoint [GO:0007095]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],GO:0000712; GO:0000727; GO:0003677; GO:0005634; GO:0007095; GO:0031297; GO:0031573; GO:0046872; GO:0048257; GO:0048476,,,,PF02732;,Holliday junction resolvase complex [GO:0048476]; nucleus [GO:0005634]; 3'-flap endonuclease activity [GO:0048257]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; mitotic G2 DNA damage checkpoint [GO:0007095]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]
Q8N2E2,CHOYP_LOC100199379.1.2|m.59875,0.5,0,0,0,0,0,0,0,3.00E-27,von Willebrand factor D and EGF domain-containing protein,VWDE,1590,,GO:0005576,,,,PF00094;,extracellular region [GO:0005576]
P61315,CHOYP_LOC100206557.1.1|m.11857,0.5,0,0,0,0,0,0,0,7.00E-37,"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)",Gal3st3,431,glycolipid biosynthetic process [GO:0009247],GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694,PATHWAY: Protein modification; carbohydrate sulfation.,,,PF06990;,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
P49746,CHOYP_LOC100367144.1.1|m.34153,0,0,0,0,0,0,0,0,8.00E-150,Thrombospondin-3,THBS3 TSP3,956,bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346,,,,PF11598;PF07645;PF02412;PF05735;,extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]
Q16820,CHOYP_LOC100372616.2.3|m.5692,0,0,0,0,0,0,0,0,7.00E-44,Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta),MEP1B,701,digestion [GO:0007586]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],GO:0004222; GO:0005615; GO:0005886; GO:0005887; GO:0006954; GO:0007586; GO:0008270; GO:1901998,,,cd06263;cd04282;,PF01400;PF00629;,extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; digestion [GO:0007586]; inflammatory response [GO:0006954]; toxin transport [GO:1901998]
Q1XHU0,CHOYP_LOC100374741.38.83|m.33463,0,0,0,0,0,0,0,0,0.000003,E3 ubiquitin-protein ligase TRIM39 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM39) (Tripartite motif-containing protein 39),TRIM39,518,apoptotic process [GO:0006915]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein ubiquitination [GO:0016567],GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0016567; GO:0016740; GO:2000059; GO:2001235,PATHWAY: Protein modification; protein ubiquitination.,,,PF13765;PF00622;PF00643;,cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein ubiquitination [GO:0016567]
Q55E58,CHOYP_LOC100378653.1.3|m.42107,0,0,0,0,0,0,0,0,9.00E-15,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),pats1 DDB_G0269250,3184,cheating during chimeric sorocarp development [GO:0099139]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; small GTPase mediated signal transduction [GO:0007264],GO:0000281; GO:0004674; GO:0004721; GO:0004871; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0006470; GO:0007264; GO:0035556; GO:0042641; GO:0099139,,,,PF16095;PF06602;PF07714;PF08477;,actomyosin [GO:0042641]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; signal transducer activity [GO:0004871]; cheating during chimeric sorocarp development [GO:0099139]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; small GTPase mediated signal transduction [GO:0007264]
Q9R001,CHOYP_LOC100770235.1.1|m.2514,0,0,0,0,0,0,0,0,6.00E-34,A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAM-TS 5) (ADAM-TS5) (ADAMTS-5) (EC 3.4.24.-) (ADMP-2) (Aggrecanase-2) (Implantin),Adamts5,930,defense response to bacterium [GO:0042742]; tooth eruption [GO:0044691],GO:0004222; GO:0005578; GO:0005615; GO:0008201; GO:0008237; GO:0008270; GO:0042742; GO:0044691; GO:0050840,,,,PF05986;PF01562;PF01421;PF00090;,extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; tooth eruption [GO:0044691]
Q923L3,CHOYP_LOC100906063.1.3|m.20630,0,0,0,0,0,0,0,0,7.00E-13,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),Csmd1,3564,glucose homeostasis [GO:0042593]; startle response [GO:0001964],GO:0001964; GO:0016021; GO:0042593,,,cd00033;cd00041;,PF00431;PF00084;,integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
Q6DCY9,CHOYP_LOC583843.1.1|m.11191,0,0,0,0,0,0,0,0,2.00E-73,HAUS augmin-like complex subunit 3,haus3,597,cell division [GO:0051301]; centrosome organization [GO:0051297]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225],GO:0005737; GO:0005815; GO:0005819; GO:0005874; GO:0007067; GO:0051225; GO:0051297; GO:0051301; GO:0070652,,,,PF14932;,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome organization [GO:0051297]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225]
P79110,CHOYP_LOC660776.1.1|m.53402,0,0,0,0,0,0,0,0,5.00E-142,"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)",SLC25A1 SLC20A3,311,mitochondrial citrate transport [GO:0006843],GO:0005743; GO:0006843; GO:0015137; GO:0016021,,,,PF00153;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; citrate transmembrane transporter activity [GO:0015137]; mitochondrial citrate transport [GO:0006843]
Q8N3A8,CHOYP_PARP8.1.1|m.55346,0,0,0,0,0,0,0,0,8.00E-165,Poly [ADP-ribose] polymerase 8 (PARP-8) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 16) (ARTD16),PARP8,854,,GO:0003950; GO:0005622,,,,PF00644;,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]
H2A0M7,CHOYP_PLSP.4.5|m.44386,0,0,0,0,0,0,0,0,1.00E-136,Peroxidase-like protein,,793,response to oxidative stress [GO:0006979],GO:0004601; GO:0005576; GO:0006979; GO:0020037,,,,PF03098;,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]
Q2EY13,CHOYP_PRTG.2.3|m.27411,0,0,0,0,0,0,0,0,7.00E-107,Protogenin B (Fragment),prtgb,1069,multicellular organism development [GO:0007275],GO:0007275; GO:0016021,,,cd00063;,PF00041;PF07679;,integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275]
Q923L3,CHOYP_SELE.2.2|m.50343,0,0,0,0,0,0,0,0,1.00E-28,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),Csmd1,3564,glucose homeostasis [GO:0042593]; startle response [GO:0001964],GO:0001964; GO:0016021; GO:0042593,,,cd00033;cd00041;,PF00431;PF00084;,integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
Q7ZWG6,CHOYP_SLC46A1.1.1|m.9990,0,0,0,0,0,0,0,0,8.00E-34,Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1),slc46a1 hcp1 pcft zgc:56400,481,transmembrane transport [GO:0055085],GO:0005542; GO:0016021; GO:0055085,,,cd06174;,PF07690;,integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
P20749,CHOYP_BCL3.1.2|m.56007,0,0,0,0,0,0,0,0,1.00E-40,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),BCL3 BCL4 D19S37,454,"antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of translation [GO:0045727]; protein import into nucleus, translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NF-kappaB import into nucleus [GO:0042345]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]",GO:0000060; GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006351; GO:0006974; GO:0007249; GO:0008134; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032729; GO:0032996; GO:0033257; GO:0042088; GO:0042345; GO:0042536; GO:0042742; GO:0042771; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0043234; GO:0045064; GO:0045082; GO:0045415; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0048471; GO:0048536; GO:0051101; GO:0051457,,,,PF12796;,"Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus, translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NF-kappaB import into nucleus [GO:0042345]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]"
Q5BLE8,CHOYP_BRAFLDRAFT_119025.1.3|m.7630,0,0,0,0,0,0,0,0,2.00E-168,"Putative all-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat)",retsat zgc:113107,607,,GO:0016020; GO:0051786,,,,PF01593;,"membrane [GO:0016020]; all-trans-retinol 13,14-reductase activity [GO:0051786]"
Q9VQG2,CHOYP_BRAFLDRAFT_123275.1.1|m.4993,0,0,0,0,0,0,0,0,9.00E-85,Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor),aph-1 PSF CG2855,238,Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of Notch signaling pathway [GO:0008593],GO:0004175; GO:0005770; GO:0005783; GO:0005887; GO:0007219; GO:0007220; GO:0008593; GO:0016485; GO:0043085; GO:0055037; GO:0070765,,,,PF06105;,endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of Notch signaling pathway [GO:0008593]
O54750,CHOYP_BRAFLDRAFT_278496.1.1|m.17793,0,0,0,0,0,0,0,0,5.00E-90,Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6),Cyp2j6,501,epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; linoleic acid metabolic process [GO:0043651]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523],GO:0001523; GO:0003958; GO:0005506; GO:0005783; GO:0005789; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0014070; GO:0019373; GO:0020037; GO:0031090; GO:0043651; GO:0070062; GO:0070330; GO:0071614,,,,PF00067;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; organelle membrane [GO:0031090]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; linoleic acid metabolic process [GO:0043651]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]"
Q14DK5,CHOYP_BRAFLDRAFT_68917.2.3|m.28554,0.5,0,0,0,0,0,0,0,9.00E-19,HHIP-like protein 1,Hhipl1 Hhip2 Kiaa1822,791,carbohydrate metabolic process [GO:0005975],GO:0005044; GO:0005576; GO:0005975; GO:0016020; GO:0016901; GO:0048038,,,,PF03024;PF07995;PF00530;,"extracellular region [GO:0005576]; membrane [GO:0016020]; oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO:0016901]; quinone binding [GO:0048038]; scavenger receptor activity [GO:0005044]; carbohydrate metabolic process [GO:0005975]"
Q5ZL00,CHOYP_BRAFLDRAFT_72541.1.2|m.13652,0,0,0,0,0,0,0,0,0,ER membrane protein complex subunit 1,EMC1 RCJMB04_8i12,983,protein folding in endoplasmic reticulum [GO:0034975],GO:0016021; GO:0034975; GO:0072546,,,,PF07774;PF13360;,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975]
Q801S8,CHOYP_COHA1.1.1|m.60326,0,0,0,0,0,0,0,0,2.00E-27,Collagen alpha-1(VI) chain,col6a1,1045,cell adhesion [GO:0007155],GO:0005578; GO:0005581; GO:0007155,,,,PF01391;PF00092;,collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
P10632,CHOYP_CP2CN.1.1|m.20209,0,0,0,0,0,0,0,0,6.00E-123,Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase),CYP2C8,490,drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008392; GO:0017144; GO:0019373; GO:0019825; GO:0020037; GO:0031090; GO:0034875; GO:0042738; GO:0055114; GO:0070330; GO:0070989; GO:0097267; GO:0101020,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]
Q9DBX3,CHOYP_CPIPJ_CPIJ017084.1.1|m.51185,0,0,0,0,0,0,0,0,2.00E-66,Sushi domain-containing protein 2,Susd2,820,immune response [GO:0006955]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782],GO:0005044; GO:0005886; GO:0006955; GO:0016021; GO:0030247; GO:0051782; GO:0070062; GO:1902807,,,cd00033;,PF03782;PF01033;PF00084;PF00094;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782]
Q20681,CHOYP_CRE_06881.1.1|m.62783,0,0,0,0,0,0,0,0,6.00E-10,BTB and MATH domain-containing protein 38,bath-38 F52H3.3,387,,,,,,PF00651;PF00917;,
Q9R0X0,CHOYP_DHX57.2.2|m.45703,0,0,0,0,0,0,0,0,2.00E-60,Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog),Med20 Trfp,212,"regulation of transcription from RNA polymerase II promoter [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0003713; GO:0005654; GO:0006351; GO:0006357; GO:0016592; GO:0035914,,,,PF08612;,"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription coactivator activity [GO:0003713]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription, DNA-templated [GO:0006351]"
Q92193,CHOYP_FAF1.1.1|m.35623,0,0,0,0,0,0,0,0,2.00E-88,Actin (Fragment),,266,,GO:0005524; GO:0005737; GO:0005856,,,,PF00022;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
Q3TLI0,CHOYP_LOC100122904.1.1|m.45984,0,0,0,0,0,0,0,0,6.00E-172,Trafficking protein particle complex subunit 10 (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1),Trappc10 Tmem1,1259,early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891],GO:0005829; GO:0006891; GO:0034498; GO:1990071,,,,PF12584;,cytosol [GO:0005829]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]
C6KFA3,CHOYP_LOC100370403.1.1|m.11269,0,0,0,0,0,0,0,0,4.00E-77,Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],adgrg6 gpr126,1185,cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],GO:0001503; GO:0004930; GO:0005518; GO:0005622; GO:0005886; GO:0007005; GO:0007166; GO:0007186; GO:0007507; GO:0014037; GO:0016021; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670,,,cd00041;,PF00002;PF00431;PF01825;PF00354;,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G-protein coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
Q07553,CHOYP_LOC100374272.3.6|m.53440,0.5,0,0,0,0,0,0,0,0.000001,Guanylate cyclase 32E (EC 4.6.1.2),Gyc32E GC CG33114,1163,cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; signal transduction [GO:0007165],GO:0004383; GO:0004872; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0008074; GO:0019934,,,,PF01094;PF00211;PF07714;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; receptor activity [GO:0004872]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; signal transduction [GO:0007165]"
Q9BZ19,CHOYP_LOC100374676.1.1|m.61638,1,0,0,0,0,0,0,0,4.00E-43,Ankyrin repeat domain-containing protein 60,ANKRD60 C20orf86,345,,,,,,PF12796;,
Q52MA5,CHOYP_LOC100377702.1.1|m.57555,0,0,0,0,0,0,0,0,0.0000002,Mitochondrial dynamics protein MID51 (Mitochondrial dynamics protein of 51 kDa homolog) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like),mief1 mid51 smcr7l,463,positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314],GO:0000166; GO:0005739; GO:0005741; GO:0016021; GO:0090141; GO:0090314,,,,PF03281;,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]
Q5EAD5,CHOYP_LOC100378658.1.1|m.38454,0,0,0,0,0,0,0,0,1.00E-155,Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta),PGGT1B,377,protein geranylgeranylation [GO:0018344],GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018344,,,,PF00432;,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]
Q6R5N8,CHOYP_LOC100559714.1.1|m.45488,0,0,0,0,0,0,0,0,2.00E-36,Toll-like receptor 13,Tlr13,991,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],GO:0002755; GO:0004872; GO:0005737; GO:0005768; GO:0005887; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042803; GO:0043408; GO:0045087,,,,PF00560;PF12799;PF13855;PF01582;,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; protein homodimerization activity [GO:0042803]; receptor activity [GO:0004872]; rRNA binding [GO:0019843]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]
Q9Y305,CHOYP_LOC100691486.1.1|m.24964,0,0,0,0,0,0,0,0,2.00E-111,"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)",ACOT9 CGI-16,439,acyl-CoA metabolic process [GO:0006637]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338],GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0035338; GO:0047617; GO:0052689,,,,,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]
A5PMU4,CHOYP_LOC101076145.1.1|m.26253,0,0,0,0,0,0,0,0,0.00000002,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,anks1b si:ch211-211o1.2 si:dkey-11k24.3,1280,regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],GO:0005737; GO:0016020; GO:1900383,,,,PF12796;PF00640;PF00536;PF07647;,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]
C6KFA3,CHOYP_LOC577191.1.1|m.25751,0,0,0,0,0,0,0,0,6.00E-60,Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],adgrg6 gpr126,1185,cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],GO:0001503; GO:0004930; GO:0005518; GO:0005622; GO:0005886; GO:0007005; GO:0007166; GO:0007186; GO:0007507; GO:0014037; GO:0016021; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670,,,cd00041;,PF00002;PF00431;PF01825;PF00354;,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G-protein coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
Q9Z0R0,CHOYP_LOC579644.1.1|m.16828,0.5,0,0,0,0,0,0,0,3.00E-97,Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (Haploid germ cell-specific nuclear protein kinase),Gsg2,754,"histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]; regulation of spindle checkpoint [GO:0090231]",GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:0090231; GO:2000134; GO:2000751,,,,PF12330;,"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]; regulation of spindle checkpoint [GO:0090231]"
Q5T0B9,CHOYP_LOC660560.4.4|m.54542,0.5,0,0,0,0,0,0,0,3.00E-32,Zinc finger protein 362,ZNF362 PP6997,420,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P15127,CHOYP_MEG10.70.91|m.54892,0,0,0,0,0,0,0,0,2.00E-19,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],Insr,1383,cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transporter activity [GO:0032410]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of phosphorylation [GO:0042327]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]; protein phosphorylation [GO:0006468]; regulation of hydrogen peroxide metabolic process [GO:0010310]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280],GO:0001933; GO:0004672; GO:0004713; GO:0005009; GO:0005524; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0006468; GO:0008286; GO:0009725; GO:0009749; GO:0010042; GO:0010310; GO:0010560; GO:0010629; GO:0014823; GO:0016021; GO:0018108; GO:0019901; GO:0019903; GO:0019904; GO:0021549; GO:0021766; GO:0031405; GO:0031667; GO:0032355; GO:0032403; GO:0032410; GO:0032868; GO:0033280; GO:0033574; GO:0034612; GO:0042327; GO:0042593; GO:0043025; GO:0043231; GO:0043423; GO:0043559; GO:0043560; GO:0045202; GO:0045444; GO:0045471; GO:0046777; GO:0051290; GO:0051384,,,cd00063;,PF00041;PF00757;PF07714;PF01030;,cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; lipoic acid binding [GO:0031405]; protein complex binding [GO:0032403]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transporter activity [GO:0032410]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of phosphorylation [GO:0042327]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]; protein phosphorylation [GO:0006468]; regulation of hydrogen peroxide metabolic process [GO:0010310]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to manganese ion [GO:0010042]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]
O15439,CHOYP_MRP4.1.3|m.6939,0,0,0,0,0,0,0,0,0,Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B),ABCC4 MRP4,1325,cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085],GO:0002576; GO:0005524; GO:0005886; GO:0005887; GO:0010243; GO:0014070; GO:0015662; GO:0016020; GO:0016323; GO:0016404; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0043225; GO:0048661; GO:0055085; GO:0060271,,,,PF00664;PF00005;,"basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [GO:0015662]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; cilium assembly [GO:0060271]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]"
P0C2B8,CHOYP_MRPL55.1.1|m.1120,0,0,0,0,0,0,0,0,2.00E-19,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)",MRPL55,126,mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]; translation [GO:0006412],GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070124; GO:0070125,,,,PF09776;,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]; translation [GO:0006412]
Q0IHH1,CHOYP_NAA30.1.1|m.50680,0,0,0,0,0,0,0,0,6.00E-88,N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),naa30 mak3 nat12,273,,GO:0004596; GO:0005634; GO:0005737; GO:0031417,,,,PF00583;,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]
Q05909,CHOYP_PTPRE.8.19|m.40114,0,0,0,0,0,0,0,0,9.00E-75,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),Ptprg,1442,negative regulation of epithelial cell migration [GO:0010633]; toxin transport [GO:1901998],GO:0004725; GO:0010633; GO:0016021; GO:0042802; GO:0070062; GO:1901998,,,cd00063;,PF00194;PF00041;PF00102;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; toxin transport [GO:1901998]
Q9Z1G4,CHOYP_VPP1.1.2|m.2769,0,0,0,0,0,0,0,0,0,V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),Atp6v0a1 Atp6n1,839,ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0015986; GO:0015991; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030659; GO:0042470; GO:0043231; GO:0046961; GO:0051117; GO:0070062; GO:0070072; GO:1901998,,,,PF01496;,"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]"
Q8N7Z5,CHOYP_WRI_006090.1.1|m.34650,9,0,0,0,0,0,0,0,1.00E-14,Putative ankyrin repeat domain-containing protein 31,ANKRD31,1873,,,,,,PF00023;PF12796;,
Q9D8Z1,CHOYP_ASCC1.1.1|m.39863,0,0,0,0,0,0,0,0,4.00E-125,Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50),Ascc1,356,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0031594,,,,PF10469;PF00013;,"neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6ZUJ8,CHOYP_BCAP.2.2|m.41601,0,0,0,0,0,0,0,0,2.00E-23,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),PIK3AP1 BCAP,805,phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0005829; GO:0005886; GO:0014066; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0046934; GO:0048015; GO:0050727,,,,PF14545;,"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]"
Q7TPQ3,CHOYP_BRAFLDRAFT_125252.1.1|m.14950,0,0,0,0,0,0,0,0,3.00E-24,"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)",Shprh,1674,cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006334; GO:0006974; GO:0008270; GO:0031625,PATHWAY: Protein modification; protein ubiquitination.,,,PF00271;PF00538;PF00176;,nucleosome [GO:0000786]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]
Q9TU53,CHOYP_BRAFLDRAFT_143777.2.2|m.64068,0,0,0,0,0,0,0,0,1.00E-38,Cubilin,CUBN,3620,cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031],GO:0005509; GO:0005765; GO:0008203; GO:0010008; GO:0015031; GO:0016324; GO:0031419,,,cd00041;,PF00431;PF00008;PF12947;PF07645;,apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]
Q96P65,CHOYP_BRAFLDRAFT_202783.1.2|m.21505,0,0,0,0,0,0,0,0,9.00E-42,Pyroglutamylated RFamide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),QRFPR GPR103,431,cellular response to hormone stimulus [GO:0032870]; G-protein coupled receptor signaling pathway [GO:0007186]; response to peptide [GO:1901652],GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0016021; GO:0032870; GO:0042277; GO:1901652,,,,PF00001;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]; cellular response to hormone stimulus [GO:0032870]; G-protein coupled receptor signaling pathway [GO:0007186]; response to peptide [GO:1901652]
P86854,CHOYP_BRAFLDRAFT_223573.1.1|m.4526,0,0,0,0,0,0,0,0,2.00E-16,Perlucin-like protein,,156,,GO:0005576; GO:0030246,,,cd03590;,PF00059;,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
O70277,CHOYP_BRAFLDRAFT_232970.5.5|m.53358,0,0,0,0,0,0,0,0,0.0000001,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,744,protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]
Q6P3Z3,CHOYP_BRAFLDRAFT_65518.1.1|m.29803,0,0,0,0,0,0,0,0,7.00E-43,THAP domain-containing protein 4,Thap4,569,,GO:0003677; GO:0046872,,,cd07828;,PF08768;PF05485;,DNA binding [GO:0003677]; metal ion binding [GO:0046872]
O75112,CHOYP_ISCW_ISCW000210.4.4|m.38490,0,0,0,0,0,0,0,0,3.00E-11,LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein),LDB3 KIAA0613 ZASP,727,sarcomere organization [GO:0045214],GO:0005856; GO:0008092; GO:0008270; GO:0030018; GO:0031143; GO:0045214; GO:0048471,,,,PF15936;PF00412;PF00595;,cytoskeleton [GO:0005856]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; Z disc [GO:0030018]; cytoskeletal protein binding [GO:0008092]; zinc ion binding [GO:0008270]; sarcomere organization [GO:0045214]
Q0VAA2,CHOYP_LOC100187037.1.1|m.55673,0,0,0,0,0,0,0,0,3.00E-66,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),LRRC74A C14orf166B LRRC74,488,,,,,,PF13516;,
Q3UPW2,CHOYP_LOC100368128.1.1|m.9893,0,0,0,0,0,0,0,0,9.00E-30,ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1),Elf3 Ert Esx Jen,391,"anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]",GO:0000978; GO:0001077; GO:0001824; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0006954; GO:0009653; GO:0030154; GO:0030198; GO:0030855; GO:0045892; GO:0045893; GO:0045944; GO:0060056,,,,PF00178;PF02198;,"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
Q32LJ3,CHOYP_LOC100373454.1.1|m.59681,2.5,0,0,0,0,0,0,0,9.00E-12,Uncharacterized protein CXorf65 homolog,,174,,,,,,,
A1L2I9,CHOYP_LOC100559294.1.1|m.8325,0,0,0,0,0,0,0,0,1.00E-96,Transmembrane protein 214-B,tmem214-b,679,apoptotic process [GO:0006915],GO:0005789; GO:0006915; GO:0016021,,,,PF10151;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]
Q5BK09,CHOYP_LOC100576447.2.2|m.55515,0.5,0,0,0,0,0,0,0,1.00E-38,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),Dram2 Tmem77,267,apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],GO:0001917; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0045494,,,,PF10277;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]
Q9QYP0,CHOYP_LOC101156767.1.1|m.65605,0,0,0,0,0,0,0,0,0,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Megf8 Egfl4,2788,BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],GO:0003143; GO:0005509; GO:0005634; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0048704; GO:0048842; GO:0060971; GO:0060972; GO:0061371; GO:0071907; GO:0097155,,,cd00041;,PF00431;PF12947;PF07645;PF00053;PF01437;PF17205;,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]
Q91W89,CHOYP_MA2C1.1.1|m.46709,0,0,0,0,0,0,0,0,0,Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1),Man2c1,1039,mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],GO:0004559; GO:0005654; GO:0005773; GO:0006013; GO:0006517; GO:0008270; GO:0030246,,,,PF09261;PF01074;PF07748;,nucleoplasm [GO:0005654]; vacuole [GO:0005773]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; zinc ion binding [GO:0008270]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]
P41885,CHOYP_PCLO.1.2|m.27122,0,0,0,0,0,0,0,0,9.00E-19,Rabphilin-1,rbf-1 F37A4.7,1106,calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; dense core granule exocytosis [GO:1990504]; intracellular protein transport [GO:0006886]; positive regulation of locomotion [GO:0040017]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle fusion [GO:0006906],GO:0005509; GO:0005544; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0040017; GO:0048791; GO:1990504,,,,PF00168;PF02318;,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; dense core granule exocytosis [GO:1990504]; intracellular protein transport [GO:0006886]; positive regulation of locomotion [GO:0040017]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle fusion [GO:0006906]
O95822,CHOYP_PHUM_PHUM479110.1.1|m.54103,0.5,0,0,0,0,0,0,0,1.00E-133,"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)",MLYCD,493,acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],GO:0002931; GO:0005102; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0046321; GO:0050080; GO:2001294,PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis; acetyl-CoA from malonyl-CoA: step 1/1.,,,PF05292;,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; malonyl-CoA decarboxylase activity [GO:0050080]; receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]
Q7ZUC7,CHOYP_PHUM_PHUM580720.1.1|m.14624,0,0,0,0,0,0,0,0,5.00E-77,Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2),ptges2 pges2 ptgesl,377,cell redox homeostasis [GO:0045454]; prostaglandin biosynthetic process [GO:0001516],GO:0000139; GO:0001516; GO:0009055; GO:0015035; GO:0016021; GO:0016829; GO:0020037; GO:0043295; GO:0045454; GO:0050220,PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000250|UniProtKB:Q66LN0}.,,cd03197;,PF00462;PF00043;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; electron carrier activity [GO:0009055]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; prostaglandin biosynthetic process [GO:0001516]
P86854,CHOYP_PLC.3.5|m.7658,0,0,0,0,0,0,0,0,2.00E-23,Perlucin-like protein,,156,,GO:0005576; GO:0030246,,,cd03590;,PF00059;,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
B2RU80,CHOYP_PTP10.3.3|m.46720,0,0,0,0,0,0,0,0,8.00E-87,Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP),Ptprb,1998,angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],GO:0001525; GO:0004725; GO:0016021; GO:0016311; GO:0043235,,,cd00063;,PF00041;PF00102;,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]
P29352,CHOYP_PTPRF.2.6|m.17540,1,0,0,0,0,0,0,0,4.00E-45,Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (PEST-domain phosphatase) (PEP),Ptpn22 Ptpn8,802,"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of leukocyte migration [GO:0002685]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]",GO:0002230; GO:0002685; GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032720; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035549; GO:0035644; GO:0042993; GO:0043508; GO:0048471; GO:0050730; GO:0050852; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1900165; GO:1901222; GO:1902523; GO:1902715; GO:1902741; GO:1903169; GO:1903753; GO:2000483; GO:2000566,,,,PF00102;,"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of leukocyte migration [GO:0002685]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"
O00237,CHOYP_RN103.1.1|m.60665,0,0,0,0,0,0,0,0,6.00E-107,E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (KF-1) (hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog) (Zfp-103),RNF103 ZFP103,685,central nervous system development [GO:0007417]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005783; GO:0005789; GO:0007417; GO:0008270; GO:0016021; GO:0016567; GO:0030433; GO:0044322; GO:1904264; GO:1904380,PATHWAY: Protein modification; protein ubiquitination.,,,PF13639;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein ubiquitination [GO:0016567]
Q60857,CHOYP_SC6A7.1.1|m.64266,0,0,0,0,0,0,0,0,4.00E-139,Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4),Slc6a4 Htt Sert,630,"brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine uptake involved in synaptic transmission [GO:0051583]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; protein homooligomerization [GO:0051260]; protein oligomerization [GO:0051259]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; thalamus development [GO:0021794]; vasoconstriction [GO:0042310]",GO:0001666; GO:0005330; GO:0005335; GO:0005829; GO:0005886; GO:0005887; GO:0006837; GO:0007584; GO:0007613; GO:0007623; GO:0008504; GO:0009636; GO:0010008; GO:0010628; GO:0012505; GO:0014064; GO:0015222; GO:0015844; GO:0017137; GO:0019811; GO:0021794; GO:0021941; GO:0032227; GO:0032355; GO:0035176; GO:0042310; GO:0042493; GO:0042713; GO:0043005; GO:0045121; GO:0045665; GO:0045787; GO:0046621; GO:0046872; GO:0048854; GO:0050998; GO:0051015; GO:0051259; GO:0051260; GO:0051583; GO:0051610; GO:0071300; GO:0071310; GO:0071321; GO:0098793,,,,PF03491;PF00209;,"cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; nitric-oxide synthase binding [GO:0050998]; Rab GTPase binding [GO:0017137]; serotonin transmembrane transporter activity [GO:0015222]; serotonin:sodium symporter activity [GO:0005335]; brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine uptake involved in synaptic transmission [GO:0051583]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; protein homooligomerization [GO:0051260]; protein oligomerization [GO:0051259]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; thalamus development [GO:0021794]; vasoconstriction [GO:0042310]"
Q8K078,CHOYP_SO4A1.1.1|m.46501,0,0,0,0,0,0,0,0,0,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Slco4a1 Oatp4a1 Oatpe Slc21a12,723,organic anion transport [GO:0015711],GO:0005887; GO:0008514; GO:0015711,,,cd06174;,PF07648;PF03137;,integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; organic anion transport [GO:0015711]
F4JLS1,CHOYP_SORBIDRAFT_06G032450.1.1|m.16356,0,0,0,0,0,0,0,0,2.00E-33,Lysine-specific histone demethylase 1 homolog 3 (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 3) (Protein LSD1-like 3),LDL3 At4g16310/At4g16320 dl4185w/dl4190w FCAALL.342/ FCAALL.344,1628,"covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0016491; GO:0016569,,,,PF01593;PF04433;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; oxidoreductase activity [GO:0016491]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
O00534,CHOYP_VMA5A.1.1|m.24860,0,0,0,0,0,0,0,0,2.00E-112,von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein),VWA5A BCSC1 LOH11CR2A,786,,,,,,PF08487;PF13768;,
P15287,CHOYP_AGSA.1.1|m.5200,0,0,0,0,0,0,0,0,3.00E-55,Adenosine deaminase AGSA (EC 3.5.4.4) (Atrial gland-specific antigen) (AGSA) (Mollusk-derived growth factor) (MDGF),,525,,GO:0004000; GO:0005615; GO:0046872,,,,PF00962;PF08451;,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]
O57579,CHOYP_APN.1.3|m.316,0,0,0,0,0,0,0,0,0,Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N),ANPEP APDE,972,cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165],GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006,,,cd09601;,PF11838;PF01433;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]
O43736,CHOYP_BRAFLDRAFT_120146.1.1|m.26173,0,0,0,0,0,0,0,0,2.00E-14,Integral membrane protein 2A (Protein E25),ITM2A UNQ603/PRO1189,263,immunoglobulin production [GO:0002377]; plasma cell differentiation [GO:0002317],GO:0002317; GO:0002377; GO:0016021,,,,PF04089;,integral component of membrane [GO:0016021]; immunoglobulin production [GO:0002377]; plasma cell differentiation [GO:0002317]
Q96IG2,CHOYP_BRAFLDRAFT_74861.1.1|m.16599,0,0,0,0,0,0,0,0,4.00E-11,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),FBXL20 FBL2,436,behavioral fear response [GO:0001662]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0001662; GO:0004842; GO:0005829,,,,PF12937;PF13516;,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; protein polyubiquitination [GO:0000209]
B3EWZ3,CHOYP_BRAFLDRAFT_85664.10.10|m.45430,0,0,0,0,0,0,0,0,1.00E-98,Coadhesin (Fragment),,1675,,GO:0016021,,,,PF00754;PF00090;PF00092;,integral component of membrane [GO:0016021]
Q9TUQ3,CHOYP_BRAFLDRAFT_85664.2.10|m.9436,0,0,0,0,0,0,0,0,0.000000004,Complement component C7,C7,843,"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]",GO:0005576; GO:0005579; GO:0006957; GO:0006958; GO:0019835,,,cd00033;,PF00057;PF01823;PF00084;PF00090;,"extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]"
Q9D3P8,CHOYP_BRAFLDRAFT_88556.1.1|m.50506,0,0,0,0,0,0,0,0,9.00E-37,Plasminogen receptor (KT) (Plg-R(KT)),Plgrkt,147,chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756],GO:0005739; GO:0005887; GO:0006935; GO:0006954; GO:0010756,,,,PF10166;,integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756]
B3EWY9,CHOYP_BRAFLDRAFT_92365.3.3|m.51160,0,0,0,0,0,0,0,0,6.00E-47,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
A9JRL3,CHOYP_CBPC1.1.1|m.30712,0,0,0,0,0,0,0,0,0,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1),agtpbp1 ccp1,1226,cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; C-terminal protein deglutamylation [GO:0035609]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; T cell differentiation in thymus [GO:0033077],GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0033077; GO:0035609; GO:0035610; GO:0043009; GO:0050905,,,cd06906;,PF00246;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; T cell differentiation in thymus [GO:0033077]
Q28CF8,CHOYP_ENTPD4.1.1|m.15533,0.5,0,0,0,0,0,0,0,3.00E-162,Ectonucleoside triphosphate diphosphohydrolase 7 (NTPDase 7) (EC 3.6.1.-),entpd7 TGas060f02.1,610,,GO:0016021; GO:0016787; GO:0030659; GO:0046872,,,,PF01150;,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
Q68FD7,CHOYP_FNIP1.1.1|m.23640,0,0,0,0,0,0,0,0,4.00E-97,Folliculin-interacting protein 1,Fnip1 Kiaa1961,1165,cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0009267; GO:0031334; GO:0031929; GO:0032007; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:2000973,,,,PF14638;PF14637;PF14636;,cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]
Q8TB96,CHOYP_ITFG1.1.1|m.51655,0,0,0,0,0,0,0,0,2.00E-140,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),ITFG1 LNKN-1 TIP CDA08,612,,GO:0016021; GO:0070062,,,,,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]
P55214,CHOYP_LOC100068258.1.1|m.37406,0,0,0,0,0,0,0,0,5.00E-69,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (ICE-like apoptotic protease 3) (ICE-LAP3) (SREBP cleavage activity 2) (SCA-2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7 MCH3,303,apoptotic process [GO:0006915],GO:0004197; GO:0005737; GO:0006915,,,cd00032;,,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]
Q4L208,CHOYP_LOC100159032.1.1|m.14934,0,0,0,0,0,0,0,0,3.00E-175,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),Slc9a8 Nhe8,575,potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453],GO:0000139; GO:0005794; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805,,,,PF00999;,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]
Q5RH71,CHOYP_LOC100162380.1.1|m.23942,0,0,0,0,0,0,0,0,6.00E-48,Tetraspanin-33 (Tspan-33),tspan33 zgc:92266,281,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
Q9JM83,CHOYP_LOC100261610.1.1|m.6374,1.5,0,0,0,0,0,0,0,1.00E-15,Calmodulin-4 (Calcium-binding protein Dd112),Calm4 Dd112,148,,GO:0005509; GO:0070062,,,cd00051;,PF13499;,extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]
Q502L2,CHOYP_LOC100367769.1.2|m.27169,0,0,0,0,0,0,0,0,2.00E-93,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)",pgam5 si:dkey-69p22.1 zgc:92057,289,programmed cell death [GO:0012501],GO:0004721; GO:0005741; GO:0012501; GO:0016021,,,cd07067;,PF00300;,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; phosphoprotein phosphatase activity [GO:0004721]; programmed cell death [GO:0012501]
Q7K4Y6,CHOYP_LOC100375514.4.6|m.41109,0,0,0,0,0,0,0,0,3.00E-172,Sodium-dependent dopamine transporter (Protein fumin),DAT fmn CG8380,631,adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431],GO:0005328; GO:0005329; GO:0005887; GO:0008344; GO:0015872; GO:0019811; GO:0030431; GO:0042745; GO:0046872; GO:0098793; GO:0099509; GO:1990834,,,,PF00209;,integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; cocaine binding [GO:0019811]; dopamine transmembrane transporter activity [GO:0005329]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]
Q22549,CHOYP_LOC100533355.1.2|m.6485,0,0,0,0,0,0,0,0,5.00E-79,Innexin-10 (Protein opu-10),inx-10 opu-10 T18H9.5,559,ion transport [GO:0006811],GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021; GO:0055077,,,,PF00876;,gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transport [GO:0006811]
Q5M9G3,CHOYP_LOC100565981.1.1|m.29912,0,0,0,0,0,0,0,0,7.00E-55,Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (RNA granule protein 105),Caprin1 Gpiap1 Rng105,707,negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],GO:0000932; GO:0003723; GO:0005829; GO:0010494; GO:0017148; GO:0030425; GO:0050775; GO:0061003,,,,PF12287;,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; P-body [GO:0000932]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]
Q2PFD7,CHOYP_LOC100864134.1.1|m.41690,0,0,0,0,0,0,0,0,3.00E-137,PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Pleckstrin homology and SEC7 domain-containing protein 3),Psd3 Efa6d Kiaa0942,1037,ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012],GO:0005086; GO:0005622; GO:0014069; GO:0016020; GO:0030054; GO:0032011; GO:0032012; GO:0045211,,,,PF01369;,cell junction [GO:0030054]; intracellular [GO:0005622]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012]
P61805,CHOYP_LOC578220.1.2|m.16983,0,0,0,0,0,0,0,0,3.00E-56,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (EC 2.4.99.18) (Defender against cell death 1) (DAD-1),Dad1,113,apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to drug [GO:0042493]; response to nutrient [GO:0007584],GO:0001824; GO:0004579; GO:0006486; GO:0006487; GO:0006915; GO:0007584; GO:0008250; GO:0016021; GO:0042493; GO:0043066; GO:0070062,PATHWAY: Protein modification; protein glycosylation.,,,PF02109;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to drug [GO:0042493]; response to nutrient [GO:0007584]
Q8N841,CHOYP_LOC660482.1.1|m.8222,0,0,0,0,0,0,0,0,1.00E-21,Tubulin polyglutamylase TTLL6 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 6),TTLL6 TTL.6,843,microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095],GO:0001578; GO:0003353; GO:0005524; GO:0005737; GO:0005874; GO:0015631; GO:0018095; GO:0036064; GO:0051013; GO:0070739,,,,PF03133;,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]
O43614,CHOYP_LOC762961.3.5|m.46330,0.5,0,0,0,0,0,0,0,8.00E-25,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),HCRTR2,444,"cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0005886; GO:0005887; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0042277; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
A2AJ76,CHOYP_LOC763793.3.7|m.24306,0,0,0,0,0,0,0,0,0.00000007,Hemicentin-2,Hmcn2,5100,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
O88382,CHOYP_MAGI1.1.1|m.66921,0,0,0,0,0,0,0,0,2.00E-140,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Membrane-associated guanylate kinase inverted 2) (MAGI-2) (Synaptic-scaffolding molecule) (S-SCAM)",Magi2 Acvrinp1 Aip1 Sscam,1277,cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; SMAD protein signal transduction [GO:0060395],GO:0002092; GO:0003094; GO:0004871; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005923; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032403; GO:0032516; GO:0032926; GO:0036057; GO:0038180; GO:0043113; GO:0043234; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070699; GO:0071850; GO:0072015; GO:1990090,,,,PF00625;PF00595;PF00397;,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein complex [GO:0043234]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; protein complex binding [GO:0032403]; receptor signaling complex scaffold activity [GO:0030159]; signal transducer activity [GO:0004871]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; SMAD protein signal transduction [GO:0060395]
Q6AY62,CHOYP_NEUFC.1.1|m.44515,0,0,0,0,0,0,0,0,6.00E-69,Neuferricin (Cytochrome b5 domain-containing protein 2),Cyb5d2,263,positive regulation of neuron differentiation [GO:0045666],GO:0005576; GO:0012505; GO:0016020; GO:0020037; GO:0045666,,,,PF00173;,endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]; heme binding [GO:0020037]; positive regulation of neuron differentiation [GO:0045666]
Q96CD2,CHOYP_PPCDC.1.1|m.41651,0,0,0,0,0,0,0,0,4.00E-78,Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC),PPCDC COAC MDS018 UNQ9365/PRO34154,204,coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],GO:0004633; GO:0005829; GO:0009108; GO:0015937; GO:0042802,PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 3/5.,,,PF02441;,cytosol [GO:0005829]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]
P23470,CHOYP_PTPRG.3.3|m.65311,0,0,0,0,0,0,0,0,4.00E-83,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),PTPRG PTPG,1445,brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005001; GO:0005615; GO:0005887; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062,,,cd00063;,PF00194;PF00041;PF00102;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
B3EWY9,CHOYP_contig_050919|m.60703,0,0,0,0,0,0,0,0,3.00E-95,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
P55096,CHOYP_ABCD3.1.1|m.14559,0,0,0,0,0,0,0,0,0,ATP-binding cassette sub-family D member 3 (68 kDa peroxisomal membrane protein) (PMP68) (70 kDa peroxisomal membrane protein) (PMP70),Abcd3 Pmp70 Pxmp1,659,fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; peroxisomal long-chain fatty acid import [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760],GO:0005324; GO:0005524; GO:0005739; GO:0005743; GO:0005777; GO:0005778; GO:0005782; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231,,,,PF06472;PF00005;,"integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; peroxisomal long-chain fatty acid import [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760]"
Q54SW1,CHOYP_BRAFLDRAFT_120431.1.1|m.49038,0.5,0,0,0,0,0,0,0,0.00000005,Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0282179,DDB_G0282179,145,lipid transport [GO:0006869],GO:0006869,,,,PF02221;,lipid transport [GO:0006869]
Q9HCS2,CHOYP_BRAFLDRAFT_61250.13.14|m.57254,0,0,0,0,0,0,0,0,4.00E-117,Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12),CYP4F12 UNQ568/PRO1129,524,arachidonic acid metabolic process [GO:0019369]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; oxidation-reduction process [GO:0055114]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360],GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0005506; GO:0005737; GO:0005789; GO:0008392; GO:0016021; GO:0016324; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0019825; GO:0020037; GO:0031090; GO:0036101; GO:0042360; GO:0043231; GO:0050051; GO:0055078; GO:0055114; GO:0070330,,,,PF00067;,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; oxygen binding [GO:0019825]; arachidonic acid metabolic process [GO:0019369]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; oxidation-reduction process [GO:0055114]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]
O75382,CHOYP_BRAFLDRAFT_86890.2.4|m.23914,0,0,0,0,0,0,0,0,5.00E-13,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),TRIM3 BERP RNF22 RNF97,744,nervous system development [GO:0007399]; protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; protein transport [GO:0015031]
Q28IU1,CHOYP_DHB12.1.1|m.62534,0,0,0,0,0,0,0,0,2.00E-103,Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62),hsd17b12 TNeu053h21.1,320,estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; steroid biosynthetic process [GO:0006694],GO:0004303; GO:0005789; GO:0006633; GO:0006694; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342,PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000250|UniProtKB:Q53GQ0}.; PATHWAY: Steroid biosynthesis; estrogen biosynthesis. {ECO:0000250|UniProtKB:Q53GQ0}.,,,PF00106;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; steroid biosynthetic process [GO:0006694]
Q99JY4,CHOYP_ISCW_ISCW013325.1.2|m.5734,0,0,0,0,0,0,0,0,4.00E-87,TraB domain-containing protein,Trabd,376,,,,,,PF01963;,
O75496,CHOYP_LOC100313617.1.1|m.18024,0,0,0,0,0,0,0,0,3.00E-15,Geminin,GMNN,209,"animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; protein complex assembly [GO:0006461]",GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006461; GO:0007049; GO:0008156; GO:0009887; GO:0042826; GO:0045786; GO:0045892,,,,PF07412;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; protein complex assembly [GO:0006461]"
Q96S38,CHOYP_LOC100371127.1.1|m.23427,0,0,0,0,0,0,0,0,7.00E-59,Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein),RPS6KC1 RPK118,1066,signal transduction [GO:0007165],GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091,,,,PF04212;PF00069;PF00787;,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]
Q6ZUK4,CHOYP_LOC100372311.1.1|m.6654,0,0,0,0,0,0,0,0,4.00E-39,Transmembrane protein 26,TMEM26,368,,GO:0016021,,,,PF09772;,integral component of membrane [GO:0016021]
Q03164,CHOYP_LOC100377495.1.1|m.17707,0,0,0,0,0,0,0,0,9.00E-22,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1,3969,"anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of cell proliferation [GO:0008285]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein complex assembly [GO:0006461]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; transcription from RNA polymerase II promoter [GO:0006366]; visual learning [GO:0008542]",GO:0001046; GO:0003680; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0006366; GO:0006461; GO:0006915; GO:0008270; GO:0008285; GO:0008542; GO:0009791; GO:0009952; GO:0018024; GO:0018026; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044212; GO:0044648; GO:0045322; GO:0045893; GO:0045944; GO:0048172; GO:0048536; GO:0048873; GO:0051568; GO:0051571; GO:0051899; GO:0060216; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:1901674; GO:2000615; GO:2001040,,,,PF05965;PF05964;PF00628;PF00856;PF02008;,"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of cell proliferation [GO:0008285]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein complex assembly [GO:0006461]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; transcription from RNA polymerase II promoter [GO:0006366]; visual learning [GO:0008542]"
P15848,CHOYP_LOC100377677.1.2|m.23471,0.5,0,0,0,0,0,0,0,0,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),ARSB,533,autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; glycosphingolipid metabolic process [GO:0006687]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; post-translational protein modification [GO:0043687]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006687; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0043687; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,,,,PF00884;,azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; glycosphingolipid metabolic process [GO:0006687]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; post-translational protein modification [GO:0043687]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
P48181,CHOYP_LOC100533245.3.6|m.31982,0,0,0,0,0,0,0,0,1.00E-143,Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29),unc-29 T08G11.5,493,locomotion [GO:0040011]; neuromuscular synaptic transmission [GO:0007274]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051],GO:0007274; GO:0016021; GO:0022848; GO:0030054; GO:0040011; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662,,,,PF02931;PF02932;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; locomotion [GO:0040011]; neuromuscular synaptic transmission [GO:0007274]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]
Q8R000,CHOYP_OSTA.1.1|m.11011,0,0,0,0,0,0,0,0,5.00E-26,Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha),Slc51a Osta,340,bile acid and bile salt transport [GO:0015721]; transport [GO:0006810],GO:0005215; GO:0005789; GO:0005886; GO:0006810; GO:0015721; GO:0016021; GO:0042803; GO:0043234; GO:0046982,,,,PF03619;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; transport [GO:0006810]
O75382,CHOYP_PE2R3.2.2|m.61863,0,0,0,0,0,0,0,0,2.00E-13,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),TRIM3 BERP RNF22 RNF97,744,nervous system development [GO:0007399]; protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; protein transport [GO:0015031]
Q22813,CHOYP_TBX20.3.4|m.49132,0,0,0,0,0,0,0,0,0.000000003,Putative T-box protein 41,tbx-41 T26C11.1,233,"transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0006351,,,,PF00907;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription, DNA-templated [GO:0006351]"
Q9R182,CHOYP_TL5A.3.3|m.59951,0,0,0,0,0,0,0,0,8.00E-36,Angiopoietin-related protein 3 (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-224)],Angptl3,455,acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipid metabolic process [GO:0045834]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641],GO:0001525; GO:0004857; GO:0004859; GO:0005178; GO:0005576; GO:0005615; GO:0005769; GO:0005794; GO:0006071; GO:0006631; GO:0006641; GO:0006644; GO:0007160; GO:0007165; GO:0008083; GO:0008201; GO:0008203; GO:0009395; GO:0009725; GO:0009986; GO:0010519; GO:0019915; GO:0030027; GO:0030335; GO:0042632; GO:0045766; GO:0045834; GO:0048844; GO:0050996; GO:0051005; GO:0055088; GO:0055090; GO:0055091; GO:0070328,,,cd00087;,PF00147;,cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipid metabolic process [GO:0045834]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]
Q1ZXD6,CHOYP_TRIADDRAFT_61416.1.1|m.26099,0,0,0,0,0,0,0,0,0.00000001,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),roco5 DDB_G0294533,2800,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0004871; GO:0005089; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0007264; GO:0030587; GO:0035023; GO:0035556,,,,PF16095;PF13516;PF13855;PF07714;PF00621;PF08477;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]
A4IGL7,CHOYP_UNC89.16.19|m.57422,0,0,0,0,0,0,0,0,0.000001,Peroxidasin (EC 1.11.1.7),pxdn pxn,1457,hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005615; GO:0006979; GO:0020037; GO:0042744; GO:0046872,,,,PF03098;PF07679;PF13855;PF00093;,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
Q9H222,CHOYP_ABCG8.1.1|m.3707,0,0,0,0,0,0,0,0,1.00E-163,ATP-binding cassette sub-family G member 5 (Sterolin-1),ABCG5,651,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; drug transmembrane transport [GO:0006855]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085],GO:0005524; GO:0005886; GO:0006855; GO:0007584; GO:0007588; GO:0010212; GO:0010949; GO:0015918; GO:0016324; GO:0017127; GO:0030299; GO:0033344; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046982; GO:0055085,,,,PF01061;PF00005;,"apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; cholesterol transporter activity [GO:0017127]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; drug transmembrane transport [GO:0006855]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]"
Q96QF0,CHOYP_BRAFLDRAFT_199346.1.3|m.11369,0,0,0,0,0,0,0,0,3.00E-89,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),RAB3IP RABIN8,476,ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; membrane organization [GO:0061024]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0006612; GO:0006893; GO:0017112; GO:0030027; GO:0033365; GO:0036064; GO:0060271; GO:0061024; GO:0097711,,,,PF06428;,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; membrane organization [GO:0061024]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612]
Q6DGP2,CHOYP_BRAFLDRAFT_238139.1.1|m.12224,0.5,0,0,0,0,0,0,0,1.00E-92,Pre-mRNA-splicing factor syf2,syf2 zgc:92835,238,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0000974; GO:0006397; GO:0008380; GO:0071013; GO:0071014,,,,PF08231;,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
Q8EYT0,CHOYP_BRAFLDRAFT_84838.6.6|m.66693,0,0,0,0,0,0,0,0,3.00E-27,Macro domain-containing protein LA_4133,LA_4133,175,,,,,,PF01661;,
Q8IYE0,CHOYP_CCDC146.1.1|m.11347,1.5,0,0,0,0,0,0,0,0,Coiled-coil domain-containing protein 146,CCDC146 KIAA1505,955,,GO:0005814,,,,,centriole [GO:0005814]
P07207,CHOYP_DLL1.1.1|m.4589,0,0,0,0,0,0,0,0,6.00E-26,Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein],N CG3936,2703,"actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; I-kappaB phosphorylation [GO:0007252]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]",GO:0000122; GO:0001708; GO:0001745; GO:0002213; GO:0003682; GO:0004872; GO:0004888; GO:0005509; GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0006351; GO:0007015; GO:0007155; GO:0007157; GO:0007219; GO:0007252; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007424; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007460; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009952; GO:0009986; GO:0010001; GO:0010629; GO:0010906; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0022416; GO:0030139; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0035003; GO:0035153; GO:0035155; GO:0035157; GO:0035162; GO:0035165; GO:0035167; GO:0035170; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043234; GO:0045316; GO:0045463; GO:0045465; GO:0045466; GO:0045468; GO:0045595; GO:0045747; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048666; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060429; GO:0061331; GO:0061382; GO:1900087; GO:2000048,,,,PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; I-kappaB phosphorylation [GO:0007252]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
Q8MRC9,CHOYP_DPSE_GA25136.1.1|m.66680,0.5,0,0,0,0,0,0,0,2.00E-35,Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9),pgant9 CG30463,650,multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;PF00652;,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]
Q5XIS2,CHOYP_DSIM_GD25210.1.1|m.29275,0.5,0,0,0,0,0,0,0,4.00E-42,Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP),Cptp Gltpd1,216,ceramide 1-phosphate transport [GO:1902389],GO:0005543; GO:0005548; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0017089; GO:0051861; GO:1902387; GO:1902388; GO:1902389,,,,PF08718;,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]
Q8SWR3,CHOYP_DVIR_GJ18645.1.1|m.55503,0,0,0,0,0,0,0,0,2.00E-41,Sex peptide receptor,SPR CG16752,435,"G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]",GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042,,,,PF10324;,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled peptide receptor activity [GO:0008528]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
P86787,CHOYP_GIGA4.1.3|m.10521,0,0,0,0,0,0,0,0,7.00E-37,Gigasin-4 (Fragment),,58,,,,,,,
P48566,CHOYP_GRT1A.1.2|m.29772,0,0,0,0,0,0,0,0,4.00E-24,GTPase-activating protein GYP3 (Multicopy suppressor of bud emergence 3) (Protein MSB3),MSB3 GYP3 YNL293W N0470,633,activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; formin-nucleated actin cable assembly [GO:0070649]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880],GO:0000131; GO:0000133; GO:0000329; GO:0005096; GO:0005770; GO:0005829; GO:0005886; GO:0005934; GO:0005935; GO:0006887; GO:0006897; GO:0032880; GO:0043087; GO:0070649; GO:0090630,,,,PF00566;,cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytosol [GO:0005829]; fungal-type vacuole membrane [GO:0000329]; incipient cellular bud site [GO:0000131]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; polarisome [GO:0000133]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; formin-nucleated actin cable assembly [GO:0070649]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]
Q8N7X2,CHOYP_LOC100175702.1.1|m.56240,1.5,0,0,0,0,0,0,0,0.0000006,Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3),STPG3 C9orf173,389,,,,,,,
Q14159,CHOYP_LOC100374845.1.1|m.49323,0.5,0,0,0,0,0,0,0,0.00000001,DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair),SPIDR KIAA0146,915,cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202],GO:0000228; GO:0000724; GO:0005654; GO:0006974; GO:0010569; GO:0031334; GO:0070202; GO:0071479; GO:0072711; GO:0072757; GO:2000781,,,,PF14950;PF14951;,nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202]
Q3T0Z5,CHOYP_LOC100375896.1.2|m.23761,0,0,0,0,0,0,0,0,3.00E-32,Leukocyte receptor cluster member 1 homolog,LENG1,263,,,,,,PF10197;,
Q2LK54,CHOYP_LOC100563402.1.1|m.5257,0,0,0,0,0,0,0,0,2.00E-21,Collectin-12 (Collectin-3) (CL-3) (cCL-3),COLEC12 CL3,742,,GO:0005581; GO:0016021; GO:0030246; GO:0046872,,,cd03590;,PF01391;PF00059;,collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]
Q9DDT2,CHOYP_LOC101078145.1.1|m.54616,0,0,0,0,0,0,0,0,3.00E-13,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),PIK3AP1 BCAP,800,cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0031929; GO:0032869; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042325; GO:0043549; GO:0050727,,,,PF14545;,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929]
Q9NX08,CHOYP_LOC584270.1.1|m.49225,0.5,0,0,0,0,0,0,0,2.00E-41,COMM domain-containing protein 8,COMMD8 MDS022,183,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005654; GO:0005829; GO:0006351; GO:0006355,,,,PF07258;,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5UQX8,CHOYP_LOC753709.10.44|m.22246,0,0,0,0,0,0,0,0,2.00E-15,Putative ankyrin repeat protein R880,MIMI_R880,255,,,,,,PF12796;,
Q46AN4,CHOYP_RS3A.10.15|m.40676,0,0,0,0,0,0,0,0,6.00E-21,30S ribosomal protein S3Ae (Ribosomal protein S1e),rps3ae Mbar_A2127,207,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01015;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
P08842,CHOYP_STS.1.1|m.35785,0,0,0,0,0,0,0,0,8.00E-158,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),STS ARSC1,583,epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; steroid catabolic process [GO:0006706],GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0043687; GO:0046872,,,,PF00884;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; steroid catabolic process [GO:0006706]
O23300,CHOYP_TRIADDRAFT_52755.1.1|m.64495,0,0,0,0,0,0,0,0,1.00E-25,"Enoyl-CoA delta isomerase 3 (EC 5.3.3.8) (3-hydroxyacyl-CoA dehydratase 1) (Delta(3),Delta(2)-enoyl CoA isomerase 3) (AtECI3)",ECI3 HCD1 At4g14440 dl3260c,238,fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167],GO:0004165; GO:0005634; GO:0005829; GO:0006635; GO:0009062; GO:0080167,PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000305}.,,,PF00378;,cytosol [GO:0005829]; nucleus [GO:0005634]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167]
Q5UPV1,CHOYP_TVAG_291510.9.9|m.53036,0,0,0,0,0,0,0,0,0.000000007,Putative ankyrin repeat protein L271,MIMI_L271,728,,,,,,PF12796;,
Q8R205,CHOYP_ZC3HA.1.1|m.27569,1,0,0,0,0,0,0,0,3.00E-76,Zinc finger CCCH domain-containing protein 10,Zc3h10,435,,GO:0003723; GO:0046872,,,,PF00642;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]
Q80ZA4,CHOYP_BRAFLDRAFT_118430.2.2|m.44188,0,0,0,0,0,0,0,0,0.00000003,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Pkhd1l1,4249,,GO:0005929; GO:0016021,,,,PF10162;PF07691;PF01833;,cilium [GO:0005929]; integral component of membrane [GO:0016021]
A0JPH4,CHOYP_BRAFLDRAFT_118545.2.2|m.54585,0,0,0,0,0,0,0,0,0,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),scap,1311,cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0015485; GO:0016021; GO:0032933,,,,PF12349;PF00400;,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]
Q9UHB4,CHOYP_BRAFLDRAFT_122922.1.1|m.17746,0,0,0,0,0,0,0,0,0,NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1),NDOR1 NR1,597,cell death [GO:0008219]; cellular response to menadione [GO:0036245]; oxidation-reduction process [GO:0055114],GO:0003958; GO:0005634; GO:0005737; GO:0005829; GO:0008219; GO:0010181; GO:0016491; GO:0036245; GO:0045111; GO:0048471; GO:0050660; GO:0050661; GO:0055114,,,,PF00667;PF00258;PF00175;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; oxidation-reduction process [GO:0055114]
P58340,CHOYP_BRAFLDRAFT_127486.1.1|m.57687,0.5,0,0,0,0,0,0,0,4.00E-39,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),MLF1,268,"cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]",GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0006351; GO:0007050; GO:0019904,,,,PF10248;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]"
P35447,CHOYP_BRAFLDRAFT_236936.2.6|m.17168,0,0,0,0,0,0,0,0,4.00E-20,Spondin-1 (F-spondin),spon1,803,cell adhesion [GO:0007155],GO:0005578; GO:0007155; GO:0046872,,,cd08544;,PF02014;PF06468;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
P57102,CHOYP_HAND1.1.1|m.10874,0,0,0,0,0,0,0,0,6.00E-53,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",hand2 dhand,208,"cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription, DNA-templated [GO:0006355]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]",GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908,,,,PF00010;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription, DNA-templated [GO:0006355]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]"
B4JTF5,CHOYP_LOC100366797.2.3|m.54046,0,0,0,0,0,0,0,0,0.000002,Protein hedgehog [Cleaved into: Protein hedgehog N-product; Protein hedgehog C-product],hh GH23852,479,"anterior commissure morphogenesis [GO:0021960]; Bolwig's organ morphogenesis [GO:0001746]; cell-cell signaling involved in cell fate commitment [GO:0045168]; cytoneme assembly [GO:0035231]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc anterior/posterior pattern formation [GO:0035224]; glial cell migration [GO:0008347]; gonadal mesoderm development [GO:0007506]; heart formation [GO:0060914]; hindgut morphogenesis [GO:0007442]; intein-mediated protein splicing [GO:0016539]; labial disc development [GO:0035217]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; mucosal immune response [GO:0002385]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; pole cell migration [GO:0007280]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of transcription factor import into nucleus [GO:0042993]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; protein autoprocessing [GO:0016540]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral midline development [GO:0007418]",GO:0001746; GO:0002385; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0007228; GO:0007280; GO:0007346; GO:0007367; GO:0007418; GO:0007427; GO:0007442; GO:0007458; GO:0007506; GO:0008233; GO:0008347; GO:0016015; GO:0016335; GO:0016539; GO:0016540; GO:0021960; GO:0030139; GO:0031397; GO:0035217; GO:0035224; GO:0035231; GO:0035277; GO:0042993; GO:0045168; GO:0045743; GO:0045861; GO:0046872; GO:0060914; GO:2000274,,,,PF01085;PF01079;,"cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; morphogen activity [GO:0016015]; peptidase activity [GO:0008233]; anterior commissure morphogenesis [GO:0021960]; Bolwig's organ morphogenesis [GO:0001746]; cell-cell signaling involved in cell fate commitment [GO:0045168]; cytoneme assembly [GO:0035231]; epithelial cell migration, open tracheal system [GO:0007427]; genital disc anterior/posterior pattern formation [GO:0035224]; glial cell migration [GO:0008347]; gonadal mesoderm development [GO:0007506]; heart formation [GO:0060914]; hindgut morphogenesis [GO:0007442]; intein-mediated protein splicing [GO:0016539]; labial disc development [GO:0035217]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; mucosal immune response [GO:0002385]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; pole cell migration [GO:0007280]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of transcription factor import into nucleus [GO:0042993]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; protein autoprocessing [GO:0016540]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; regulation of mitotic cell cycle [GO:0007346]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral midline development [GO:0007418]"
Q66IC8,CHOYP_LOC100371143.1.1|m.27046,1.5,0,0,0,0,0,0,0,2.00E-26,Tctex1 domain-containing protein 1,tctex1d1 zgc:101774,173,,,,,,PF03645;,
P38942,CHOYP_LOC100372560.1.1|m.25500,0,0,0,0,0,0,0,0,2.00E-25,4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-),cat2 CKL_3018,429,acetyl-CoA metabolic process [GO:0006084],GO:0006084; GO:0016740,,,,PF13336;PF02550;,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084]
Q9R1R2,CHOYP_LOC100374741.55.83|m.53276,0,0,0,0,0,0,0,0,2.00E-12,Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1),Trim3 Hac1 Rnf22,744,protein transport [GO:0015031]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
P39429,CHOYP_LOC100697308.1.1|m.5118,0,0,0,0,0,0,0,0,3.00E-120,TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2),Traf2,501,activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein complex assembly [GO:0043623]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000151; GO:0002726; GO:0004842; GO:0005164; GO:0005174; GO:0005737; GO:0005829; GO:0005938; GO:0006915; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0030163; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0035631; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043507; GO:0043623; GO:0045121; GO:0046328; GO:0046625; GO:0051023; GO:0051091; GO:0051092; GO:0051291; GO:0051865; GO:0070207; GO:0070534; GO:0071732; GO:0090073; GO:0097057; GO:0097300; GO:1903265; GO:1903721; GO:1990604; GO:2001238,PATHWAY: Protein modification; protein ubiquitination.,,,PF16673;PF00097;PF02176;,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein complex assembly [GO:0043623]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
Q5ZJL9,CHOYP_LOC566621.1.1|m.45550,0,0,0,0,0,0,0,0,8.00E-92,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-),SAMHD1 RCJMB04_17d8,614,dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; dGTP catabolic process [GO:0006203]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088],GO:0003676; GO:0003723; GO:0005634; GO:0006203; GO:0008270; GO:0008832; GO:0032567; GO:0045087; GO:0045088; GO:0046061; GO:0051607,,,,PF01966;,nucleus [GO:0005634]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; dGTP catabolic process [GO:0006203]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088]
A1A4J8,CHOYP_LOC657827.1.1|m.26986,0,0,0,0,0,0,0,0,2.00E-71,"Protein SCO1 homolog, mitochondrial",SCO1 SCOD1,305,cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799],GO:0005739; GO:0006878; GO:0030016; GO:0033617; GO:0046872; GO:0072492; GO:1901799,,,cd02968;,PF02630;,host cell mitochondrial intermembrane space [GO:0072492]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; metal ion binding [GO:0046872]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]
Q6P423,CHOYP_MED23.1.1|m.13417,0,0,0,0,0,0,0,0,0,Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23),med23,1369,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355,,,,PF11573;,"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q91XN4,CHOYP_MGC81574.1.1|m.8983,0,0,0,0,0,0,0,0,1.00E-27,BMP and activin membrane-bound inhibitor homolog (Kinase-deficient TGFbeta superfamily receptor subunit),Bambi,260,"cell migration [GO:0016477]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catenin import into nucleus [GO:0035413]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]",GO:0005737; GO:0005886; GO:0007179; GO:0008284; GO:0008360; GO:0010718; GO:0016021; GO:0016477; GO:0030512; GO:0032092; GO:0035413; GO:0045893; GO:0090263,,,,PF06211;,"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catenin import into nucleus [GO:0035413]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
Q9D9R9,CHOYP_NEMVEDRAFT_V1G214844.22.34|m.54623,1.5,0,0,0,0,0,0,0,3.00E-25,Protein FAM186A,FAM186A Gm920,1790,,,,,,,
O62760,CHOYP_SASB.2.3|m.37538,0,0,0,0,0,0,0,0,2.00E-62,Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase),BCHE,602,,GO:0003990; GO:0004104; GO:0005641; GO:0005783; GO:0052689; GO:0072562,,,,PF08674;PF00135;,blood microparticle [GO:0072562]; endoplasmic reticulum [GO:0005783]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; carboxylic ester hydrolase activity [GO:0052689]; cholinesterase activity [GO:0004104]
Q9QYI4,CHOYP_BRAFLDRAFT_209304.2.2|m.63768,0,0,0,0,0,0,0,0,1.00E-106,DnaJ homolog subfamily B member 12 (mDj10),Dnajb12,376,,GO:0016020; GO:0016021,,,cd06257;,PF00226;PF09320;,integral component of membrane [GO:0016021]; membrane [GO:0016020]
Q498J9,CHOYP_BRAFLDRAFT_227287.1.1|m.14669,0.5,0,0,0,0,0,0,0,1.00E-49,Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-),mblac1,233,,GO:0016787; GO:0046872,,,,PF00753;,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
P13635,CHOYP_BRAFLDRAFT_74383.1.1|m.14279,0,0,0,0,0,0,0,0,1.00E-88,Ceruloplasmin (EC 1.16.3.1) (Ferroxidase),Cp,1059,aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; liver development [GO:0001889]; lung development [GO:0030324]; plasma membrane copper ion transport [GO:0015679]; response to copper ion [GO:0046688]; response to nutrient [GO:0007584],GO:0001889; GO:0004322; GO:0005507; GO:0005615; GO:0006879; GO:0007568; GO:0007584; GO:0015679; GO:0030324; GO:0046658; GO:0046688,,,,PF00394;PF07731;PF07732;,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; liver development [GO:0001889]; lung development [GO:0030324]; plasma membrane copper ion transport [GO:0015679]; response to copper ion [GO:0046688]; response to nutrient [GO:0007584]
Q761V0,CHOYP_DGRI_GH22876.2.3|m.54068,0.5,0,0,0,0,0,0,0,1.00E-180,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Slc6a5 Glyt2,799,"glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]",GO:0005328; GO:0005886; GO:0005887; GO:0015375; GO:0036233; GO:0046872; GO:0060012,,,,PF00209;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]"
A7T167,CHOYP_GDAP2.1.1|m.57049,0.5,0,0,0,0,0,0,0,8.00E-169,Protein GDAP2 homolog,gdap2 v1g195342,502,,,,,,PF13716;PF01661;,
Q5RDQ2,CHOYP_LOC100158931.1.1|m.8283,0,0,0,0,0,0,0,0,0,MAGUK p55 subfamily member 5,MPP5,675,bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162],GO:0005886; GO:0005923; GO:0012505; GO:0070830; GO:0090162,,,,PF00625;PF02828;PF09060;PF00595;PF07653;,bicellular tight junction [GO:0005923]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]
Q68LP1,CHOYP_LOC100865663.1.1|m.9283,0,0,0,0,0,0,0,0,8.00E-23,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Mib2,971,Notch signaling pathway [GO:0007219],GO:0004842; GO:0005737; GO:0005768; GO:0007219; GO:0008270,PATHWAY: Protein modification; protein ubiquitination.,,,PF12796;PF06701;PF00569;,cytoplasm [GO:0005737]; endosome [GO:0005768]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]
O95490,CHOYP_LOC578280.1.1|m.42277,0,0,0,0,0,0,0,0,1.00E-63,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),ADGRL2 KIAA0786 LEC1 LPHH1 LPHN2,1459,cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0007166; GO:0007186; GO:0016021; GO:0016524; GO:0030246,,,,PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;,integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; G-protein coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186]
A4IF87,CHOYP_LOC590838.1.1|m.24953,0,0,0,0,0,0,0,0,6.00E-167,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),GNPAT,680,ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650],GO:0005778; GO:0006650; GO:0008611; GO:0016287,PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.,,,PF01553;,peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]
Q5ZJ41,CHOYP_MARH5.1.1|m.45222,0,0,0,0,0,0,0,0,1.00E-111,E3 ubiquitin-protein ligase MARCH5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCH5),MARCH5 RCJMB04_20o22,281,negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],GO:0000209; GO:0004842; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051865; GO:0070585; GO:0090140; GO:0090141; GO:0090344,PATHWAY: Protein modification; protein ubiquitination.,,,PF12906;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140]
Q9H9B4,CHOYP_SFXN1.1.1|m.27758,0,0,0,0,0,0,0,0,9.00E-158,Sideroflexin-1 (Tricarboxylate carrier protein) (TCC),SFXN1,322,erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826],GO:0005739; GO:0005743; GO:0006826; GO:0015075; GO:0016021; GO:0030218; GO:0055072,,,,PF03820;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]
Q01841,CHOYP_TGM1.2.2|m.59718,0,0,0,0,0,0,0,0,2.00E-117,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase-2) (TGase-2),TGL2,689,peptide cross-linking [GO:0018149],GO:0003810; GO:0018149; GO:0046872,,,,PF00927;PF01841;PF00868;,metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
Q24K03,CHOYP_THUM1.1.1|m.47876,0.5,0,0,0,0,0,0,0,8.00E-67,THUMP domain-containing protein 1,THUMPD1,357,tRNA modification [GO:0006400],GO:0003723; GO:0006400,,,,PF02926;,RNA binding [GO:0003723]; tRNA modification [GO:0006400]
P70701,CHOYP_WN10A.1.1|m.28564,0,0,0,0,0,0,0,0,1.00E-123,Protein Wnt-10a,Wnt10a,417,animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055],GO:0001942; GO:0005102; GO:0005109; GO:0005578; GO:0005615; GO:0007165; GO:0007267; GO:0009887; GO:0010628; GO:0014033; GO:0016055; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048730; GO:0048733; GO:0071560,,,,PF00110;,extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; frizzled binding [GO:0005109]; receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055]
Q8IUH5,CHOYP_ZDHHC17.1.1|m.29726,0.5,0,0,0,0,0,0,0,0,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17),ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294,632,lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],GO:0000139; GO:0004871; GO:0005794; GO:0005829; GO:0015095; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231,,,,PF12796;PF01529;,cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signal transducer activity [GO:0004871]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]
Q8QGW7,CHOYP_BCL3.2.2|m.57487,0,0,0,0,0,0,0,0,7.00E-24,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome),LITAF SIMPLE,148,"cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]",GO:0001816; GO:0005125; GO:0005765; GO:0006351; GO:0006355; GO:0019953,,,,PF10601;,"lysosomal membrane [GO:0005765]; cytokine activity [GO:0005125]; cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]"
Q6IR74,CHOYP_BRAFLDRAFT_130395.1.1|m.38394,0,0,0,0,0,0,0,0,0,Choline transporter-like protein 1 (Solute carrier family 44 member 1),slc44a1 ctl1,651,,GO:0016021,,,,PF04515;,integral component of membrane [GO:0016021]
Q29RU4,CHOYP_BRAFLDRAFT_85664.3.10|m.26597,0.5,0,0,0,0,0,0,0,0.00000002,Complement component C6,C6,932,"complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; innate immune response [GO:0045087]",GO:0005576; GO:0005579; GO:0006958; GO:0019835; GO:0045087,,,cd00033;,PF07648;PF00057;PF01823;PF00084;PF00090;,"extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; innate immune response [GO:0045087]"
Q65YR7,CHOYP_CPIB.2.3|m.44557,0,0,0,0,0,0,0,0,1.00E-18,Cystatin-A2,cpiB DDB_G0280439,95,proteolysis [GO:0006508],GO:0004869; GO:0005829; GO:0006508,,,,PF00031;,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508]
Q28I29,CHOYP_DTWD1.1.1|m.49358,0,0,0,0,0,0,0,0,3.00E-68,DTW domain-containing protein 1,dtwd1 TEgg073n17.1,294,,,,,,PF03942;,
Q6GQ69,CHOYP_FAF2A.1.1|m.27947,0,0,0,0,0,0,0,0,8.00E-169,FAS-associated factor 2-B (UBX domain-containing protein 8-B),faf2-b ubxd8-b,445,,GO:0005783; GO:0005811,,,,PF00789;,endoplasmic reticulum [GO:0005783]; lipid particle [GO:0005811]
Q9ESL4,CHOYP_FGFR2.2.3|m.53947,0.5,0,0,0,0,0,0,0,3.00E-25,Mitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25) (Leucine zipper- and sterile alpha motif kinase ZAK) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),Zak Mltk,802,activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cell cycle checkpoint [GO:0000075]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; intracellular signal transduction [GO:0035556]; limb development [GO:0060173]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; response to radiation [GO:0009314],GO:0000075; GO:0000077; GO:0000287; GO:0003723; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007050; GO:0007257; GO:0009314; GO:0035556; GO:0042733; GO:0043065; GO:0060173,,,,PF07714;PF00536;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cell cycle checkpoint [GO:0000075]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; intracellular signal transduction [GO:0035556]; limb development [GO:0060173]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; response to radiation [GO:0009314]
Q8QGW7,CHOYP_GLRA3.1.2|m.53462,0,0,0,0,0,0,0,0,4.00E-22,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome),LITAF SIMPLE,148,"cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]",GO:0001816; GO:0005125; GO:0005765; GO:0006351; GO:0006355; GO:0019953,,,,PF10601;,"lysosomal membrane [GO:0005765]; cytokine activity [GO:0005125]; cytokine production [GO:0001816]; regulation of transcription, DNA-templated [GO:0006355]; sexual reproduction [GO:0019953]; transcription, DNA-templated [GO:0006351]"
P61374,CHOYP_ISL1.1.1|m.10993,0.5,0,0,0,0,0,0,0,1.00E-156,Insulin gene enhancer protein ISL-1 (Islet-1),Isl1,349,"atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of Stat3 protein [GO:0042517]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]",GO:0000978; GO:0001077; GO:0001105; GO:0001158; GO:0001755; GO:0003139; GO:0003148; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0005654; GO:0006355; GO:0008270; GO:0008284; GO:0010575; GO:0016922; GO:0021520; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042517; GO:0043388; GO:0043524; GO:0043565; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0048880; GO:0048936; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0071385; GO:0071657; GO:0090074; GO:0090090; GO:1990841,,,,PF00046;PF00412;,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; ligand-dependent nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator activity [GO:0001105]; sequence-specific DNA binding [GO:0043565]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; zinc ion binding [GO:0008270]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of Stat3 protein [GO:0042517]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]"
Q96L93,CHOYP_KI16B.1.3|m.42636,0,0,0,0,0,0,0,0,0,Kinesin-like protein KIF16B (Sorting nexin-23),KIF16B C20orf23 KIAA1590 SNX23,1317,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919],GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008543; GO:0008574; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025,,,,PF00498;PF00225;PF00787;,"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]"
Q64127,CHOYP_LOC100373444.22.79|m.26109,0,0,0,0,0,0,0,0,0.00000003,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Trim24 Tif1 Tif1a,1051,"calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription, DNA-templated [GO:0006351]",GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006351; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,PATHWAY: Protein modification; protein ubiquitination.,,,PF00439;PF00628;PF00643;,"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; ligand-dependent nuclear receptor binding [GO:0016922]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription, DNA-templated [GO:0006351]"
Q65YR7,CHOYP_LOC100899149.1.2|m.6146,0.5,0,0,0,0,0,0,0,1.00E-12,Cystatin-A2,cpiB DDB_G0280439,95,proteolysis [GO:0006508],GO:0004869; GO:0005829; GO:0006508,,,,PF00031;,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508]
Q9UGU0,CHOYP_LOC591426.1.1|m.19353,0,0,0,0,0,0,0,0,1.00E-25,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),TCF20 KIAA0292 SPBP,1960,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0008270; GO:0016604; GO:0044212,,,,,"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q54BT3,CHOYP_MDR1.1.2|m.22971,0,0,0,0,0,0,0,0,0,ABC transporter B family member 2 (ABC transporter ABCB.2),abcB2 DDB_G0293438,1397,,GO:0005215; GO:0005524; GO:0016021; GO:0042626,,,,PF00664;PF00005;,"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]"
Q9H5P4,CHOYP_PDZD7B.1.1|m.64961,0,0,0,0,0,0,0,0,2.00E-48,PDZ domain-containing protein 7,PDZD7 PDZK7,517,auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184],GO:0002141; GO:0005615; GO:0005634; GO:0005929; GO:0045184; GO:0050910; GO:0060088; GO:1990696,,,,PF00595;,cilium [GO:0005929]; extracellular space [GO:0005615]; nucleus [GO:0005634]; stereocilia ankle link [GO:0002141]; USH2 complex [GO:1990696]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]
Q3ZBG9,CHOYP_PLS2.1.1|m.25963,0,0,0,0,0,0,0,0,4.00E-62,Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2),PLSCR2,293,,GO:0005886; GO:0016021; GO:0017128; GO:0046872,,,,PF03803;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]
Q17R09,CHOYP_PRP16.1.1|m.19094,0,0,0,0,0,0,0,0,0,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),DHX38 PRP16,1227,"mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0003676; GO:0004004; GO:0005524; GO:0005681; GO:0005737,,,,PF00270;PF04408;PF00271;PF07717;,"cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]"
Q6P1M0,CHOYP_S27A4.2.2|m.14401,0,0,0,0,0,0,0,0,0,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4),SLC27A4 ACSVL4 FATP4,643,fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport [GO:0006810]; very long-chain fatty acid catabolic process [GO:0042760],GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005789; GO:0005886; GO:0005902; GO:0006629; GO:0006810; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043588; GO:0044539,,,,PF00501;PF13193;,brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport [GO:0006810]; very long-chain fatty acid catabolic process [GO:0042760]
P23978,CHOYP_SC6A5.7.7|m.62985,0,0,0,0,0,0,0,0,8.00E-159,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),Slc6a1 Gabt1 Gat-1 Gat1,599,"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]",GO:0005328; GO:0005332; GO:0005886; GO:0005887; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0030424; GO:0032229; GO:0032355; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939,,,,PF00209;,"axon [GO:0030424]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]"
Q6P3W7,CHOYP_SCYL2.1.1|m.6216,0,0,0,0,0,0,0,0,0,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),SCYL2 CVAK104 KIAA1360,929,endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286],GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370,,,,PF00069;,clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]
Q6Q0C0,CHOYP_SMC2.1.4|m.17837,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),TRAF7 RFWD1 RNF119,670,"activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0000151; GO:0000185; GO:0004842; GO:0005886; GO:0006351; GO:0006355; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:2001235,PATHWAY: Protein modification; protein ubiquitination.,,,PF00400;PF13445;,"cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5U4U6,CHOYP_T23O.5.6|m.52216,0,0,0,0,0,0,0,0,2.00E-80,"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)",tdo2,406,protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],GO:0004833; GO:0019441; GO:0020037; GO:0046872; GO:0051289,PATHWAY: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03020}.,,,PF03301;,"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441]"
Q75A43,CHOYP_TBB2.2.2|m.53000,0,0,0,0,0,0,0,0,4.00E-79,Tubulin gamma chain (Gamma-tubulin),TUB4 ADR076C,470,cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; mitotic spindle organization in nucleus [GO:0030472]; positive regulation of cytoplasmic translation [GO:2000767],GO:0000928; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005822; GO:0005824; GO:0005874; GO:0007020; GO:0030472; GO:0031122; GO:2000767,,,cd02188;,PF00091;PF03953;,"gamma-tubulin small complex, spindle pole body [GO:0000928]; inner plaque of spindle pole body [GO:0005822]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer plaque of spindle pole body [GO:0005824]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; mitotic spindle organization in nucleus [GO:0030472]; positive regulation of cytoplasmic translation [GO:2000767]"
Q9BVM4,CHOYP_A2LDB.1.1|m.29880,0,0,0,0,0,0,0,0,1.00E-32,Gamma-glutamylaminecyclotransferase (GGACT) (EC 2.3.2.4) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase),GGACT A2LD1,153,cellular modified amino acid catabolic process [GO:0042219],GO:0003839; GO:0042219; GO:0070062,,,cd06661;,PF06094;,extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; cellular modified amino acid catabolic process [GO:0042219]
P83388,CHOYP_ACDOPBH.9.9|m.63296,0,0,0,0,0,0,0,0,2.00E-10,Probable peptidyl-glycine alpha-amidating monooxygenase pamn-1 (PAM) [Includes: Probable peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)],pamn-1 T19B4.1,663,peptide metabolic process [GO:0006518],GO:0004504; GO:0004598; GO:0005507; GO:0005576; GO:0006518; GO:0016020,,,,PF03712;PF01082;PF01436;,extracellular region [GO:0005576]; membrane [GO:0016020]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide metabolic process [GO:0006518]
Q28298,CHOYP_AGO2.1.1|m.17145,0,0,0,0,0,0,0,0,2.00E-17,Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp),RRBP1 P180,1534,protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412],GO:0004872; GO:0005840; GO:0006412; GO:0007165; GO:0015031; GO:0030176,,,,PF05104;,integral component of endoplasmic reticulum membrane [GO:0030176]; ribosome [GO:0005840]; receptor activity [GO:0004872]; protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412]
Q96KG7,CHOYP_CELE_Y64G10A.7.3.4|m.53262,0,0,0,0,0,0,0,0,1.00E-27,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),MEGF10 KIAA1780,1140,apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],GO:0001849; GO:0001891; GO:0005044; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0016323; GO:0034109; GO:0042995; GO:0043652; GO:0043654; GO:0048641; GO:0051147; GO:0055001; GO:1902742,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; complement component C1q binding [GO:0001849]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
P27701,CHOYP_DSEC_GM10209.1.1|m.49171,0,0,0,0,0,0,0,0,5.00E-14,CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82),CD82 KAI1 SAR2 ST6 TSPAN27,267,cell surface receptor signaling pathway [GO:0007166],GO:0005886; GO:0005887; GO:0007166; GO:0070062,,,,PF00335;,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166]
Q90705,CHOYP_EEF2.2.2|m.54908,0,0,0,0,0,0,0,0,8.00E-160,Elongation factor 2 (EF-2),EEF2,858,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF00679;PF14492;PF03764;PF03144;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
P86939,CHOYP_EF-1A.5.9|m.37988,0,0,0,0,0,0,0,0,4.00E-120,Elongation factor 1-alpha 2 (EF-1-alpha 2),Tb10.70.5670,449,calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017],GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005622; GO:0005737; GO:0007017; GO:0019722,,,,PF03144;PF03143;,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; calcium-mediated signaling [GO:0019722]; microtubule-based process [GO:0007017]
Q8BZ21,CHOYP_KAT6B.1.2|m.10955,0.5,0,0,0,0,0,0,0,0,"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein)",Kat6a Moz Myst3,2003,"aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]",GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006351; GO:0006473; GO:0008134; GO:0008270; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0043433; GO:0043966; GO:0045892; GO:0045893; GO:0060325; GO:0070776; GO:0090398,,,,PF01853;PF00628;,"cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]"
Q90705,CHOYP_LOC100203564.1.1|m.22544,0,0,0,0,0,0,0,0,0,Elongation factor 2 (EF-2),EEF2,858,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF00679;PF14492;PF03764;PF03144;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
Q2A865,CHOYP_LOC100375514.2.6|m.12927,0,0,0,0,0,0,0,0,2.00E-88,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),Slc6a19 B0at1,634,response to nutrient [GO:0007584],GO:0005328; GO:0005887; GO:0007584; GO:0015175; GO:0031526; GO:0070062,,,,PF00209;,brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; response to nutrient [GO:0007584]
O15484,CHOYP_LOC100554578.1.2|m.7421,1,0,0,0,0,0,0,0,0,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,640,proteolysis [GO:0006508]; signal transduction [GO:0007165],GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062,,,cd04046;cd00214;cd00044;,PF01067;PF00648;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]
Q9H3K2,CHOYP_LOC100693508.1.1|m.16381,0,0,0,0,0,0,0,0,4.00E-116,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),GHITM DERP2 MICS1 TMBIM5 My021 UNQ244/PRO281,345,apoptotic process [GO:0006915],GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062,,,,PF01027;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]
Q5U2Z0,CHOYP_LOC100727208.1.1|m.9365,0,0,0,0,0,0,0,0,2.00E-56,Zinc finger protein 367,Znf367 Zfp367,340,"regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005654; GO:0006351; GO:0006357; GO:0046872,,,,PF13912;,"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]"
Q13310,CHOYP_LOC100741783.1.1|m.10158,0,0,0,0,0,0,0,0,3.00E-122,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),PABPC4 APP1 PABP4,644,blood coagulation [GO:0007596]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],GO:0000166; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0030529,,,,PF00658;PF00076;,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; intracellular ribonucleoprotein complex [GO:0030529]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]
P98163,CHOYP_LOC578599.1.8|m.12749,0,0,0,0,0,0,0,0,3.00E-35,Putative vitellogenin receptor (Protein yolkless) (YL),yl CG1372,1984,oogenesis [GO:0048477],GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477,,,,PF12662;PF07645;PF00057;PF00058;,coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]
E2AX35,CHOYP_LOC658640.1.2|m.36016,0,0,0,0,0,0,0,0,7.00E-20,IDLSRF-like peptide,EAG_01737,201,neuropeptide signaling pathway [GO:0007218],GO:0005576; GO:0007218,,,,PF00057;,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
Q16363,CHOYP_MEG10.67.91|m.52967,0.5,0,0,0,0,0,0,0,3.00E-11,Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha),LAMA4,1823,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995],GO:0005201; GO:0005576; GO:0005604; GO:0005605; GO:0007155; GO:0030155; GO:0030198; GO:0030334; GO:0045995; GO:0070062,,,,PF00053;PF02210;PF06008;PF06009;,basal lamina [GO:0005605]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]
Q6PIJ4,CHOYP_NFRKB.1.1|m.18027,1.5,0,0,0,0,0,0,0,5.00E-166,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B),Nfrkb,1296,"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0002020; GO:0003677; GO:0005634; GO:0006281; GO:0006310; GO:0006351; GO:0006355; GO:0031011,,,,PF14465;,"Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q8VID6,CHOYP_PDE11.3.3|m.51375,0,0,0,0,0,0,0,0,0,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Pde11a,935,cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165],GO:0004112; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0030552; GO:0030553; GO:0043204; GO:0046069; GO:0046872; GO:0047555,,,,PF01590;PF00233;,"cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165]"
Q69ZS0,CHOYP_PDZRN3.1.1|m.18229,0,0,0,0,0,0,0,0,2.00E-89,E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3),Pdzrn3 Kiaa1095 Semcap3,1063,neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0007528; GO:0008270; GO:0016567; GO:0031594; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF00595;,cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
O18973,CHOYP_RABX5.1.2|m.26033,0,0,0,0,0,0,0,0,4.00E-152,Rab5 GDP/GTP exchange factor (Rabex-5),RABGEF1 RABEX5,492,endocytosis [GO:0006897]; protein transport [GO:0015031],GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037,,,,PF02204;PF01754;,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]
O61231,CHOYP_RPL10.1.2|m.4994,0,0,0,0,0,0,0,0,1.00E-68,60S ribosomal protein L10 (QM protein homolog) (dQM),RpL10 Qm CG17521,218,centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; sensory perception of pain [GO:0019233],GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0005840; GO:0019233; GO:0022625; GO:0022626; GO:0043025; GO:0051297; GO:0051298,,,cd01433;,PF00252;,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; sensory perception of pain [GO:0019233]
Q66PY1,CHOYP_RS3A.9.15|m.36330,0,0,0,0,0,0,0,0,0.0000006,"Signal peptide, CUB and EGF-like domain-containing protein 3",Scube3,993,cell differentiation [GO:0030154]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260],GO:0005509; GO:0005615; GO:0009986; GO:0030154; GO:0045880; GO:0051260; GO:0051291,,,cd00041;,PF12662;PF00431;PF12947;PF07645;PF07699;,cell surface [GO:0009986]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]
Q689D1,CHOYP_TLR2.6.7|m.54975,0,0,0,0,0,0,0,0,3.00E-40,Toll-like receptor 2 (CD antigen CD282),TLR2,785,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0002755; GO:0004872; GO:0004888; GO:0005794; GO:0006954; GO:0016021; GO:0030670; GO:0031226; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727,,,,PF13855;PF01463;PF01582;,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
A6H603,CHOYP_TRIADDRAFT_19804.1.1|m.8993,0.5,0,0,0,0,0,0,0,2.00E-35,NACHT domain- and WD repeat-containing protein 1,Nwd1,1563,RNA splicing [GO:0008380],GO:0005524; GO:0005682; GO:0005829; GO:0008380; GO:0071011; GO:0071013,,,,PF12894;PF00400;,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; precatalytic spliceosome [GO:0071011]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA splicing [GO:0008380]
A5HK05,CHOYP_APBP2.1.1|m.62244,0,0,0,0,0,0,0,0,0,Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2),Appbp2,585,intracellular transport [GO:0046907]; protein transport [GO:0015031],GO:0005634; GO:0005874; GO:0015031; GO:0030659; GO:0046907,,,,PF13374;,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031]
Q6GPV5,CHOYP_ARALYDRAFT_496711.1.1|m.58259,0,0,0,0,0,0,0,0,2.00E-15,E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181),rnf181,156,protein ubiquitination [GO:0016567],GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF13639;,transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
Q6TXF1,CHOYP_ARRD-6.1.1|m.9470,0.5,0,0,0,0,0,0,0,3.00E-39,Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048),Arrdc3,414,fat pad development [GO:0060613]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of multicellular organismal metabolic process [GO:0044252]; positive regulation of adrenergic receptor signaling pathway [GO:0071879]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction [GO:0007165]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],GO:0001659; GO:0005764; GO:0005769; GO:0005886; GO:0007165; GO:0031651; GO:0043588; GO:0044252; GO:0051443; GO:0060613; GO:0071879; GO:0090327,,,,PF02752;PF00339;,early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; fat pad development [GO:0060613]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of multicellular organismal metabolic process [GO:0044252]; positive regulation of adrenergic receptor signaling pathway [GO:0071879]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; signal transduction [GO:0007165]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]
Q8K1J5,CHOYP_BRAFLDRAFT_120767.1.1|m.16005,0,0,0,0,0,0,0,0,3.00E-68,Protein SDE2 homolog,Sde2,448,,GO:0005634,,,,PF13019;,nucleus [GO:0005634]
Q7Z7G8,CHOYP_BRAFLDRAFT_75094.1.2|m.24898,0,0,0,0,0,0,0,0,3.00E-116,Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1),VPS13B CHS1 COH1 KIAA0532,4022,protein transport [GO:0015031],GO:0015031,,,,PF12624;PF06650;PF16909;,protein transport [GO:0015031]
G3XD24,CHOYP_CAHD1.5.6|m.53893,0,0,0,0,0,0,0,0,0.000004,Methyl-accepting chemotaxis protein PctA,pctA PA4309,629,chemotaxis [GO:0006935]; response to amino acid [GO:0043200],GO:0004871; GO:0005886; GO:0006935; GO:0016021; GO:0016597; GO:0043200,,,cd06225;,PF02743;PF00672;PF00015;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; signal transducer activity [GO:0004871]; chemotaxis [GO:0006935]; response to amino acid [GO:0043200]
P30650,CHOYP_CALCR.4.6|m.38626,0,0,0,0,0,0,0,0,4.00E-34,G-protein coupled receptor seb-2,seb-2 ZK643.3,480,cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275],GO:0004930; GO:0005886; GO:0007166; GO:0007275; GO:0016021,,,,PF00002;PF02793;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275]
Q2NL17,CHOYP_CLPT1.1.1|m.50172,0.5,0,0,0,0,0,0,0,0,Cleft lip and palate transmembrane protein 1 homolog,CLPTM1,670,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],GO:0005887; GO:0007275; GO:0030154,,,,PF05602;,integral component of plasma membrane [GO:0005887]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
P10076,CHOYP_LOC100013817.1.1|m.34914,0,0,0,0,0,0,0,0,2.00E-57,Zinc finger protein 26 (Zfp-26) (Protein mKR3),Zfp26 Kiaa4196 Mkr3 Zfp-26,861,"regulation of transcription, DNA-templated [GO:0006355]",GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872,,,cd07765;,PF01352;PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]"
P49715,CHOYP_LOC100204711.1.1|m.21838,0,0,0,0,0,0,0,0,1.00E-18,CCAAT/enhancer-binding protein alpha (C/EBP alpha),CEBPA CEBP,358,"brown fat cell differentiation [GO:0050873]; cell maturation [GO:0048469]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; inner ear development [GO:0048839]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase III promoter [GO:0045945]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]; transcription from RNA polymerase II promoter [GO:0006366]; transcription from RNA polymerase I promoter [GO:0006360]; urea cycle [GO:0000050]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]",GO:0000050; GO:0000122; GO:0000978; GO:0001013; GO:0001077; GO:0001228; GO:0001889; GO:0001892; GO:0003677; GO:0003700; GO:0003705; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006091; GO:0006351; GO:0006360; GO:0006366; GO:0007005; GO:0007219; GO:0008134; GO:0008203; GO:0008285; GO:0016032; GO:0019221; GO:0019900; GO:0030099; GO:0030225; GO:0030324; GO:0030851; GO:0032436; GO:0042593; GO:0042803; GO:0043231; GO:0044212; GO:0045444; GO:0045600; GO:0045669; GO:0045736; GO:0045892; GO:0045944; GO:0045945; GO:0048469; GO:0048839; GO:0050872; GO:0050873; GO:0055088; GO:0071285; GO:0071356; GO:0071407; GO:0090575,,,,PF07716;,"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; RNA polymerase I regulatory region DNA binding [GO:0001013]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0003705]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; brown fat cell differentiation [GO:0050873]; cell maturation [GO:0048469]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; inner ear development [GO:0048839]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase III promoter [GO:0045945]; transcription from RNA polymerase I promoter [GO:0006360]; transcription from RNA polymerase II promoter [GO:0006366]; transcription, DNA-templated [GO:0006351]; urea cycle [GO:0000050]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"
H2MTR9,CHOYP_LOC100367423.1.1|m.23397,0,0,0,0,0,0,0,0,4.00E-60,Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein),ssx2ip,583,cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0007155; GO:0007368; GO:0036064,,,,PF11559;,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368]
Q8WY91,CHOYP_LOC100376482.1.7|m.7553,0,0,0,0,0,0,0,0,0.00000001,THAP domain-containing protein 4,THAP4 CGI-36 PP238,577,,GO:0003677; GO:0046872,,,cd07828;,PF08768;PF05485;,DNA binding [GO:0003677]; metal ion binding [GO:0046872]
Q6AXS0,CHOYP_LOC100448959.1.1|m.5342,0,0,0,0,0,0,0,0,6.00E-32,"Sodium/potassium/calcium exchanger 6, mitochondrial (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Slc8b1 Nckx6 Nclx Slc24a6,585,glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896],GO:0005432; GO:0005739; GO:0005743; GO:0006851; GO:0030061; GO:0032592; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560,,,,PF01699;,integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; sarcolemma [GO:0042383]; calcium:sodium antiporter activity [GO:0005432]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896]
P08011,CHOYP_MGST1.1.1|m.21583,0,0,0,0,0,0,0,0,1.00E-39,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),Mgst1 Gst12,155,cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243],GO:0004364; GO:0004602; GO:0005634; GO:0005739; GO:0005741; GO:0005743; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0010243; GO:0016021; GO:0032496; GO:0033327; GO:0042493; GO:0042802; GO:0042803; GO:0043295; GO:0045177; GO:0070207; GO:0071449,,,,PF01124;,apical part of cell [GO:0045177]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; Leydig cell differentiation [GO:0033327]; protein homotrimerization [GO:0070207]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]
Q6AXS0,CHOYP_NCKX6.1.1|m.52502,0,0,0,0,0,0,0,0,2.00E-158,"Sodium/potassium/calcium exchanger 6, mitochondrial (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Slc8b1 Nckx6 Nclx Slc24a6,585,glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896],GO:0005432; GO:0005739; GO:0005743; GO:0006851; GO:0030061; GO:0032592; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560,,,,PF01699;,integral component of mitochondrial membrane [GO:0032592]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; sarcolemma [GO:0042383]; calcium:sodium antiporter activity [GO:0005432]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; response to stimulus [GO:0050896]
Q8I0P7,CHOYP_PDE3A.1.3|m.22256,0,0,0,0,0,0,0,0,4.00E-97,"Probable 3',5'-cyclic phosphodiesterase pde-3 (EC 3.1.4.17)",pde-3 E01F3.1,678,chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; negative regulation of cGMP biosynthetic process [GO:0030827]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],GO:0004114; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0030827; GO:0042542; GO:0046872,,,,PF00233;,"3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; negative regulation of cGMP biosynthetic process [GO:0030827]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542]"
P28699,CHOYP_RORA.1.2|m.59037,0,0,0,0,0,0,0,0,1.00E-40,Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3),rarg nr1b3,476,"transcription, DNA-templated [GO:0006351]",GO:0003707; GO:0003708; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; retinoic acid receptor activity [GO:0003708]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
P33628,CHOYP_TBA1.7.9|m.44107,0,0,0,0,0,0,0,0,4.00E-67,Tubulin alpha chain (Fragment),TUBA,113,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q8IZS6,CHOYP_BRAFLDRAFT_126379.1.3|m.5102,1,0,0,0,0,0,0,0,4.00E-13,Tctex1 domain-containing protein 3 (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3) (Tcte-3),TCTE3 TCTEX1D3,198,transport [GO:0006810],GO:0003774; GO:0005737; GO:0005874; GO:0006810; GO:0016020; GO:0030286,,,,PF03645;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; motor activity [GO:0003774]; transport [GO:0006810]
D2GXS7,CHOYP_BRAFLDRAFT_84664.1.7|m.3969,0,0,0,0,0,0,0,0,0.0000002,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q03601,CHOYP_BRAFLDRAFT_88223.3.22|m.20538,0,0,0,0,0,0,0,0,0.000003,RING finger protein nhl-1,nhl-1 F54G8.4,974,protein ubiquitination [GO:0016567],GO:0004842; GO:0008270; GO:0016567,,,,PF01436;PF00097;,ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
H2A0L4,CHOYP_CHI1.1.1|m.40259,0,0,0,0,0,0,0,0,0,Putative chitinase 1 (EC 3.2.1.14) (Chitinase-like protein 1) (Clp1),,468,carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],GO:0004568; GO:0005576; GO:0005975; GO:0006032,,,,PF00704;,extracellular region [GO:0005576]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]
Q96MM6,CHOYP_HSPA12B.1.1|m.36165,0,0,0,0,0,0,0,0,1.00E-24,Heat shock 70 kDa protein 12B,HSPA12B C20orf60,686,,GO:0005524,,,,,ATP binding [GO:0005524]
Q9ESM0,CHOYP_IP6K1.1.1|m.54347,0,0,0,0,0,0,0,0,1.00E-108,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),Ip6k1 Ihpk1,433,phosphatidylinositol phosphorylation [GO:0046854],GO:0000832; GO:0001650; GO:0005524; GO:0005829; GO:0008440; GO:0046854; GO:0052723; GO:0052724,,,,PF03770;,"cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; phosphatidylinositol phosphorylation [GO:0046854]"
P06276,CHOYP_LOC100371735.1.1|m.33649,0,0,0,0,0,0,0,0,2.00E-56,Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase),BCHE CHE1,602,choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to drug [GO:0042493]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384],GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005641; GO:0005788; GO:0007612; GO:0008285; GO:0014016; GO:0016020; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042493; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0072562,,,,PF08674;PF00135;,"blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; beta-amyloid binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to drug [GO:0042493]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]"
P70031,CHOYP_LOC100890822.1.2|m.23399,0,0,0,0,0,0,0,0,0.00000001,Cholecystokinin receptor (CCK-XLR),cckar,453,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
P38650,CHOYP_LOC577805.3.4|m.46026,0.5,0,0,0,0,0,0,0,1.00E-39,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C)",Dync1h1 Dhc1 Dnch1 Dnchc1 Dnec1 Dyhc Map1c,4644,microtubule-based movement [GO:0007018]; transport [GO:0006810],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0006810; GO:0007018; GO:0016887; GO:0030286,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; transport [GO:0006810]
Q5XIU9,CHOYP_PGRMC1.1.1|m.38547,0,0,0,0,0,0,0,0,1.00E-62,Membrane-associated progesterone receptor component 2,Pgrmc2,217,,GO:0005496; GO:0005635; GO:0012505; GO:0016020; GO:0016021; GO:0020037,,,,PF00173;,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; heme binding [GO:0020037]; steroid binding [GO:0005496]
Q6ZPY2,CHOYP_SMG5.1.1|m.21320,0,0,0,0,0,0,0,0,0,Protein SMG5 (EST1-like protein B) (SMG-5 homolog),Smg5 Est1b Kiaa1089,1017,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]",GO:0000184; GO:0000932; GO:0004540; GO:0005634; GO:0005697; GO:0005737; GO:0006406; GO:0007004; GO:0031625; GO:0032204; GO:0035303; GO:0042162; GO:0042826; GO:0043021; GO:0043487; GO:0051721; GO:0070034; GO:0070182,,,,PF10374;PF10373;PF13638;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]"
P56719,CHOYP_AAEL_AAEL010626.1.1|m.52019,0,0,0,0,0,0,0,0,1.00E-11,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),Hcrtr2,460,"cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G-protein coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0004930; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; G-protein coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G-protein coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
Q8NF91,CHOYP_ACTN.2.2|m.63975,0,0,0,0,0,0,0,0,4.00E-37,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1,8797,cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292,,,cd00014;,PF00307;PF10541;PF00435;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; LINC complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]
O54905,CHOYP_B3GN5.2.4|m.35685,0,0,0,0,0,0,0,0,7.00E-49,"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)",B3galt2,422,oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0008499; GO:0009312; GO:0016021; GO:0047275,PATHWAY: Protein modification; protein glycosylation.,,,PF01762;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]"
A4IF63,CHOYP_BRAFLDRAFT_273508.4.4|m.61165,0,0,0,0,0,0,0,0,0.0000004,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q04281,CHOYP_BRAFLDRAFT_278777.1.1|m.1970,0,0,0,0,0,0,0,0,1.00E-55,Homeobox protein XHOX-7.1 (Fragment),,295,"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]",GO:0005634; GO:0006355; GO:0007275; GO:0043565,,,,PF00046;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
A4IF63,CHOYP_BRAFLDRAFT_63298.6.6|m.60187,0,0,0,0,0,0,0,0,0.000000001,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q9IBG7,CHOYP_BRAFLDRAFT_74063.2.5|m.9454,0,0,0,0,0,0,0,0,0,Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin),kcp crim2,2327,positive regulation of BMP signaling pathway [GO:0030513],GO:0005615; GO:0030513,,,,PF00093;PF00094;,extracellular space [GO:0005615]; positive regulation of BMP signaling pathway [GO:0030513]
S4R2P9,CHOYP_BRAFLDRAFT_78683.1.4|m.29747,0,0,0,0,0,0,0,0,6.00E-140,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Slc8a3 Ncx3,928,calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],GO:0002244; GO:0005432; GO:0005741; GO:0005789; GO:0005874; GO:0005887; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0099580; GO:1990034; GO:1990035,,,,PF03160;PF01699;PF16494;,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]
P02676,CHOYP_BRAFLDRAFT_86061.10.13|m.52540,0,0,0,0,0,0,0,0,4.00E-45,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain],FGB,468,adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; platelet activation [GO:0030168]; protein polymerization [GO:0051258]; signal transduction [GO:0007165],GO:0001948; GO:0002250; GO:0005577; GO:0007165; GO:0030168; GO:0045087; GO:0051258,,,cd00087;,PF08702;PF00147;,fibrinogen complex [GO:0005577]; glycoprotein binding [GO:0001948]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; platelet activation [GO:0030168]; protein polymerization [GO:0051258]; signal transduction [GO:0007165]
Q8WWF6,CHOYP_DNAJB6B.1.2|m.1265,0,0,0,0,0,0,0,0,5.00E-39,DnaJ homolog subfamily B member 3,DNAJB3 HCG3,145,,GO:0070062,,,cd06257;,PF00226;,extracellular exosome [GO:0070062]
O70400,CHOYP_ISCW_ISCW000210.2.4|m.14990,0,0,0,0,0,0,0,0,1.00E-10,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),Pdlim1 Clim1,327,"regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]",GO:0001666; GO:0003713; GO:0005667; GO:0005737; GO:0005856; GO:0005913; GO:0005925; GO:0006355; GO:0008270; GO:0098641,,,,PF15936;PF00412;PF00595;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; transcription factor complex [GO:0005667]; cadherin binding involved in cell-cell adhesion [GO:0098641]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"
Q9R1C6,CHOYP_ISCW_ISCW016328.1.1|m.10256,0,0,0,0,0,0,0,0,2.00E-149,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Dgke,564,intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205],GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0035556; GO:0046834; GO:0046872,,,cd00029;,PF00130;PF00609;PF00781;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]
P27398,CHOYP_LOC100165317.1.1|m.8504,0,0,0,0,0,0,0,0,6.00E-76,Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein),sol CalpD CG1391,1594,nervous system development [GO:0007399]; proteolysis [GO:0006508]; temperature compensation of the circadian clock [GO:0010378]; visual perception [GO:0007601],GO:0004198; GO:0005622; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0008270; GO:0010378,,,cd00044;,PF00648;PF00641;,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; temperature compensation of the circadian clock [GO:0010378]; visual perception [GO:0007601]
A4IF63,CHOYP_LOC100373444.72.79|m.60850,0,0,0,0,0,0,0,0,3.00E-13,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
A4IF63,CHOYP_LOC100375551.2.2|m.63719,0.5,0,0,0,0,0,0,0,0.000000003,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q5ND28,CHOYP_LOC100490321.2.2|m.54266,0.5,0,0,0,0,0,0,0,3.00E-33,Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1 protein) (SREC-I),Scarf1 Kiaa0149 Srec,820,cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],GO:0005044; GO:0005886; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0048680,,,,PF00053;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
Q9UM13,CHOYP_LOC100642984.1.1|m.28915,0,0,0,0,0,0,0,0,4.00E-80,Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10),ANAPC10 APC10,185,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439],GO:0005654; GO:0005680; GO:0005829; GO:0007067; GO:0030071; GO:0031145; GO:0042787; GO:0043161; GO:0051301; GO:0051436; GO:0051437; GO:0051439; GO:0070979,PATHWAY: Protein modification; protein ubiquitination.,,,PF03256;,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051439]
Q5E9P6,CHOYP_LOC100699837.1.1|m.54956,0,0,0,0,0,0,0,0,7.00E-76,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog),BSCL2,394,fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid particle organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995,,,,PF06775;,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid particle organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]
Q3U2J5,CHOYP_LOC100892187.1.1|m.12761,0,0,0,0,0,0,0,0,8.00E-87,Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60),Camkmt Clnmt,323,mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022],GO:0005634; GO:0005794; GO:0007005; GO:0018022; GO:0018025,,,,PF10294;,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]
A2AVA0,CHOYP_LOC100906063.3.3|m.63970,0,0,0,0,0,0,0,0,3.00E-14,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Svep1,3567,cell adhesion [GO:0007155],GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020,,,cd00033;cd00152;,PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
Q96JQ0,CHOYP_LOC101157079.2.2|m.7067,0,0,0,0,0,0,0,0,6.00E-99,Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1),DCHS1 CDH19 CDH25 FIB1 KIAA1773 PCDH16,3298,branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659],GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005622; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102,,,,PF00028;,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]
Q9UA35,CHOYP_LOC574602.1.1|m.44079,0.5,0,0,0,0,0,0,0,1.00E-132,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT),SLC28A3 CNT3,683,,GO:0005337; GO:0005887,,,,PF07670;PF07662;PF01773;,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
Q6PDJ1,CHOYP_NEMVEDRAFT_V1G238894.7.11|m.61041,0,0,0,0,0,0,0,0,5.00E-90,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),Cachd1 Kiaa1573 Vwcd1,1288,calcium ion transport [GO:0006816],GO:0006816; GO:0016021,,,,PF00092;PF08399;,integral component of membrane [GO:0016021]; calcium ion transport [GO:0006816]
P74148,CHOYP_NEMVEDRAFT_V1G242153.1.4|m.7718,0,0,0,0,0,0,0,0,7.00E-11,Universal stress protein Sll1388 (USP Sll1388),sll1388,154,response to stress [GO:0006950],GO:0006950,,,,PF00582;,response to stress [GO:0006950]
Q9BKZ9,CHOYP_PHUM_PHUM122670.1.1|m.38346,0,0,0,0,0,0,0,0,3.00E-112,Protein Fe65 homolog,feh-1 Y54F10AM.2,665,"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005856; GO:0006351; GO:0006355; GO:0007631; GO:0008134; GO:0009792,,,,PF00640;,"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; beta-amyloid binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q96C23,CHOYP_RHOM172_0471.1.1|m.60636,0,0,0,0,0,0,0,0,1.00E-75,Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase),GALM BLOCK25,342,galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006],GO:0004034; GO:0005737; GO:0006006; GO:0006012; GO:0030246; GO:0033499; GO:0070062,PATHWAY: Carbohydrate metabolism; hexose metabolism.,,,PF01263;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]
E1BJS7,CHOYP_ZF_BBOX_RING_-1.3.10|m.29555,0,0,0,0,0,0,0,0,3.00E-10,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),TRIM71 LIN41,868,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;,P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
Q5JWF8,CHOYP_ACT3.1.3|m.23292,0,0,0,0,0,0,0,0,5.00E-48,Actin-like protein 10,ACTL10 C20orf134,245,,,,,,PF00022;,
Q3UWM4,CHOYP_BRAFLDRAFT_119367.1.1|m.59963,0,0,0,0,0,0,0,0,0,Lysine-specific demethylase 7A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7),Kdm7a Jhdm1d Kdm7 Kiaa1718,940,"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",GO:0005506; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558,,,,PF02373;PF00628;,"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
Q6NT55,CHOYP_BRAFLDRAFT_225290.1.1|m.5737,0,0,0,0,0,0,0,0,5.00E-125,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,531,icosanoid metabolic process [GO:0006690],GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
Q6NT55,CHOYP_BRAFLDRAFT_61250.5.14|m.37733,0,0,0,0,0,0,0,0,3.00E-129,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,531,icosanoid metabolic process [GO:0006690],GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
Q8NCX0,CHOYP_CCDC150.1.1|m.58800,0,0,0,0,0,0,0,0,7.00E-68,Coiled-coil domain-containing protein 150,CCDC150,1101,,,,,,,
P19133,CHOYP_FRIS.10.11|m.66055,0,0,0,0,0,0,0,0,2.00E-17,Ferritin light chain (Ferritin L subunit) (Fragment),FTL,78,intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826],GO:0005506; GO:0005737; GO:0006826; GO:0006880; GO:0008043; GO:0008199,,,,PF00210;,cytoplasm [GO:0005737]; intracellular ferritin complex [GO:0008043]; ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]
Q6DCG4,CHOYP_LOC100370684.1.2|m.61027,0,0,0,0,0,0,0,0,4.00E-143,Ammonium transporter Rh type B-B (Rhesus blood group family type B glycoprotein B) (Rh family type B glycoprotein B) (Rh type B glycoprotein B),rhbg-b,460,,GO:0008519; GO:0016021; GO:0016323; GO:0030659,,,,PF00909;,basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]
Q5ZJH7,CHOYP_LOC100372380.1.1|m.51206,0,0,0,0,0,0,0,0,8.00E-62,Protein CNPPD1,CNPPD1 RCJMB04_3a20,439,regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],GO:0000079; GO:0016021,,,,PF08613;,integral component of membrane [GO:0016021]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
Q6AXK4,CHOYP_LOC100373186.1.1|m.58981,1,0,0,0,0,0,0,0,4.00E-55,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),babam1 merit40 nba1 Zgc:100909,370,cell division [GO:0051301]; covalent chromatin modification [GO:0016569]; double-strand break repair [GO:0006302]; G2 DNA damage checkpoint [GO:0031572]; mitotic nuclear division [GO:0007067]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212],GO:0005634; GO:0005737; GO:0006302; GO:0007067; GO:0010212; GO:0016569; GO:0031572; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070552,,,,,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell division [GO:0051301]; covalent chromatin modification [GO:0016569]; double-strand break repair [GO:0006302]; G2 DNA damage checkpoint [GO:0031572]; mitotic nuclear division [GO:0007067]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]
Q8N157,CHOYP_LOC100373327.2.13|m.16978,0,0,0,0,0,0,0,0,0,Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1),AHI1,1196,cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192],GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097711; GO:0097730,,,,PF00018;PF00400;,adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]
Q8K2C9,CHOYP_LOC100376136.1.1|m.4906,0,0,0,0,0,0,0,0,4.00E-78,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),Hacd3 Ptplad1,362,fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; very long-chain fatty acid biosynthetic process [GO:0042761],GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005925; GO:0007249; GO:0007254; GO:0007266; GO:0016021; GO:0018812; GO:0019899; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102344; GO:0102345,PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000250|UniProtKB:Q9P035}.,,,PF04387;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; very long-chain fatty acid biosynthetic process [GO:0042761]
P22897,CHOYP_LOC100378295.1.4|m.3278,0,0,0,0,0,0,0,0,3.00E-167,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),MRC1 CLEC13D CLEC13DL MRC1L1,1456,cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],GO:0001618; GO:0004872; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0071222; GO:0071346; GO:0071353,,,cd00062;,PF00040;PF00059;PF00652;,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
Q6NT55,CHOYP_LOC100379072.1.1|m.43496,0,0,0,0,0,0,0,0,1.00E-128,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,531,icosanoid metabolic process [GO:0006690],GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
O88488,CHOYP_LOC100491367.2.3|m.38110,0,0,0,0,0,0,0,0,1.00E-14,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48),Ptprq Ptpgmc1,2302,cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of fat cell differentiation [GO:0045598],GO:0004725; GO:0005886; GO:0016021; GO:0030154; GO:0042472; GO:0045598; GO:0046856,,,cd00063;,PF00041;PF00102;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of fat cell differentiation [GO:0045598]
Q5RJ80,CHOYP_LOC100697720.1.2|m.5790,0,0,0,0,0,0,0,0,2.00E-10,Caprin-2 (RNA granule protein 140),caprin2 rng140 si:ch211-11c20.4,914,dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],GO:0003723; GO:0005737; GO:0005886; GO:0009953; GO:0017148; GO:0030177; GO:0040008; GO:0046872; GO:0050775; GO:0061003; GO:0090263; GO:2000055,,,,PF00386;PF12287;,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008]
Q8TD19,CHOYP_NEK9.1.1|m.19497,0.5,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8),NEK9 KIAA1995 NEK8 NERCC,979,cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mitotic nuclear envelope disassembly [GO:0007077],GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007067; GO:0007077; GO:0019901; GO:0046872; GO:0051301,,,,PF00069;PF00415;,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mitotic nuclear envelope disassembly [GO:0007077]
P81718,CHOYP_PTPRT.1.45|m.2628,0,0,0,0,0,0,0,0,1.00E-49,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Protein-tyrosine phosphatase SHP-1),Ptpn6 Ptph6,613,cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611],GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0006470; GO:0008283; GO:0009611; GO:0030154; GO:0046703; GO:0070372,,,,PF00017;PF00102;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; natural killer cell lectin-like receptor binding [GO:0046703]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611]
Q80ZA5,CHOYP_S4A8.1.1|m.28334,0,0,0,0,0,0,0,0,0,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Slc4a10 Ncbe,1117,anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814],GO:0005452; GO:0005887; GO:0006814; GO:0007399; GO:0008509; GO:0015293; GO:0015297; GO:0015701; GO:0051453; GO:0098656,,,,PF07565;PF00955;,integral component of plasma membrane [GO:0005887]; anion transmembrane transporter activity [GO:0008509]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]
Q8BYH3,CHOYP_TRM13.1.1|m.16853,0,0,0,0,0,0,0,0,6.00E-88,tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76),Trmt13 Ccdc76,481,tRNA methylation [GO:0030488],GO:0008175; GO:0030488; GO:0046872,,,,PF05206;PF11722;PF05253;,metal ion binding [GO:0046872]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]
O35309,CHOYP_BRAFLDRAFT_208436.29.32|m.61623,0,0,0,0,0,0,0,0,0.000001,N-myc-interactor (Nmi) (N-myc and STAT interactor),Nmi,314,interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha biosynthetic process [GO:0045355]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of type I interferon production [GO:0032480]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000166; GO:0003712; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0032480; GO:0042802; GO:0045355; GO:0045358; GO:0045824; GO:0060333; GO:1902524,,,,PF07334;PF07292;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; transcription cofactor activity [GO:0003712]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha biosynthetic process [GO:0045355]; negative regulation of interferon-beta biosynthetic process [GO:0045358]; negative regulation of type I interferon production [GO:0032480]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; transcription from RNA polymerase II promoter [GO:0006366]
Q3TV65,CHOYP_BRAFLDRAFT_221394.1.1|m.66239,0,0,0,0,0,0,0,0,7.00E-82,MPN domain-containing protein (EC 3.4.-.-),Mpnd,487,,GO:0008233,,,,PF01398;,peptidase activity [GO:0008233]
B2IZD3,CHOYP_BRAFLDRAFT_81322.1.2|m.17860,0,0,0,0,0,0,0,0,2.00E-11,Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5),Npun_R6513,693,,GO:0003924; GO:0005525; GO:0005886; GO:0008289; GO:0016021,,,,PF00350;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]
O08560,CHOYP_DGKZA.1.2|m.29620,0,0,0,0,0,0,0,0,0,Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (104 kDa diacylglycerol kinase) (DGK-IV) (Diglyceride kinase zeta) (DGK-zeta),Dgkz Dagk6,929,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205],GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007205; GO:0016607; GO:0030027; GO:0035556; GO:0046339; GO:0046834; GO:0046872,,,cd00029;,PF12796;PF00130;PF00609;PF00781;,cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]
Q96EV8,CHOYP_DTNBP1.1.1|m.66644,0,0,0,0,0,0,0,0,2.00E-30,Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein),DTNBP1 BLOC1S8 My031,351,actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506],GO:0001956; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0007596; GO:0008089; GO:0010008; GO:0010628; GO:0014059; GO:0014069; GO:0015630; GO:0016528; GO:0030054; GO:0030424; GO:0030426; GO:0030496; GO:0030672; GO:0031083; GO:0031175; GO:0031532; GO:0032091; GO:0032438; GO:0033162; GO:0042383; GO:0043005; GO:0043197; GO:0043506; GO:0045211; GO:0048490; GO:0048812; GO:0048813; GO:0060155; GO:0060159; GO:0071901; GO:1904115,,,,PF04440;,axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; growth cone [GO:0030426]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]
P18700,CHOYP_LOC100366728.1.1|m.57452,0,0,0,0,0,0,0,0,0,Tubulin beta chain (Beta-tubulin) (Fragment),,292,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;PF03953;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q02763,CHOYP_LOC100371242.3.6|m.39821,0,0,0,0,0,0,0,0,5.00E-13,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b),TEK TIE2 VMCM VMCM1,1124,angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0000165; GO:0001525; GO:0001666; GO:0001934; GO:0001935; GO:0001938; GO:0001958; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0004872; GO:0005088; GO:0005524; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0034446; GO:0043066; GO:0043114; GO:0043434; GO:0043552; GO:0043627; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0050900; GO:0051259; GO:0051591; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352,,,cd00063;,PF00041;PF10430;PF07714;,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor activity [GO:0004872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q9R1M5,CHOYP_LOC100372392.1.8|m.6461,0,0,0,0,0,0,0,0,6.00E-14,"NACHT, LRR and PYD domains-containing protein 5 (Maternal antigen that embryos require) (Mater protein) (Ooplasm-specific protein 1) (OP1)",Nlrp5 Mater Nalp5,1163,animal organ morphogenesis [GO:0009887]; cellular protein complex assembly [GO:0043623]; cellular protein localization [GO:0034613]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; neuron death [GO:0070997]; regulation of protein stability [GO:0031647]; regulation of RNA stability [GO:0043487],GO:0001701; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005938; GO:0007566; GO:0009566; GO:0009887; GO:0031647; GO:0034613; GO:0043234; GO:0043487; GO:0043623; GO:0045179; GO:0070997,,,,PF13516;,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein complex [GO:0043234]; ATP binding [GO:0005524]; animal organ morphogenesis [GO:0009887]; cellular protein complex assembly [GO:0043623]; cellular protein localization [GO:0034613]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; neuron death [GO:0070997]; regulation of protein stability [GO:0031647]; regulation of RNA stability [GO:0043487]
P92555,CHOYP_LOC100490320.2.2|m.36450,0,0,0,0,0,0,0,0,0.000003,Uncharacterized mitochondrial protein AtMg01250 (ORF102),AtMg01250; At2g07697,122,,GO:0005739,,,,PF00078;,mitochondrion [GO:0005739]
Q17QJ5,CHOYP_LOC100645644.1.1|m.55634,0,0,0,0,0,0,0,0,4.00E-89,Tetraspanin-5 (Tspan-5),TSPAN5,268,cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604],GO:0005887; GO:0007166; GO:0045747; GO:0051604; GO:0090002,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; establishment of protein localization to plasma membrane [GO:0090002]; positive regulation of Notch signaling pathway [GO:0045747]; protein maturation [GO:0051604]
Q8K2L8,CHOYP_LOC100659825.1.1|m.62706,0.5,0,0,0,0,0,0,0,3.00E-139,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15),Trappc12 Ttc15,797,metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle-mediated transport [GO:0016192],GO:0000776; GO:0004175; GO:0005634; GO:0005793; GO:0016192; GO:0051310; GO:0090234; GO:1905342,,,,,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle-mediated transport [GO:0016192]
O34309,CHOYP_LOC100890479.1.3|m.8193,0,0,0,0,0,0,0,0,8.00E-49,"Putative phosphoenolpyruvate synthase (Putative PEP synthase) (Pyruvate, water dikinase)",pps BSU18830,866,,GO:0005524; GO:0016301,,,,PF00391;PF01326;,ATP binding [GO:0005524]; kinase activity [GO:0016301]
Q16513,CHOYP_LOC582022.1.1|m.31,0,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),PKN2 PRK2 PRKCL2,984,"apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006351; GO:0006355; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016020; GO:0016301; GO:0018105; GO:0030027; GO:0030496; GO:0032154; GO:0032467; GO:0035556; GO:0042826; GO:0043234; GO:0043296; GO:0043297; GO:0045070; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:2000145,,,,PF02185;PF00069;PF00433;,"apical junction complex [GO:0043296]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex [GO:0043234]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"
Q2TGI5,CHOYP_LOC764485.2.2|m.9579,0,0,0,0,0,0,0,0,5.00E-20,Probable palmitoyltransferase ZDHHC24 (EC 2.3.1.225) (Membrane-associated zinc finger protein DHHC25) (Zinc finger DHHC domain-containing protein 24) (DHHC-24),Zdhhc24,284,,GO:0016021; GO:0019706,,,,PF01529;,integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]
B7QDG3,CHOYP_NNRE.2.2|m.27199,0.5,0,0,0,0,0,0,0,5.00E-96,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase),ISCW022186,275,,GO:0000166; GO:0005739; GO:0046872; GO:0052856; GO:0052857,,,,PF03853;,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]
Q8CIC2,CHOYP_NUPL2.1.2|m.4693,0,0,0,0,0,0,0,0,5.00E-23,Nucleoporin-like protein 2 (NLP-1),Nupl2,420,mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],GO:0001750; GO:0003723; GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006611; GO:0031965; GO:0046872; GO:0051028,,,,,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]
Q5DRB6,CHOYP_PCDH1.2.3|m.8055,0,0,0,0,0,0,0,0,2.00E-94,Protocadherin gamma-A4 (PCDH-gamma-A4),PCDHGA4,931,cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399],GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399,,,,PF00028;PF08266;PF16492;PF15974;,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]
Q8VCX6,CHOYP_PNO1.2.3|m.47801,0,0,0,0,0,0,0,0,8.00E-74,Kaptin,Kptn,430,actin filament organization [GO:0007015],GO:0007015; GO:0015629; GO:0030426; GO:0032420; GO:0048471,,,,,actin cytoskeleton [GO:0015629]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; actin filament organization [GO:0007015]
E9Q612,CHOYP_PTPRK.6.20|m.6291,0,0,0,0,0,0,0,0,1.00E-59,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),Ptpro GLEPP1 Ptpn15 PTPU2,1226,axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glomerular filtration [GO:0003105]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060],GO:0000902; GO:0002548; GO:0003093; GO:0003105; GO:0004725; GO:0005886; GO:0007411; GO:0016021; GO:0016324; GO:0016328; GO:0017147; GO:0030032; GO:0032835; GO:0035335; GO:0036060; GO:0042803; GO:0043197; GO:0070062; GO:0072112; GO:0090090,,,cd00063;,PF00041;PF00102;,apical plasma membrane [GO:0016324]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glomerular filtration [GO:0003105]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060]
Q9VAC5,CHOYP_AAEL_AAEL003910.1.1|m.36530,0,0,0,0,0,0,0,0,6.00E-143,ADAM 17-like protease (EC 3.4.24.-),Tace CG7908,732,membrane protein ectodomain proteolysis [GO:0006509],GO:0004222; GO:0006509; GO:0016021; GO:0046872,,,cd04270;,PF16698;PF00200;PF01562;,integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]
O88450,CHOYP_BRAFLDRAFT_75725.1.1|m.9603,0,0,0,0,0,0,0,0,2.00E-67,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin),Deaf1 Spn,565,"embryonic skeletal system development [GO:0048706]; neural tube closure [GO:0001843]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of multicellular organismal development [GO:2000026]; transcription, DNA-templated [GO:0006351]",GO:0001843; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0006351; GO:0033599; GO:0045944; GO:0046872; GO:0048706; GO:2000026,,,,PF01342;PF01753;,"extracellular region [GO:0005576]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; embryonic skeletal system development [GO:0048706]; neural tube closure [GO:0001843]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of multicellular organismal development [GO:2000026]; transcription, DNA-templated [GO:0006351]"
P08053,CHOYP_CALM.32.50|m.48894,2,0,0,0,0,0,0,0,2.00E-34,Myosin regulatory light chain (Calcium-binding light chain),,147,,GO:0005509; GO:0016459,,,cd00051;,PF00036;PF13499;,myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
P24862,CHOYP_CCNB.2.2|m.16937,0,0,0,0,0,0,0,0,1.00E-175,G2/mitotic-specific cyclin-B,,408,cell division [GO:0051301]; mitotic nuclear division [GO:0007067],GO:0005634; GO:0007067; GO:0051301,,,,PF02984;PF00134;,nucleus [GO:0005634]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]
Q921G8,CHOYP_GCP2.1.1|m.23103,0,0,0,0,0,0,0,0,0,Gamma-tubulin complex component 2 (GCP-2),Tubgcp2 Gcp2,905,centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; interphase microtubule nucleation by interphase microtubule organizing center [GO:0051415]; meiotic nuclear division [GO:0007126]; mitotic spindle assembly [GO:0090307],GO:0000922; GO:0000923; GO:0005200; GO:0005654; GO:0005813; GO:0005874; GO:0007126; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051298; GO:0051415; GO:0090307,,,,PF04130;,centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; interphase microtubule nucleation by interphase microtubule organizing center [GO:0051415]; meiotic nuclear division [GO:0007126]; mitotic spindle assembly [GO:0090307]
O77245,CHOYP_LOC100161053.1.1|m.6306,0,0,0,0,0,0,0,0,3.00E-84,Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3),E75 NR1D3,606,"transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0003707; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
Q9W735,CHOYP_LOC100374504.1.2|m.27883,0,0,0,0,0,0,0,0,3.00E-101,Prominin-1-A (Prominin-like protein 1),prom1a proml1,826,,GO:0005783; GO:0005793; GO:0005886; GO:0016021; GO:0016324; GO:0031528,,,,PF05478;,apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]
Q8CCH7,CHOYP_LOC100577801.1.1|m.7007,0,0,0,0,0,0,0,0,2.00E-10,Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (mFOG-2) (Zinc finger protein multitype 2),Zfpm2 Fog2,1151,"atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; mitral valve formation [GO:0003192]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; transcription, DNA-templated [GO:0006351]; tricuspid valve formation [GO:0003195]; vasculogenesis [GO:0001570]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular septum morphogenesis [GO:0060412]",GO:0000122; GO:0001078; GO:0001085; GO:0001570; GO:0001701; GO:0003148; GO:0003151; GO:0003181; GO:0003192; GO:0003195; GO:0003221; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0007507; GO:0008134; GO:0030324; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048568; GO:0048738; GO:0055008; GO:0060045; GO:0060412; GO:0060548; GO:0060979; GO:2000020; GO:2000195,,,,,"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; mitral valve formation [GO:0003192]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; transcription, DNA-templated [GO:0006351]; tricuspid valve formation [GO:0003195]; vasculogenesis [GO:0001570]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular septum morphogenesis [GO:0060412]"
P46012,CHOYP_LOC587946.1.1|m.5037,0.5,0,0,0,0,0,0,0,2.00E-12,Uncharacterized protein C01G6.5,C01G6.5,952,,,,,,PF00498;,
Q5URB8,CHOYP_LOC589750.3.5|m.42967,0.5,0,0,0,0,0,0,0,5.00E-21,Putative ankyrin repeat protein R841,MIMI_R841,601,,,,,,PF00023;PF12796;,
Q9V439,CHOYP_LOC659964.1.1|m.25995,1,0,0,0,0,0,0,0,1.00E-56,Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (dMED24),MED22 Med24 CG3034,143,"mitotic nuclear division [GO:0007067]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; transcription, DNA-templated [GO:0006351]",GO:0000785; GO:0001104; GO:0005634; GO:0005730; GO:0006351; GO:0006357; GO:0007067; GO:0007406; GO:0016592; GO:1902064,,,,PF06179;,"chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II transcription cofactor activity [GO:0001104]; mitotic nuclear division [GO:0007067]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; transcription, DNA-templated [GO:0006351]"
Q9P0M2,CHOYP_LOC754150.1.1|m.29730,0.5,0,0,0,0,0,0,0,2.00E-19,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),AKAP7 AKAP18,348,protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738],GO:0000166; GO:0005634; GO:0005829; GO:0008104; GO:0010738; GO:0034237; GO:0051018,,,,PF10469;PF10470;,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738]
A6BM72,CHOYP_MEG10.11.91|m.21604,0,0,0,0,0,0,0,0,3.00E-27,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),MEGF11 KIAA1781 UNQ1949/PRO4432,1044,homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],GO:0010842; GO:0016021; GO:0016323; GO:0034109,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
Q9Y2M2,CHOYP_NEMVEDRAFT_V1G100491.1.1|m.7381,0,0,0,0,0,0,0,0,4.00E-59,Protein SSUH2 homolog (Protein ssu-2 homolog),SSUH2 C3orf32 FLS485,353,,GO:0005737,,,,,cytoplasm [GO:0005737]
Q9VBP3,CHOYP_PARP14.19.22|m.59129,0,0,0,0,0,0,0,0,9.00E-11,Tankyrase (dTNKS) (EC 2.4.2.30) (Poly [ADP-ribose] polymerase),Tnks tankyrase CG4719,1181,chaeta development [GO:0022416]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; regulation of proteasome assembly [GO:0090364]; spindle assembly [GO:0051225]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055],GO:0003950; GO:0006471; GO:0016055; GO:0022416; GO:0032212; GO:0035220; GO:0046872; GO:0051225; GO:0090364; GO:0097110,,,,PF00023;PF12796;PF00644;PF07647;,metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; scaffold protein binding [GO:0097110]; chaeta development [GO:0022416]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; regulation of proteasome assembly [GO:0090364]; spindle assembly [GO:0051225]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]
Q6R7L6,CHOYP_PRIM.1.1|m.30784,0,0,0,0,0,0,0,0,0,Putative primase (EC 2.7.7.-),ORF7,1181,,GO:0003896,,,,PF01896;,DNA primase activity [GO:0003896]
Q5E9W3,CHOYP_PYRD.1.1|m.47593,0,0,0,0,0,0,0,0,4.00E-149,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",DHODH,395,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],GO:0004152; GO:0005743; GO:0006207; GO:0016021; GO:0044205,PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway; orotate from (S)-dihydroorotate (quinone route): step 1/1.,,cd04738;,PF01180;,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]
Q8VE97,CHOYP_RS3A.4.15|m.15366,0.5,0,0,0,0,0,0,0,4.00E-96,"Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4)",Srsf4 Sfrs4 MNCb-2616,489,"hematopoietic progenitor cell differentiation [GO:0002244]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]",GO:0000166; GO:0002244; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0048025,,,,PF00076;,"nuclear speck [GO:0016607]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]"
Q05B65,CHOYP_SRFB1.1.2|m.18320,0,0,0,0,0,0,0,0,1.00E-19,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein),SRFBP1,428,"maturation of SSU-rRNA [GO:0030490]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355; GO:0030490; GO:0030686; GO:0048471,,,,PF09073;,"90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q1JPJ2,CHOYP_TRIADDRAFT_64367.1.1|m.42126,0.5,0,0,0,0,0,0,0,1.00E-161,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",XPNPEP1,623,bradykinin catabolic process [GO:0010815],GO:0005829; GO:0010815; GO:0030145; GO:0070006; GO:0070062,,,cd01085;,PF01321;PF00557;PF16188;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; bradykinin catabolic process [GO:0010815]
Q8K1J6,CHOYP_TRNT1.1.1|m.1512,0,0,0,0,0,0,0,0,7.00E-137,"CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",Trnt1,434,tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033],GO:0000049; GO:0001680; GO:0004810; GO:0005524; GO:0005622; GO:0005739; GO:0008033; GO:0009022; GO:0042780; GO:0052927; GO:0052928; GO:0052929,,,cd05398;,PF01743;PF12627;,intracellular [GO:0005622]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA adenylyltransferase activity [GO:0004810]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]
Q26474,CHOYP_TTN.2.9|m.17508,0,0,0,0,0,0,0,0,7.00E-20,Lachesin,LAC,349,cell adhesion [GO:0007155]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004714; GO:0005886; GO:0007155; GO:0007169; GO:0031225,,,,PF07679;,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell adhesion [GO:0007155]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q6P7B7,CHOYP_ZFY27.1.1|m.31417,0,0,0,0,0,0,0,0,5.00E-25,Protrudin (Zinc finger FYVE domain-containing protein 27),Zfyve27,404,endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],GO:0005783; GO:0016021; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659,,,,PF01363;,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]
Q6H236,CHOYP_contig_050507|m.60115,0,0,0,0,0,0,0,0,5.00E-16,Paternally-expressed gene 3 protein,PEG3,2387,"apoptotic process [GO:0006915]; transcription, DNA-templated [GO:0006351]",GO:0000981; GO:0003676; GO:0005634; GO:0005737; GO:0006351; GO:0006915; GO:0046872,,,,PF02023;PF00096;PF13912;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; apoptotic process [GO:0006915]; transcription, DNA-templated [GO:0006351]"
None,CHOYP_contig_048148|m.56980,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050355|m.59899,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3.4.7|m.42801,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004029|m.4597,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008102|m.9380,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100497926.1.2|m.30153,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367405.1.2|m.10570,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_65361.2.3|m.48007,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024730|m.28114,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KARG.4.11|m.5401,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IWS1.1.1|m.13973,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052729|m.63227,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC584740.2.2|m.34290,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PTPRQ.6.8|m.45809,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005830|m.6680,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052147|m.62461,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014109|m.16087,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.54.83|m.47294,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACAC.2.2|m.58115,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS8.2.14|m.14441,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MUC5B.1.1|m.15734,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368311.1.2|m.26733,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043680|m.50456,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018098|m.21196,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.12.15|m.49134,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF-1A.1.9|m.5616,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035470|m.40228,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_241726.22.22|m.52736,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_76943.1.1|m.58001,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_114866.4.5|m.35626,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026383|m.30057,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_001360|m.1426,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053146|m.63745,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC594151.1.2|m.7270,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EEF1A.1.3|m.18896,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004011|m.4571,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050388|m.59942,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,LYSC_HUMAN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GEMIN4.1.1|m.16714,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87634.1.1|m.39992,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023639|m.26898,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031279|m.35700,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC584416.1.1|m.34286,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100890844.1.2|m.46790,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375342.3.3|m.40363,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533388.4.6|m.45039,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041765|m.47848,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373653.2.3|m.43046,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533220.2.2|m.13991,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012366|m.14229,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047333|m.55799,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GLNA.1.5|m.1591,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_61712.1.1|m.38683,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_62546.2.2|m.56798,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100879487.1.3|m.20887,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FUT2.4.5|m.54048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049099|m.58219,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AFUA_1G01020.24.50|m.32940,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_129048.1.1|m.1769,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_OSBL8.1.2|m.7583,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ZNF510.1.1|m.10853,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050319|m.59838,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,KRUC_SHEEP,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC575793.1.2|m.34691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRI45.18.23|m.48495,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_019914|m.23170,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28241.1.1|m.18767,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DYAK_GE25484.1.1|m.6273,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_237339.1.1|m.15256,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FUT2.5.5|m.63708,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_89105.1.1|m.2234,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052570|m.63028,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67258.12.18|m.47677,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100633075.1.4|m.4467,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NAEGRDRAFT_49892.1.1|m.10608,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_99539.1.1|m.55866,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G199564.4.6|m.54685,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IAP2.4.5|m.56879,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041073|m.46786,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031433|m.35919,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC575944.1.5|m.22547,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044629|m.51700,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100893261.2.3|m.49437,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28568.7.9|m.48623,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL013229.2.2|m.57593,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367809.2.2|m.44174,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100369686.2.2|m.30008,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014339|m.16407,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042066|m.48310,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G206150.1.1|m.39762,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC373275.7.7|m.63851,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368521.3.3|m.41435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052844|m.63401,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_90820.1.1|m.9279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023301|m.26512,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046883|m.55107,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CED1.20.29|m.45054,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006664|m.7577,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015931|m.18654,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000189|m.198,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377009.9.10|m.60552,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100617548.1.1|m.64248,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_045427|m.52825,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF1B.3.7|m.35082,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032534|m.37120,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100122438.2.2|m.60108,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026140|m.29796,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SACS.6.17|m.35149,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOAG_00625.1.1|m.34418,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008740|m.10166,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100488715.1.1|m.61241,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004193|m.4802,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM377430.1.2|m.29459,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000003|m.1,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009806|m.11429,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.20.83|m.20589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004513|m.5183,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ASPM.1.4|m.6650,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.11.15|m.43498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100708650.1.3|m.10354,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018444|m.21618,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012437|m.14312,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ISCW_ISCW008596.1.2|m.8803,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374116.1.1|m.37009,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041336|m.47149,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578656.2.15|m.11315,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042864|m.49442,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375194.5.7|m.46447,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043212|m.49892,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368251.3.6|m.40053,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LCAZH_2403.1.1|m.47655,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_034345|m.39015,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC588385.1.2|m.18390,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010233|m.11921,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.11.59|m.24279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TSP_10783.1.2|m.5651,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027562|m.31253,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF-1A.2.9|m.10123,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101067432.1.1|m.16927,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS15A.6.11|m.23616,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100904558.2.2|m.26621,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040334|m.45722,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_UNC-89.2.2|m.64371,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF-1A.6.9|m.43621,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_88566.1.11|m.2935,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACTA.1.2|m.13068,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023311|m.26521,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYSP.2.9|m.1763,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533245.3.6|m.31983,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048420|m.57335,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GPR98.4.5|m.21296,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CAOG_05733.1.2|m.29878,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.65.83|m.53330,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KCNC4.3.5|m.49537,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008016|m.9273,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGAP_AGAP004367.1.1|m.17195,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042616|m.49103,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044824|m.51993,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TITIN.1.19|m.2116,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PTPRA.9.22|m.46547,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100210520.1.1|m.22500,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI19977.1.1|m.66449,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87336.4.9|m.23926,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100379079.4.5|m.23435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_124260.1.1|m.8355,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003069|m.3372,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CAS1_BOVIN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KARG.8.11|m.45498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024665|m.28048,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC753176.2.3|m.33553,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL002467.1.2|m.47358,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PMAR_PMAR009545.1.1|m.28734,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009697|m.11280,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC660560.1.4|m.31035,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013486|m.15438,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047294|m.55755,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KPYK.4.4|m.48513,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028737|m.32661,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA17556.1.1|m.110,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_91321.1.10|m.20278,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100369333.28.32|m.53859,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_036103|m.40829,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.15.15|m.63175,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117283.2.2|m.37544,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_64071.9.35|m.13313,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100366763.1.1|m.53709,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_79377.21.30|m.53309,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TBB2.2.2|m.53003,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LACBIDRAFT_295117.3.10|m.29879,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_POP7.1.2|m.28402,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RSSA.3.10|m.22114,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027678|m.31381,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006220|m.7061,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050222|m.59713,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018768|m.22023,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_95739.2.2|m.57592,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_75616.1.2|m.9949,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PEAR1.6.16|m.37314,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021664|m.24884,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHCHD1.1.1|m.25210,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KLLA0E01035G.1.1|m.13451,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026644|m.30335,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87864.1.1|m.23722,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374839.1.1|m.63735,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003213|m.3589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009333|m.10861,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008837|m.10279,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533411.1.1|m.37112,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042901|m.49495,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_224325.1.3|m.26136,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.84.91|m.63832,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYBX.3.4|m.53061,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100634688.5.6|m.51871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025959|m.29617,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACINU.1.1|m.9352,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048781|m.57879,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005138|m.5873,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100366892.2.3|m.51427,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016752|m.19715,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039465|m.44679,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_355490.3.22|m.9919,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM3.37.58|m.39048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100872674.2.2|m.28811,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_029942|m.33992,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100907797.3.4|m.54168,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PLXA3.1.1|m.51322,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023675|m.26925,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100636931.6.8|m.48882,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002806|m.3116,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037561|m.42354,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AT10A.1.1|m.56662,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC373275.4.7|m.47552,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025058|m.28495,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CLCN7.2.3|m.47039,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_F48E3.8.1.1|m.46349,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008926|m.10391,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014324|m.16389,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGAP_AGAP011396.1.1|m.1458,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002228|m.2410,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_355490.20.22|m.57012,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.5.15|m.18769,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.8.15|m.27209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033072|m.37776,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67741.2.2|m.37743,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC579946.14.24|m.49258,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.16.59|m.31979,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040238|m.45605,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376767.1.1|m.49887,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049771|m.59128,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FLOT1.1.2|m.21435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHD5.1.2|m.18513,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FMRF.2.4|m.37051,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RN213.10.13|m.56907,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DNAJC4.2.2|m.19500,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037938|m.42800,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS9.3.13|m.30475,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117187.2.4|m.3553,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101060411.1.1|m.54761,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CDC42.11.11|m.60002,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_001251|m.1283,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042272|m.48643,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031486|m.35972,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022951|m.26161,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026852|m.30581,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PGCB.2.2|m.43444,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000422|m.391,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL009219.4.4|m.49371,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100371228.1.4|m.6670,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ZGC_113208.1.1|m.15618,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.47.59|m.53277,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL13.4.4|m.53596,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SI_CH211-197G15.7.1.3|m.4409,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SAFB2.1.3|m.11138,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021494|m.24691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_WKK_06610.2.2|m.50131,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117284.5.7|m.53216,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PAES_2382.1.1|m.53692,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS2.8.10|m.48098,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010659|m.12347,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032666|m.37309,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RN213.8.13|m.52889,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043576|m.50359,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003783|m.4287,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040388|m.45791,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100378116.1.3|m.22707,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008509|m.9905,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AMO.5.5|m.66428,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TB11.01.6740.1.1|m.42560,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022641|m.25871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100633059.1.1|m.20098,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039943|m.45170,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048994|m.58122,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021478|m.24670,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF1A2.2.3|m.37043,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051346|m.61337,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PCDH1.3.3|m.63887,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_C1QT3.4.8|m.22821,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031210|m.35616,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026871|m.30597,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.40.59|m.46665,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_S28A3.2.3|m.7477,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023043|m.26235,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051715|m.61878,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TENA.5.5|m.43448,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002896|m.3210,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367089.2.4|m.1910,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_291510.8.9|m.51135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026679|m.30379,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027899|m.31627,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100329955.1.1|m.11340,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027703|m.31406,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G241446.1.2|m.22601,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049102|m.58220,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67264.4.6|m.42082,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037956|m.42826,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003161|m.3509,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047394|m.55871,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014279|m.16311,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_480920.2.3|m.38258,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040503|m.45959,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002467|m.2727,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100462678.2.2|m.28619,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_355490.12.22|m.45126,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TSP1.1.1|m.43967,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039208|m.44410,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100491753.1.3|m.45589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,TRFL_HUMAN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024935|m.28365,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_95073.3.9|m.27326,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033663|m.38288,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016540|m.19484,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_58035.2.2|m.65815,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024662|m.28044,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044310|m.51269,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KARG.9.11|m.50527,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI23261.1.2|m.12269,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_URIC.1.2|m.35940,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_045851|m.53508,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002407|m.2657,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013437|m.15402,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G197314.1.2|m.61421,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67258.17.18|m.57125,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014867|m.17143,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TDRD3.2.2|m.8522,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004202|m.4814,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042378|m.48796,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002707|m.2981,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009306|m.10820,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376214.9.11|m.53354,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038550|m.43669,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030744|m.35041,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020411|m.23625,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SMP_148730.1.1|m.58317,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100690874.1.2|m.62880,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013163|m.15116,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014215|m.16209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043898|m.50728,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021870|m.25105,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100906268.2.2|m.44952,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043488|m.50266,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL24.6.9|m.43124,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.1.59|m.1169,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100889159.1.3|m.11532,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM049590.1.4|m.14204,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_73101.3.4|m.32464,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048274|m.57147,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_224574.3.18|m.20799,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.28.59|m.37722,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CED1.26.29|m.53629,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG11.15.25|m.46952,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPER_GL24378.1.1|m.64285,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030794|m.35106,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_OSHV1_GP010.1.2|m.28853,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009887|m.11524,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_USO1.11.11|m.64787,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100638431.10.10|m.59513,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118054.1.1|m.18488,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM465390.1.1|m.21142,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042449|m.48875,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040481|m.45927,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHS2.1.1|m.63783,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_YL086.1.1|m.33481,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_328180.1.1|m.55509,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG11.8.25|m.39826,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100485356.1.1|m.21339,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042540|m.49007,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS4.10.11|m.60432,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INVS.2.6|m.8331,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_122381.3.4|m.23140,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RHDF1.2.3|m.45435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101067075.1.2|m.30552,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_125516.1.1|m.13150,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28568.4.9|m.21893,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000121|m.127,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RPS24.1.8|m.571,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100634184.2.3|m.15892,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CGL.1.2|m.31959,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_HBX5.1.1|m.11081,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC569612.1.1|m.18528,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100164822.1.1|m.47189,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100892516.1.1|m.38152,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CBG20816.1.1|m.49333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020507|m.23691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040513|m.45971,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282105.2.2|m.59782,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.1.15|m.2270,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100749806.3.3|m.54541,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023474|m.26716,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047907|m.56621,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008101|m.9378,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533220.2.2|m.13990,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYD88.4.7|m.31202,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039638|m.44850,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
